0001437749-24-008443.txt : 20240319 0001437749-24-008443.hdr.sgml : 20240319 20240319120047 ACCESSION NUMBER: 0001437749-24-008443 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OCULUS VISIONTECH INC. CENTRAL INDEX KEY: 0001107280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 061576391 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29651 FILM NUMBER: 24761679 BUSINESS ADDRESS: STREET 1: 837 WEST HASTINGS STREET STREET 2: SUITE 507 CITY: VANCOUVER STATE: A1 ZIP: V6C 3N6 BUSINESS PHONE: 6046851017 MAIL ADDRESS: STREET 1: 837 WEST HASTINGS STREET STREET 2: SUITE 507 CITY: VANCOUVER STATE: A1 ZIP: V6C 3N6 FORMER COMPANY: FORMER CONFORMED NAME: OCULUS VISION TECH INC. DATE OF NAME CHANGE: 20120201 FORMER COMPANY: FORMER CONFORMED NAME: USA VIDEO INTERACTIVE CORP DATE OF NAME CHANGE: 20000217 10-K 1 ovtz20231231_10k.htm FORM 10-K ovtz20231231_10k.htm
0001107280 OCULUS VISIONTECH INC. false --12-31 FY 2023 0 0 250,000,000 250,000,000 0 0 - - 0 0 500,000,000 500,000,000 91,422,569 91,422,569 91,422,569 91,422,569 0.01 0 500,000,000 91,422,569 0 0 January 29, 2024 June 10, 2024 October 14, 2024 January 31, 2025 12,500,000 false false false false expires subsequent to December 31, 2023 No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) revenue sales projections per ComplyTrust Inc.’s 5-year proformas, or 2) listing on a major US exchange, or 3) change of control. 00011072802023-01-012023-12-31 iso4217:USD 00011072802023-06-30 xbrli:shares 00011072802024-03-19 thunderdome:item 00011072802023-12-31 00011072802022-12-31 0001107280us-gaap:NonrelatedPartyMember2023-12-31 0001107280us-gaap:NonrelatedPartyMember2022-12-31 0001107280us-gaap:RelatedPartyMember2023-12-31 0001107280us-gaap:RelatedPartyMember2022-12-31 iso4217:USDxbrli:shares 00011072802022-01-012022-12-31 0001107280us-gaap:CommonStockMember2021-12-31 0001107280us-gaap:AdditionalPaidInCapitalMember2021-12-31 0001107280ovtz:CommitmentToIssueSharesMember2021-12-31 0001107280us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-31 0001107280us-gaap:RetainedEarningsMember2021-12-31 00011072802021-12-31 0001107280us-gaap:CommonStockMember2022-01-012022-12-31 0001107280us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-31 0001107280ovtz:CommitmentToIssueSharesMember2022-01-012022-12-31 0001107280us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-31 0001107280us-gaap:RetainedEarningsMember2022-01-012022-12-31 0001107280us-gaap:CommonStockMember2022-12-31 0001107280us-gaap:AdditionalPaidInCapitalMember2022-12-31 0001107280ovtz:CommitmentToIssueSharesMember2022-12-31 0001107280us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-31 0001107280us-gaap:RetainedEarningsMember2022-12-31 0001107280us-gaap:CommonStockMember2023-01-012023-12-31 0001107280us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-31 0001107280ovtz:CommitmentToIssueSharesMember2023-01-012023-12-31 0001107280us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-31 0001107280us-gaap:RetainedEarningsMember2023-01-012023-12-31 0001107280us-gaap:CommonStockMember2023-12-31 0001107280us-gaap:AdditionalPaidInCapitalMember2023-12-31 0001107280ovtz:CommitmentToIssueSharesMember2023-12-31 0001107280us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-31 0001107280us-gaap:RetainedEarningsMember2023-12-31 0001107280us-gaap:EmployeeStockOptionMember2023-01-012023-12-31 0001107280us-gaap:EmployeeStockOptionMember2022-01-012022-12-31 0001107280us-gaap:WarrantMember2023-01-012023-12-31 0001107280us-gaap:WarrantMember2022-01-012022-12-31 xbrli:pure 0001107280ovtz:RollingStockOptionPlanMember2023-12-31 0001107280ovtz:RollingStockOptionPlanMemberovtz:VestingEverySixMonthsMember2023-01-012023-12-31 0001107280ovtz:RollingStockOptionPlanMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2023-01-012023-12-31 0001107280ovtz:RollingStockOptionPlanMember2023-01-012023-12-31 0001107280ovtz:RollingStockOptionPlanMember2022-01-012022-12-31 0001107280ovtz:RangeThreeMember2023-12-31 0001107280ovtz:RangeThreeMember2023-01-012023-12-31 utr:Y 0001107280ovtz:RangeFourMember2023-12-31 0001107280ovtz:RangeFourMember2023-01-012023-12-31 0001107280ovtz:RangeFiveMember2023-12-31 0001107280ovtz:RangeFiveMember2023-01-012023-12-31 0001107280ovtz:RangeSixMember2023-12-31 0001107280ovtz:RangeSixMember2023-01-012023-12-31 0001107280us-gaap:EmployeeStockOptionMember2022-01-012022-12-31 iso4217:CADxbrli:shares 0001107280us-gaap:EmployeeStockOptionMember2022-12-31 0001107280ovtz:WarrantsExpiringOnJune42025Member2023-12-31 0001107280ovtz:WarrantsExpiringOnJune42025Member2023-01-012023-12-31 0001107280us-gaap:ForeignCountryMemberus-gaap:CanadaRevenueAgencyMember2023-12-31 0001107280us-gaap:ForeignCountryMemberus-gaap:CanadaRevenueAgencyMember2022-12-31 0001107280us-gaap:DomesticCountryMemberus-gaap:InternalRevenueServiceIRSMember2023-12-31 0001107280us-gaap:DomesticCountryMemberus-gaap:InternalRevenueServiceIRSMember2022-12-31 0001107280ovtz:ConsultingFeesMember2023-01-012023-12-31 0001107280ovtz:ConsultingFeesMember2022-01-012022-12-31 0001107280us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-12-31 0001107280us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-12-31 0001107280ovtz:SharebasedCompensationMember2023-01-012023-12-31 0001107280ovtz:SharebasedCompensationMember2022-01-012022-12-31 0001107280ovtz:ReimbursementMember2023-01-012023-12-31 0001107280ovtz:ReimbursementMember2022-01-012022-12-31 0001107280ovtz:ConsultingFeesMember2023-01-012023-12-31 0001107280ovtz:ConsultingFeesMember2022-01-012022-12-31 0001107280ovtz:VancouverCAOperatingLeaseMember2023-01-012023-12-31 0001107280ovtz:VancouverCAOperatingLeaseMember2022-01-012022-12-31
 

 

Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-K

 

ANNUAL REPORT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the fiscal year ended December 31, 2023

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

Commission file number 000-29651

 

ovtz20231231_10kimg001.jpg

 

 

OCULUS VISIONTECH INC.


(Exact name of registrant as specified in its charter)

 

Wyoming 

 

06-1576391

(State or Other Jurisdiction of 

 

(I.R.S. Employer Identification No.)

Incorporation of Organization)

  

 

#507, 837 West Hastings Street, Vancouver, BC

V6C 3N6

(Address of principal executive offices)

(ZIP Code)

 

Registrant’s telephone number, including area code:

(604) 685-1017

 

Securities registered pursuant to Section 12(b) of the Act:         None

 

Title of Each Class

Trading Symbol(s)

Name of each exchange on which registered

N/A

N/A

N/A

 

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, no par value

(Title of Class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant as required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐.

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or fur such shorter period that the registrant was required to submit such files). Yes ☒ No ☐.

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

  

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Exchange Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).  ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes No ☒.

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold as of the last business day of the registrant’s most recently completed second fiscal quarter ($0.06 on June 30, 2023) was approximately $4.0 million.

 

The registrant had 91,422,569 shares of common stock outstanding as of March 19th, 2024.

 

  

 

TABLE OF CONTENTS

 

Part 1

 

Item 1 

Description of Business

5

Item 1A

Risk Factors

15

Item 1B

Unresolved Staff Comments

22

Item 2

Description of Properties

22

Item 3

Legal Proceedings

22

Item 4

Mine Safety Disclosure

22

     

Part II

 

Item 5

Market for Registration’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

23

Item 6

Selected Financial Data

31

Item 7

Management’s Discussion and Analysis of Financial Condition and Results of Operation

32

Item 7A

Quantitative and Qualitative Disclosures About Market Risk

34

Item 8

Financial Statements and Supplementary Data

34

Item 9

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

Item 9A

Controls and Procedures

54

Item 9B

Other Information

54

Item 9C

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

54

     

PART III

 

Item 10

Directors, Executive Officers and Corporate Governance

55

Item 11

Executive Compensation

59

Item 12

Security Ownership of Certain Beneficial Owners and Management

62

Item 13

Certain Relationships and Related Transactions

63

Item 14

Principal Accountant Fees and Services

63

Item 15

Exhibits, Financial Statement Schedules, and Reports on Form 8-K

64

Item 16

Form 10-K Summary

65

 

  

 

GENERAL

 

References herein to "we," "us," and "the Company" are to Oculus VisionTech Inc. and our subsidiary.

 

Cautionary Statement regarding Forward-Looking Statements

 

This annual report on Form 10-K contains "forward-looking statements" within the meaning of the Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements made in this annual report, other than statements of historical fact, including statements addressing operating and financial performance, our products and services, including our digital watermarking technology and Cloud-based document protection system, our data privacy and data protection services and solutions, our technology, our cash needs, including our ability to fund our future capital expenditures and working capital requirements, and our expectations regarding competition and growth in our sector, are forward looking statements. Because they refer to future events or conditions, forward-looking statements may include words such as "anticipate," "believe," "estimate," "intend," "could," "should," "would," "may," "seek," "plan," "might," "will," "expect," "predict," "project," "forecast," "potential," "continue," "up to," and similar terms and phrases. Though we believe that the expectations reflected in these statements are reasonable, they involve certain assumptions, risks and uncertainties. For a discussion of the risks, uncertainties and assumptions that could affect our future events, developments or results, you should carefully review the risk factors described in "Item 1A. Risk Factors" below in this annual report, as well as "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" below in this annual report. Many of those factors are outside of our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements. All subsequent written and oral forward-looking statements concerning other matters addressed in this Report and attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this annual report. Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

 

Exchange Rate for Canadian Dollar

 

The accounts for Oculus are maintained in Canadian dollars which is the Company's functional currency. All dollar amounts contained herein are expressed in U.S. dollars, except as otherwise indicated. As at March 19th, 2024, the exchange rate for Canadian dollars/United States dollars based on the Bank of Canada closing rate was $1.00 (CAD) = $0.7393 (U.S.).

 

Set forth below are the exchange rates based on the Bank of Canada noon rates for the Canadian dollar equivalent expressed in United States currency during 2023 and 2022.

 

   

Years ended December 31,

 
   

2023

   

2022

 

At End of Year

    0.7383       0.7383  

Average

    0.7692       0.7692  

High

    0.8031       0.8031  

Low

    0.7217       0.7217  

 

 

PART I

 

Item 1.

Description of Business

 

Overview

 

Oculus VisionTech Inc. (OVTZ) is a Canadian-based development-stage technology company focused on cyber security, data privacy and data protection solutions for Enterprise business customers. Headquartered in Vancouver, British Columbia, Canada, the company was originally founded by image processing experts and is operated by experienced leadership. Our mission is to provide intelligent software tools for continual enablement of data privacy and data protection for individuals, organizations and their customers worldwide, through a vision of mutually trusted data governance compliance. Currently, OVTZ is expanding and investing in a suite of new data protection and data privacy security products that will revolutionize CCPA, GDPR, LGPD and other data privacy legislation compliance for both data subjects and data controllers worldwide. Based on the initial data protection and data privacy product development and release, new cyber security product development can commence.

 

Our Forget-Me-Yes® data privacy product is a Software-as-a-Service (SaaS) platform developed to specifically address the global ‘Right-to-be-Forgotten’ (RtbF) and Right-of-Erase (RoE) data subject deletion request legal compliance components of Brazil’s LGPD, Europe’s GDPR, California’s Consumer Privacy Act (CCPA), China’s Personal Information Protection Law (PIPL), Colorado’s Consumer Protection Act (CPA), Virginia’s Consumer Data Protection Act (CDPA) and Washington’s Privacy Act (WPA) regulations. Additional new data protection software tools are being developed to address public cloud data governance compliance globally. Our Cloud Document Protection System (Cloud-DPS) technology leverages our digital watermarking technology enabling OVTZ to offer a SaaS-based document management platform for tamper-proof document authentication and protection. Historically, we have used our digital watermarking technology for streaming video content distribution based on embedded digital watermarking, as well as video-on-demand (VOD) systems, services and source-to-destination digital media delivery solutions that allow live or recorded digitized and compressed video to be transmitted through Internet, intranet, satellite or wireless connectivity.

 

We were incorporated on April 18, 1986, as "First Commercial Financial Group Inc." in the Province of Alberta, Canada. In 1989, our name was changed to "Micron Metals Canada Corp.", which purchased 100% of the outstanding shares of USA Video Inc., a Texas corporation, in order to focus on the digital media business. In 1995, we changed our name to "USA Video Interactive Corp." and continued out of the Province of Alberta into the State of Wyoming. At a shareholders meeting held on December 30, 2011, a resolution was passed to change our name to "Oculus VisionTech Inc." and to alter our share capital by way of a reverse stock split (share consolidation) on the basis of fifteen old common shares for one new common share. On January 25, 2012, we changed our name to "Oculus VisionTech Inc." In June 2020, OVTZ acquired OCL Technologies Corp. (“OCL”), a Delaware corporation data privacy software development startup based in San Diego, California. As a 100% wholly-owned subsidiary of OVTZ and to better align with customer and market focus, OCL has completed a corporate name change to ComplyTrust® Inc. (“CTI”) on January 21, 2021. Any and all OCL references throughout this document are synonymous with the new name change, CTI.

 

Our executive and corporate headquarter offices are located at Suite 507, 837 West Hastings Street, Vancouver, British Columbia, Canada, V6C 3N6. Our telephone number is 1-800-684-0183 and our facsimile number is 604-685-5777. Our email address is contact@ovtz.com and our website is www.ovtz.com. Our common shares are listed for trading on the TSX Venture Exchange (TSX.V – OVT, OTCQB – OVTZ, FSE – USF1).

 

Business Environment and Market Opportunity

 

In this age of digital transformation, data monetization, IoT, and massive data migration to converged hyperscale, geo-disbursed Cloud infrastructure and workloads, data protection and data privacy have taken center stage. GDPR, LGPD, CCPA, and many other new international (China, India) and upcoming US data privacy regulations enable individuals and organizations the right to access and request deletion of all personal information for a given data subject. In our ever increasing Everything-as-a-Service world, OVTZ recognizes the need for global cloud-native data privacy and data protection solutions that are multi-cloud platform-ready and can augment both existing legacy and newer agile-driven architectures. Coupled with the escalating data security threat landscape and frequency of global data cyberattacks and data breaches, OVTZ understands that cyber security has taken center-stage for not only Cloud, On-premise and hybrid infrastructure data privacy requirements, but across all organizational digital application and market segments globally. OVTZ is building modular microservices-based software solutions and services for both hybrid on-premise and multi-cloud data management that incorporate automated malware, privacy and ransomware scanning, reporting, visualization and cyber threat management.

 

 

Our new Forget-Me-Yes® (FMY) Software-as-a-Service (SaaS) data privacy solution is a highly-secure, Zero-Knowledge platform providing a single-source capability of continuous ‘right-to-be-forgotten’ (RtbF) and ‘right-of-erase’ (RoE) privacy compliance by incorporating automated policy-driven re-query services that guarantees a Data Subject’s requested RtbF/RoE data remains ‘forgotten’ over the life of their FMY subscription. FMY incorporates hybrid polymorphic encryption technology that ensures all User Interface, data-in-transit and data-at-rest remain secure and can only be accessed by the subscriber. With a cloud-native architecture, the FMY functionality can be utilized as either a complete turnkey SaaS subscription platform, or individually licensed for seamless integration with existing 3rd. party applications and data privacy platforms.

 

Our new ComplyTrust® Software-as-a-Service Suite (CTSS) is a set of software tools specifically designed to address cloud-native data management and regulatory compliant data governance. CTSS will help to remove enterprise organizational barriers and blockers to further enable successful cloud migration and deployment that benefit the cloud infrastructure providers, enterprise organizations, and users collectively. CTSS helps to automate and visualize cloud compliance reporting across accounts, regions and services based on a variety of user-definable and data driven metrics.

 

OVTZ had recognized that cloud-based, digital document security/protection products were a potentially viable business opportunity for the Company that allowed us to apply our proprietary real-time digital video watermarking technology, originally developed for studios and networks in the entertainment industry, to the digital document security/protection market. Cloud-DPS secures and protects digital documents (including text documents, photos, blueprints, etc.) from any modification, and/or attempted forgery by imperceptibly watermarking documents, using real-time image processing and watermarking algorithms, embedded into a secured/protected copy of a document. This authentication and verification process ensures the integrity of the original digital document.

 

Strategic Plan

 

Our strategic plan is to first introduce the cloud-native Forget-Me-Yes® (FMY) data privacy SaaS platform under the AWS Web Services Cloud infrastructure on a monthly subscription basis for structured data. Initial release will include subscriber connections specific to Salesforce organizations with other connectors to be added over time, including but not limited to AWS RDS, Hubspot, Adobe Marketo, Shopify, and more. Additional connectors for Database-as-a-Service (DBaaS) providers for MySQL, NoSQL and SQL databases, for both structured and unstructured data, are also planned. Going forward, we plan to license FMY API microservices for integration with 3rd. party application partners, software providers and potential OEM’s. FMY’s cloud native enables it to be integrated and run under any on-premises, hybrid or alternative cloud infrastructure. Additional plans include incorporation of AI technology for automated alert management and reporting for our FMY® Reinfection Prevention Technology (RPT).

 

The ComplyTrust® SaaS Suite (CTSS) strategic plan for the data protection market is to first introduce Amazon Web Services (AWS) tools to help AWS customers better manage organizational data protection and compliance in an automated and cloud-native fashion. As customer attainment increases, additional planned CTSS features will be rolled out to perform additional applicable data governance and management functionality. Additional CTSS plans include integration with 3rd. party software providers to provide an automated single-pane-of-glass solution for enterprise organizations worldwide.

 

The Cloud-DPS plans to re-evaluate the potential addressable market and underlying architecture in an effort to define potential next steps in the Cloud-DPS evolution, has revealed, that coupled with both the limited past market adoption and technical refresh requirements, incorporation as an additional component into the CTSS cloud-native toolset will require a significant development investment.

 

Proprietary Technologies

 

Our Forget-Me-Yes® patent-pending process locates, organizes and manages Data Subject RtbF and RoE personal information for FMY subscribers in a secure, efficient and persistent way. Automated and schedule compliance enables organizations to avoid regulatory distraction to focus on core business competencies. Our FMY zero-knowledge 3rd. party audit features provide arguable good faith and best practices to avoid litigation, fines, penalties and potential brand damage associated with bad publicity surrounding a data privacy compliance infraction.

 

 

Our DPS technology ‘personalizes’ protected documents, based on their content, thereby creating a format invariant watermarking system. A document converted into a PDF document is encrypted before delivery, such that it cannot be opened without providing proper credentials. The result is that a document watermarking system can be offered as a cloud-based software service that can:

 

 

Protect - Accept any incoming document through a web portal, watermark it and return the watermarked document as a PDF document.

 

Authenticate - The "document authenticator" is also a cloud-based software service that can accept the watermarked document and validate the authenticity of the documents.

 

 

Our DPS technology combines the access control security for electronic documents, forensic grade anti-tampering technology based on the document's content "understanding", and optional data storage into a single, unique solution. Because of its cloud-based scalable architecture, the DPS has potential to expand and grow into a complete document management, security and storage eco-system within the CTSS product suite along with FMY-specific unstructured data privacy scanning capabilities. However, DPS will require a re-architectural investment for potential integration into our new cloud native solutions.

 

Products and Services

 

Our principal products are our new Forget-Me-Yes® (FMY) data privacy SaaS solution and CTSS data protection tools, along with our legacy Cloud-DPS solution.

 

Forget-Me-Yes® (FMY)

 

The Forget-Me-Yes® (FMY) Software-as-a-Service Platform specifically manages both Organizational and Individual Right-to-be-Forgotten (RtbF) and Right-of-Erase (RoE) compliance of data subject deletion requests of structured data for Brazil’s LGPD, Europe’s GDPR, California’s Consumer Privacy Act (CCPA), China’s Personal Information Protection Law (PIPL), Colorado’s Consumer Protection Act (CPA), Virginia’s Consumer Data Protection Act (CDPA) and Washington’s Privacy Act (WPA) regulations. At the end of 2023, the United States now have 12-states with enacted data privacy regulations.

 

 

Features include easy integration, in-time and automated continuous compliance all from a secure subscription-based cloud-native application.

 

Locates, organizes and manages Data Subject personal information for FMY subscribers in a secure, efficient, and persistent way.  

 

Automated/scheduled compliance enables organizations to avoid regulatory distraction to focus on core business competencies.

 

Secure, zero-knowledge 3rd. Party audit features ensuring regulatory compliance.

 

Provides arguable good faith and best practices for companies to avoid litigation, penalties and brand damage associated with bad publicity.

 

FMY enables secure discovery and delete requests against multiple data sources, ensuring the data subject is never inadvertently “remembered FMY securely stores a single record of each data subject query request data to meet GDPR, LGPD and CCPA regulatory compliance. The open API-first design structure of FMY enables quick and seamless integration of future new US and global privacy law compliance regulations, along with the ability to be licensed for 3rd party application and platform integration.

 

ComplyTrust® SaaS Suite (CTSS)

 

The CTSS initial product offering was designed to help AWS Cloud Backup customers with cloud-native compliance and operational efficiency while facilitating significant new cloud services opportunities for the public cloud sales teams directly. Additional planned CTSS optional tools include both cyber security and data privacy tools for a variety of cloud services providers that will include AWS, Azure, Google and other platforms.

 

Cloud-DPS

 

Our Cloud-based DPS web service system architecture enhances already existing storage and collaboration solutions such as Box, DropBox and Google Drive, and more, by adding document tamper-proof protection and workflows such as document sign-offs, authentication, secure distribution and collaboration. The Cloud-DPS technology can be deployed and scaled in wide range of vertical markets such as Corporate agreements/contract management, IP protection, Real Estate contract management, HealthCare and Law Enforcement secure document management and a wide variety of Aerospace, Automotive and Engineering industrial applications.

 

 

Although the Cloud-DPS product had been previously available under a subscription-based licensing model, after undergoing an engineering/architectural review to determine effort to modernize the underlying code-base into a cloud-native-based application that could also be bundled/integrated into and with the CTSS platform, Cloud-DPS will remain in its current stand-alone state.

 

Customers and Markets

 

OVTZ intends to capture a significant portion of the cloud data privacy software and cloud native data protection service revenues within the $76B 2023 worldwide data protection market through a variety of OVTZ-developed cloud-native software tools within a 5-year timeframe. Global regulatory enforcement of data privacy legislation issued fines are breaking records each year, are non-insurable losses, and create unparalleled brand damage. The worldwide 2023 FinTech market fines of $5.8B increased by 57% from the previous year. OVTZ helps global organizations and individuals cost-effectively manage data privacy compliance. Currently OVTZ has no customers for our products and services. We are taking steps to finance and monetize our new cloud-native CTSS and FMY solutions, as well as the legacy Cloud-DPS technology in FY24.

 

Forget-Me-Yes® (FMY)

 

FMY potential addressable markets cover a wide variety of data governance, data management, data privacy and data protection segments.

 

 

Global Enterprise Governance, Risk and Compliance (eGRC) 2023 market size was valued at $54.6B with a 13.8% CAGR reaching over $134B by 2030 (Source: GrandviewResearch)

 

GDPR services market alone is projecting 20% CAGR with revenues at $3.6B in 2023, with the GDPR Data Governance market projecting 20% CAGR with revenues to reach $6B by 2026 (Source: Markets&Markets)

 

Global Enterprise data management platform market size of $98B in 2023 is forecasting a 12% CAGR (Source: GrandviewResearch)

 

Global Regulatory Technology (RegTech) market size of $12.3B in 2023 is forecasting a 24% CAGR thru 2026 (Source: Research&Markets)

 

Data Privacy Management FY23 revenues were $2.7B and are expected grow 40% annually thru 2026 (Source: FortuneBusinessInsights)

 

Initial FMY target market segment and customers will be Salesforce CRM organizations. Salesforce FY23 revenues were $31.3B, up 11% from prior year, with FY24 revenue guidance to $34B. With over 2,000 partners and 150,000 customers worldwide across every vertical market segment, Saleforce is the #1 CRM platform worldwide. Top-10 customers include Accenture, Amazon Web Services, American Express, American Red Cross, CapGemini, Canon, Deloitte, IBM, NBC Universal, L’Oreal Americas and Toyota. Our initial FMY beta release was validated by The Corrao Group, who is the #5th. ranked Salesforce consulting partner worldwide. Additional initial FMY targets will be cloud DevOps service providers seeking to reduce compliance risk and Database-as-a-Service (DBaaS) providers.

 

ComplyTrust® SaaS Suite (CTSS)

 

CTSS potential addressable market opportunities cover a wide range within the data management and data protection segments.

 

 

Worldwide public cloud service revenues were $599B in FY23, with a forecasted 21% growth in FY24 (Source: Gartner, SynergyResearch)

 

Worldwide FY23 public cloud market shares were AWS-33%, Azure-23%, AliBab-4%, GCP-11%, Other-29% (Source: Statista)

 

Worldwide FY23 cloud data storage market was $99.2B, forecasted to be $234B by 2028 (Source: Markets&Markets)

 

Worldwide FY23 public cloud revenue represents only 7.8% of overall IT FY23 spend of $4.7Trillion. (Source: Gartner)

 

Enterprise business FY23 workloads were 55% within public cloud and 45% in private cloud (Source: Gartner)

 

Worldwide data protection market FY23 revenues were $136B, with a forecasted 16.1% CAGR thru 2029 (Source: MMR)

 

Worldwide cloud backup and recovery market segment was $13.5B in 2023, driven by an $9.6B FY23 Disaster Recovery-as-a-Service (DRaaS) market, forecasting a 27% CAGR thru 2028. (Source: BusinessResearch, Gartner)

 

 

Initial CTSS customer focus will be within the cloud-native AWS segment within specific vertical markets including Aerospace, Financial Services, Genomics, Healthcare and Transportation. Follow-on cloud-native service enhancement targets include Azure, Digital Ocean, GCP, Rstor and Wasabi. Future CTSS offerings will include integration with other 3rd. party ISV’s and more.

 

Cloud-DPS

 

The original principal market for our Cloud-DPS product and services were businesses requiring digital document protection, authentication and storage. However, recent developments in the overall ‘digital watermark’ market lends a need to re-assess the current Cloud-DPS technology applications.

 

 

Worldwide digital signature and document services market has a forecasted growth of 34% Y/Y that reached $5.2B in 2023. (Source: PrecedenceResearch)

 

DocuSign owns 56% of the worldwide digital document market, with their closest competitors Adobe (12.4%), SmartWaiver (9.9%), SignRequest (7.7%), HelloSign (3.6%), SignNow (2.7%), Nitro (2.4%) and a variety of others that represent the remaining 5.3% of total market share. (Source: 6Sense)

 

Worldwide virtual data room (VDR) market was $2.2B in FY23 forecasted to approach $7B by 2030 (Source: imarcgroup)

 

Worldwide OTT content market revenues hit $450B in FY22 while losing an estimated 20% of revenues to content piracy (Source: Deloitte)

 

Worldwide automated content recognition market hit $4.3B in FY23 and is forecasted to reach $15.7B by 2026. (Source: BusinessResearch)  

 

Potential new applications for Cloud-DPS technology include audio/audience monitoring marks, content integrity, content protection, forensics, reverse-image search, user tracing and most recently package identification, tracking and monitoring. One example is the recent ‘HolyGrail’ pilot project sponsored by the World Wildlife Fund, which is targeting businesses, government, individuals and industry for application of digital watermarks on post-consumer packaging for eco-friendly, Smart-City recycling of the high-volume plastic waste. The underlying digital watermark technology in Cloud-DPS could also be a potential candidate for the Digital Watermarks Initiative that strives for No Plastics In Nature by 2030 and supports seventeen (17) of the United Nations Sustainable Development Goals (SDG’s). To-date, there are over 80+ participants in the HolyGrail2.0 project striving for viability, with Digimarc taking the lead with an announcement in late 2023 of an initial deployment throughout France in 2024.

 

CyberSecurity

 

Cybersecurity is the practice of protecting local on-premise, hybrid, private and public Cloud infrastructure (data, data centers, hardware, software) that are connected to the internet, from any unauthorized access.

 

Cybersecurity is a broad field of disciplines that fall under these seven main pillars:

 

 

Application Security (AppSec) > Security strategy protecting web applications by finding, fixing and preventing security vulnerabilities as part of a data-drive software development/deployment automation process. $9.1B in FY23 revenues with a 14.9% AGR thru 2032. (Source: imarcgroup)

 

 

Cloud Security (CloudSec) > Security strategy that includes cybersecurity controls, policies, services to protect an organization’s entire cloud deployment. $40.7B in FY23 revenues with a 9.1% AGR thru 2028 (Source: Markets&Markets)

 

 

Endpoint Security (EDR) > Security strategy for secured communication with physical devices connected and exchanging information externally with the network (desktop computers, embedded devices, IoT devices (appliances, cameras, lighting..) mobile devices, servers, virtual machines). $13.6B in FY23 revenues with a 9.5% AGR thru 2030. (Source: FortuneBusinessInsights)

 

 

IoT Security > Security strategy for secured communication with non-standard computing devices that connect wirelessly (AMQP, Bluetooth, CoAP, DDS, HTTP, MQTT, OPCUA, Websocket, XMPP) to the internet. Examples include autonomous tractors, autonomous vehicles (autos, buses, planes, trains), chiller monitors, fingerprint timeclocks, glucose monitors, robots, smart everything (glasses, lamps, lighting, locks, mirrors, phones, refrigerators, security, speakers, thermostats, toys, traffic signals, TV’s, wearables and more. $20.9B in FY23 revenues with a 23.1% AGR thru 2028. (Source: Markets&Markets)

 

 

Mobile Security (MobSec) > Security strategy for secured communication and protection for and with external users/endpoints that include smartphones, tablets, laptops and associated network. $8.3B in FY23 revenues with a 20% AGR thru 2030. (Source: GrandviewResearch)

 

 

 

Network Security (NetSec) > Security strategy that protects the entire network from breaches, intrusion and threats via a combination of access control, antivirus, application security, analytics, endpoint protection, firewalls, VPN encryption, web, wireless and more. $22.5B in FY23 revenues with a 14.8% AGR thru 2032. (Source: EMR)

 

 

Zero Trust > A security strategy that implements a set of principles (assume breach, least-privilege-access, verify explicitly) to implement a trust-by-exception that is not reliant on any specific product or service. $31.1B in FY23 revenues with a 16.9% AGR thru 2028. (Source: Markets&Markets)

 

Even with a .025% addressable market capture, there is a very large potential addressable market opportunity for the development and integration of specific cybersecurity capabilities and disciplines within the CTSS and FMY frameworks, but will require a significant new round of funding in 2024.

 

Materials and Supplies

 

We are actively in the process of building and implementing an integrated, highly-secure, agile software development and IT operations (DevSecOps) framework in conjunction with an independent 3rd party managed services and infrastructure provider. Our continuous integration/continuous delivery (CI/CD) pipeline process incorporates agile software development, test, QA and release tools, includes embedded security within our entire development and operations lifecycle. All components of our integrated project management and software development release process, inner-company and external communications processes, utilize state-of-the-art subscription-based software tools. All components and services employed by our company include backup/disaster recovery and high-availability infrastructure, processes and services. Both corporate and application-specific ISO/NIST security certifications and training are planned, as they will be required to successfully engage with our targeted Enterprise-class customers and markets. There are no seasonal limitations on our operations.

 

Competition

 

To successfully launch our products and services and derive revenues from our technology, we face competition from a number of companies with more established products and services within all our market sectors. Our specific key product technology differentiators, go-to-market efficiencies that clearly demonstrate OPEX cost benefits, will drive acceptance, adoption and relevance to meet and realize forecasted revenues. To the best of our knowledge and understanding of our competitive landscape, there are no seasonal limitations applicable. 

 

 

Forget-Me-Yes® (FMY)

 

 

OneTrust > Founded in 2016, with over $400M in FY23 revenues and a reduced valuation of $4.5B (private), OneTrust is the leader in both data privacy management market share and revenues. Average subscription cost ranges from $27./month - $500./month+.

 

 

TrustArc > Founded in 1997, with over $49,4M in FY23 revenue, acquired Nymity for their data privacy management platform. Average subscription cost is available by custom quotation only.

 

 

BigID > Founded in 2015, with over $105M in FY23 revenue and a $1.25B valuation. Average subscription cost is available by custom quotation only.

 

 

ControlCase > Founded in 2004, with over $37.4M in FY23 revenues, are primarily focused on credit card PCI-DSS compliance. Average subscription cost starts at $500.+/month.

 

 

Privitar > Founded in 2014, with $15M in FY23 revenues, are primarily focused on Average subscription cost is available by custom quotation only.

 

All above competitors have ISO/NIST and other regulatory compliant data management certifications.

 

ComplyTrust® SaaS Suite (CTSS)

 

 

Daegis/OpenText > Originally founded in 1980 and acquired by OpenText in 2015 posted a record $4.5B in FY23 revenues, is primarily focused on Enterprise information management and data governance solutions.

 

 

StoredIQ > Founded in 2001, acquired by IBM in 2012, spun off into Breakwater Solutions in 2021 and now acquired by Repario in 2023, with estimated $13.4M in FY23 revenues, with new focus on data privacy and eDiscovery.

 

 

Tibco > Founded in 1997, posted a record $1B in FY23 revenues, with primary focus on Enterprise data governance.

 

 

Varonis > Founded in 2005, with revenues of $99M in FY23, their primary focus is data security.

 

Cloud-DPS

 

Document Management-specific competitors

 

 

Adobe Doc Cloud > Founded in 2006 with revenues of $2.7B in FY23, is a close contender as the e-signature market share leader.

 

 

Docusign > Founded in 2003 with revenues of $2.7B in FY23, shares the overall lead market share with Adobe.

 

 

HelloSign > Founded in 2010 and acquired by Dropbox in 2019, reported revenues of $10M in FY23, primarily focused on digital document storage.

 

 

MSB Docs > Founded in 2003 with estimated FY23 revenues of $17.6M, signed a partnership with AuthBridge in December 2020 to provide an AI-driven OCR digital document signature solution.

 

 

OneSpan > Founded in 1991, a member of the FIDO Alliance and a partnership with Salesforce, reported FY23 revenues of $230M, and is primarily focused in the financial document management market.

 

 

SignNow > Founded in 2011 with estimated FY23 revenues of $22.4M, are primarily focused in the Healthcare document management market.

 

 

 

 

Digital Watermark-specific competitors

 

 

Digify > Founded in 2011, a GMA New Media subsidiary, with estimated FY23 revenues of $3.9M, is partnered with Samsung (SEPCO) and primarily focused on mobile application content management.

 

Digimarc > Founded in 1995 with record $34.9M in FY23 revenues, is the leader in digital identity management for all forms of media.

 

Ipsos > Founded in 2008, acquired IntraSonics in 202l, with estimated FY23 revenues of $2.4B, is primarily focused on digital audio watermarking.

 

Sivisoft > Founded in 1997 and after acquiring Wetstone Technologies in 2022, with estimated FY23 revenues of $7.2M, is focused in the cyber security/computer forensics market.

 

Vimeo > Launched in 2004 and acquired by IAC in 2016, posted revenues of $417M in FY23 and is focused on ad-free video sharing/streaming platform.

 

Current participating members in the HolyGrail-2 Digital Watermark Project cross-value chain initiative are APK, Arburg, Arca, Arla, AveryDennison, Azul, BASF, Beiersdorf, Berry, Borealis, Bosch, Braskem, CCL, Ceflex, Citeo, City of Copenhagen, ClosedLoop, Coca-Cola, Colgate-Palmolive, Constantia, DagSam, Danon, Dansk, Digimarc, DM, Dow, Elif, Elopak, Esko, Essity, Expra, FiliGrade, Finat, FlintGroup, Foboha,, Formika, FujiSeal, General Mills, Gizeh, Graham, Greiner, GS1, Henkel, HL-Repro, HTP, Indorama, Intermat, IPL, ITC, Jabil, Johnson & Johnson, Jokey, Kellog’s, Kellpo, Kiefel, Korsini, KraftHeinz, L’OREAL, MacDermid, Masterpress, MikoPac, Milliken, Mondelez, Mondi, MSS, Muller, Nestle, NYCO, Orkla, PAC, Paccor, ReturPack, PepsiCo, Proctor&Gamble, Reclay, Rewe, Reynders, Rossman, Scibic, SaicaFlex, Saueressig, Seeberger, SGK, Schulstad, Schwartz, Siegwerk, Sleever, Sonoco, Storaenso, Styrenics, Suez, Sulayr, Sun Chemical, TetraPak, Tomra, Unilever, Ghent University, Vandemoortele, Veolia, Verpa, Viappiani, Wipak, Wrap and more.

 

Cybersecurity

 

Potential Competitor Examples

 

 

Palo Alto Networks > Founded in 2005 with $6.9B in FY23, $97B market cap.

 

Crowdstrike > Founded in 2011 with $28B in FY23 revenues, $75B market cap.

 

CheckPoint > Founded in 1993 with $664M in FY23 revenues, $18B market cap.

 

Okta > Founded in 2009 with $2.1B in FY23 revenues, $17B market cap.

 

CyberArk > Founded in 1999 with a $751M in FY23 revenues, $11B market cap.

 

Qualys > Founded in 1999 with a $554M in FY23 revenues, $6B market cap.

 

Veronis > Founded in 2005 with a $499M in FY23 revenues, $5B market cap.

 

Research and Development

 

Our current research and development is split between our Cloud-DPS ‘Wavelet’ digital watermark adaptive content protection technology and our new CTSS and FMY cloud-native microservices technology.

 

Forget-Me-Yes® (FMY)

 

 

Cloud-native data extraction query engine(s) for Extract-Transform-Load (ELT) and Extract-Load-Transform (ELT) processing of both structured and unstructured data

 

Zero-knowledge symmetric encryption services

 

Cloud-native AI-driven bulk ingress/egress data processing services engine

 

Cloud-native multi-cloud services alerting/logging AI-driven engine

 

CTSS ComplyScan® (CS)

 

 

Cloud-native backup compliance reporting

 

Backup snapshot validation services

 

Snapshot metadata indexing

 

Multi-cloud DR services

 

Cloud-DPS

 

 

Image (Radiology-Xray) and Photo content protection for mobile Healthcare and Social Media markets

 

Mobile (Android/iOS) content security manager for Google Play store download

 

Block chain capable Consumer Package tagging/watermarking for sorting and cross-value chain product management

 

Our fiscal 2023 research and development expenditures were $95,884.

 

 

Acquisition of ComplyTrust Inc. (formerly OCL Technologies Corp.)

 

On June 5th, 2020, the Company completed the acquisition of 100% of the shares of ComplyTrust Inc. (“CTI”), formerly OCL Technologies Corp. (“OCL”), www.ocltechnologies.com, a Delaware Corporation, with its head office located in the technology hub of San Diego, California. CTI is specifically focused on providing enterprise organizations and individuals with highly-secure data privacy tools that provide sustained and continuous global regulatory compliance of data subject rights, while independently protecting all parties. With the burgeoning growth of privacy regulation worldwide coupled with strict regulatory oversight, companies are dedicating significant resources to achieve and maintain compliance. In the past two years alone, initiatives such as the EU GDPR (General Data Protection Regulation effective May 25, 2018) as well as the CCPA (California Consumer Privacy Act passed June 28, 2018 and effective January 1, 2020) have mandated privacy rights and data protection for entities and individuals contemplated within their legislative frameworks. In addition to these, there are additional data privacy legislative initiatives on-going in Asia and both North and South America which will require data protection solutions. Oculus believes that the acquisition of CTI is a tremendous fit within its core objective of developing robust cutting-edge technologies that address focused customer data protection requirements on a global scale.

 

Consideration for the acquisition of CTI was 12,500,000 common shares of the Company and 12,500,000 share purchase warrants exercisable for a period of five years from date of issuance. The share purchase warrants are exercisable only upon specific performance criteria being met. Such criteria being 1) targeted revenue sales projections met, or 2) listing on a major US exchange, or 3) change of control as defined below:

 

 

i.

Meeting sales forecasts:

 

 

-

(100V/$125,000,000) of the warrants shall vest on June 4, 2021 (2022 and 2023), wherein “V” is the Gross Revenue of the business (as hereinafter defined) between the period June 4, 2020 – June 4, 2025;

 

 

-

“Gross Revenue” means all monetary sums earned less any credits issued for returns and allowances, and, for certainty, Gross Revenue does not include Deferred Revenue;

 

 

-

eg: if the CTI warrant holders earn 60% of projected revenue in Year 1 then all option holders would also vest 60% .

 

 

ii.

the listing of the Company on any national securities exchange registered with the United States Securities and Exchange Commission under section 6 of the United States Securities Exchange Act of 1934, as amended, such as, but not limited to, the New York Stock Exchange, the NYSE American, and NASDAQ Stock Market; or

 

 

iii.

a Change of Control Event meaning, with reference to the Company: (a) the acquisition of a sufficient number of voting securities in the capital of the Company so that the acquirer (as referenced in the CTI Share Purchase Agreement dated for reference June 5, 2020) becomes entitled, directly or indirectly, to exercise more than 50% of the voting rights attaching to the outstanding voting securities in the capital of the Company (provided that, prior to the acquisition, the acquirer was not entitled to exercise more than 50% of the voting rights attaching to the outstanding voting securities in the capital of the Company); (b) an occurrence when a majority of the directors elected at any annual or extraordinary general meeting of shareholders of the Company are not individuals nominated by the Company’s then-incumbent board; or (c) sale of one or more assets of the Company (but for certainty excludes sales made in the normal course of Business) after the Closing Date (as defined in the CTI Share Purchase Agreement) resulting in the collection of monetary sums that is collectively more than 50% of the Gross Revenue of the Company during the twelve (12) month period immediately preceding the Closing Date (as defined in the CTI Share Purchase Agreement).

 

 

Intellectual Property

 

Our success is dependent, in part, upon our proprietary technology. We generally rely upon patents, trademarks, and trade secret laws to establish and maintain our proprietary rights in our technology products and services.

 

On June 19, 2001, United States Patent Application No. 09/884,787, "Method and Apparatus for Digitally Fingerprinting Videos", was officially filed with the U.S. Patent and Trademark Office. This patent is for "MediaSentinel™". This patent expired in February of 2010. At this time, we have elected not to patent our Cloud-DPS technology until additional software development review is initiated to determine Cloud-DPS refresh requirements to be viable in today’s cloud-native world.

 

Potential patent-pending technology encompassing the Forget-Me-Yes® data privacy architecture includes our hybrid Zero-Knowledge data security process along with proprietary query engine and automated re-query services processes.

 

In October 2020, trademark applications were made by OVTZ for both Forget-Me-Yes® and ComplyTrust® and was formally accepted and granted in November 2021. Additional trademark application for ComplyScan® was accepted and granted in June 2022.

 

Laws and Regulations

 

Our operations are or may be subject to various international, federal, provincial, state and local laws, regulations and recommendations relating to the marketing of products and relationships with data protection, intellectual property protection, the export of technology products to certain countries and privacy protection. Although we believe that we are compliance with all international, federal, provincial, state and local regulations, the risk of claims and actions against us for breach of the aforesaid laws cannot be eliminated completely. In the event of a breach of these laws, we could be held liable for any damages that result. The amount of such damages could have a materially adverse effect on our results of operations and financial condition.

 

Employees

 

We currently have no employees, as we primarily engage independent contractors to provide services as necessary. Compensation for current and future work will be conducted on a contract basis. 

 

The loss of the services of any key OVTZ management could have a materially adverse effect on the Company. We do not maintain key man life insurance on the life of its officers. In addition, our future success will depend in part upon its continuing ability to hire, train, motivate and retain key senior management and skilled technical and marketing personnel. Competition for technical personnel in the industry we compete in is intense. Our future success will depend in part on our continued ability to contract, assimilate and retain qualified personnel. To date, we have had limited success in recruiting qualified contractors, but there is no assurance that we will continue to do so in the future. Attracting qualified expertise is contingent on raising sufficient working capital and project advancement.

 

Oculus' Website

 

Our website address is https://ovtz.com/. Information found on our website is not incorporated by reference into this annual report. We make available free of charge through our website our Securities and Exchange Commission ("SEC"), filings filed pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after it electronically files such material with, or furnish it to, the SEC through its website on EDGAR www.sec.gov/edgar/search-and-access. We will also make available all financial reports filed in accordance with United States generally accepted accounting principles ("US GAAP") on SEDAR through its website https://sedar.com/. We invite investors and interested parties to sign up for "Email Alerts" on our website to receive information such as press releases as they become available.

 

 

 

Item 1A.

Risk Factors.

 

Our business and operations are subject to a number of risks and uncertainties as described below. However, the risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we may currently deem immaterial, may become important factors that harm our business, financial condition or operations. If any of the following risks actually occur, our business, financial condition or operations could suffer.

 

Impact of Pandemics

 

Pandemics, epidemics or outbreaks of an infectious disease in Canada or worldwide, including COVID-19 or any other similar illnesses, could have an adverse impact on the Company’s results, business, financial condition or liquidity.

 

On March 11, 2020, the World Health Organization declared the outbreak of a strain of novel coronavirus disease, COVID-19, a global pandemic. The COVID-19 pandemic has negatively impacted the Canadian, U.S., and global economies; disrupted Canadian, U.S., and global supply chains; disrupted financial markets; contributed to a decrease in interest rates; resulted in ratings downgrades, credit deterioration and defaults in many industries; forced the closure of many businesses, led to loss of revenues, increased unemployment and bankruptcies; and necessitated the imposition of quarantines, physical distancing, business closures, travel restrictions, and sheltering-in-place requirements in Canada, the U.S., and other countries. If the pandemic is prolonged, including through subsequent waves, or if additional variants of COVID-19 emerge which are more transmissible or cause more severe disease, or if other diseases emerge with similar effects, the adverse impact on the economy could worsen. Moreover, it remains uncertain how the macroeconomic environment, and societal and business norms will be impacted following this COVID-19 pandemic. Unexpected developments in financial markets, regulatory environments, or consumer behavior may also have adverse impacts on the Company's results, business, financial condition or liquidity, for a substantial period of time.

 

The COVID-19 pandemic has also created additional operational risks for the Company, including the need to provide enhanced safety measures for its employees and customers; comply with rapidly changing regulatory guidance; address the risk of, attempted fraudulent activity and cybersecurity threat behavior; and protect the integrity and functionality of the Company's systems, networks, and data as a larger number of employees work remotely. The Company is also exposed to human capital risks due to issues related to health and safety matters, and other environmental stressors as a result of measures implemented in response to the COVID-19 pandemic, as well as the potential for a significant proportion of the Company's employees, including key executives, to be unable to work effectively, because of illness, quarantines, sheltering-in-place arrangements, government actions or other restrictions in connection with the pandemic.

 

The extent to which the COVID-19 pandemic continues to impact the Company's results, business, financial condition or liquidity will depend on future developments in Canada, the U.S. and globally, including the development and widespread availability of efficient and accurate testing options, and effective treatment options or vaccines. Despite the approval of certain vaccines by the regulatory bodies in Canada and the U.S., the ongoing evolution of the development and distribution of an effective vaccine also continues to raise uncertainty.

 

Our limited operating history makes it difficult to evaluate our business and prospects.

 

We have a very limited operating history in the context of document protection products and services and have yet to develop an extensive record regarding the sale of our products and services. As a result, our ability to accurately forecast our future operating results is limited and subject to a number of uncertainties, including our ability to:

 

 

·

maintain or develop relationships with suppliers and marketing partners;

 

·

establish a customer base;

 

·

continue to develop and upgrade our technology, products and services;

 

·

provide superior customer service;

 

·

respond to competitive developments; and

 

·

retain and motivate qualified personnel.

 

 

In addition, we have and will continue to be subject to the risks and uncertainties frequently experienced by growing companies in rapidly changing industries. If our assumptions regarding these risks and uncertainties are incorrect or change due to market factors, or if we are unsuccessful in addressing these risks, our business could suffer.

 

We have incurred substantial losses; we expect to incur losses in the future and may never achieve profitability.

 

To date, we have not generated a profit or significant revenue from operations and in fact have incurred substantial losses. For the year ended December 31, 2023, we maintained $89,768 of working capital deficiency and sustained a net loss of $591,212 and had an accumulated deficit of $48,386,646.

 

Management has forecasted the Company will not have sufficient working capital to operate for the ensuing 12 months. We intend to fund operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management. As a result, we expect operating losses and negative cash flows to increase for the foreseeable future.

 

If we are unable to obtain substantial additional financing, we may not be able to remain in business.

 

We require substantial working capital to fund our business. We have had significant operating losses and negative cash flow from operations since the inception of our current business and expect to continue to do so for the foreseeable future. Our capital requirements will depend on several factors, including our ability to establish and expand a client base, to grow our sales and to employ effective marketing efforts. Our capital needs will also be influenced by the rate of market acceptance of our products and services.

 

We expect that we will require approximately $3,000,000 to $5,000,000 in financing to expand the research and development, and marketing of ComplyTrust’s suite of products in 2024, and further financing thereafter. If our capital requirements vary materially from those currently planned, we may require additional financing. We have no arrangements or commitments for any financing. Financing may not be available when needed on terms favorable to us, or at all. If adequate funds are not available or are not available on acceptable terms, we may be unable to further develop or enhance our products and services, take advantage of future opportunities or respond to competitive pressures, or ultimately, to remain in business.

 

Our operating results in future periods are expected to be subject to significant fluctuations, which would likely affect the trading price of our common shares.

 

Our quarterly and annual operating results are likely to fluctuate significantly in the future due to a variety of factors, many of which are outside of our control. Some of these factors include:

 

 

·

our ability to attract and retain customers;

 

·

the introduction of new enhancements in digital watermarking;

 

·

price competition;

 

·

our ability to remain competitive in our product and service offerings;

 

·

our ability to attract new personnel; and

 

·

U.S. and foreign regulations relating to the Internet.

 

As a result of the factors listed above, and others, period-to-period comparisons of our operating results may not be meaningful in predicting our future performance. It is possible that our operating results will not meet market expectations in some future quarter or quarters, which would likely result in a significant decline in our stock price.

 

The data privacy and data protection markets are highly competitive, and our failure to successfully compete will limit our ability to attain, retain and increase our market share.

 

The data privacy and data protection markets are rapidly evolving and extremely competitive. We expect competition to intensify in the future. We compete with companies that provide all or certain aspects of our services, including other data privacy and data protection providers and data-management companies. Our current market share is insignificant.

 

The data privacy market is currently dominated by a small number of larger revenue-bearing companies, while the data protection market includes a wide variety of small, medium and large providers in many different vertical segments. Most of our competitors have longer operating histories, larger customer bases, stronger brand recognition and significantly greater financial, marketing and other resources than us. In addition, larger, well-established and well-financed entities may acquire, invest in or form joint ventures with online competitors as the use of online cloud services increases.

 

 

The document protection market is highly competitive, and our failure to compete successfully would limit our ability to retain and increase our market share.

 

The cyber document security, and its superset, cyber data security are rapidly evolving and extremely competitive sectors and we expect that competition will intensify in the future. We compete with other companies that provide all or certain aspects of our services, including other cyber/document protection systems based on document digital watermarking, and others, and expect that additional competition in the future will be provided by those types of providers. Our current market share is insignificant.

 

The document protection market is currently dominated by a small number of larger companies, including ContractBook, DocHub, DocuSign, HelloSign, PandaDoc, RightSignature, SignNow and others. Most of our competitors have longer operating histories, larger customer bases, stronger brand recognition and significantly greater financial, marketing and other resources than us. In addition, larger, well-established and well-financed entities may acquire, invest in or form joint ventures with on-line competitors as the use of the Internet-centric, Cloud-based cyber document security services increases. In addition, cyber document security and cloud document management technologies and the expansion of existing B2B and B2C document protection technologies are expected to result in additional competition.

 

We may not be able to compete successfully against current and future competitors, and the inability to do so could decrease our revenues, prevent us from achieving profitability and adversely affect our ability to establish, maintain and increase our market share.

 

The video digital watermarking business is highly competitive, and our failure to compete successfully would limit our ability to retain and increase our market share.

 

The video digital watermarking market is rapidly evolving and extremely competitive. We expect competition to intensify in the future. We compete with companies that provide all or certain aspects of our services, including other media-streaming providers, content encoders, video production companies, and Internet data-management companies. Our current market share is insignificant.

 

The video digital watermarking market is currently dominated by a small number of larger companies, including Irdeto, Nagra, Synamedia and Verimatrix. Most of our competitors have longer operating histories, larger customer bases, stronger brand recognition and significantly greater financial, marketing and other resources than us. In addition, larger, well-established and well-financed entities may acquire, invest in or form joint ventures with online competitors as the use of the Internet and other online services increases. In addition, new automatic content recognition (ACR) technologies and the expansion of existing technologies are expected to result in additional competition.

 

We may not be able to compete successfully against current and future competitors, and the inability to do so could decrease our revenues, prevent us from achieving profitability and adversely affect our ability to establish, maintain and increase our market share.

 

We are subject to rapid technological change, which could render our products and services obsolete.

 

Our future success will depend in part on our ability to offer products and services that incorporate leading technology and address the increasingly sophisticated and varied needs of our current and prospective customers. Our market is characterized by rapidly changing and unproven technology, evolving industry standards, changes in customer needs, emerging competition and frequent new service introductions. These changes and developments may render our products and technologies obsolete in the future. As a result, our success depends on our ability to adapt to these changes, particularly to develop new products and services, adapt our current products and services or to acquire new products and services that can compete successfully. There can be no assurance that we will be successful in these efforts.

 

In addition, future advances in technology may not be beneficial to or compatible with our business and we may not be able to incorporate technological advances into our products and services in a cost-effective and timely manner. Keeping pace with technological advances may require substantial expenditures and lead time, particularly with respect to acquiring updated hardware and infrastructure components for our systems. We may require additional financing to fund such purchases. Any such financing may not be available on commercially reasonably terms, if at all, when needed and may result in a loss of earnings and market share.

 

 

We are dependent upon vendors and other third-party service provider and will be competing with some of these companies.

 

We are and will continue to be dependent on vendors and other providers to supply the hardware, software and co-location resources that comprise our products and services. We have no long-term or exclusive contracts or arrangements with any of these vendors or providers. We cannot be certain that our current and proposed vendors and service providers will continue to do business with us or that we will be able to establish relationships with new vendors and service providers if necessary. If we are unable to establish and maintain satisfactory relationships and arrangements with these third parties, our business could be harmed. In addition, we will be dependent upon our third-party vendors and other suppliers to adequately test their products before release, and to provide support for their products after delivery. Failure to do so could have a material adverse effect on our business.

 

Further, we currently compete with, and expect to compete with in the future, providers of some of our technology or system components. If we are unable to effectively balance our need to cooperate and compete with these companies, our business may be harmed.

 

Our services are technically complex and we may not be able to prevent defects that could decrease their market acceptance, result in product liability or harm our reputation.

 

Our document security, digital water marketing, streaming media, data privacy and data protection products and services are complex, and the steps we take to ensure that they are free of errors or defects, particularly when first introduced or when new versions or enhancements are released, may not be successful. We cannot guarantee that current versions or enhanced versions or our products will be free of significant software defects or bugs. Despite our testing, and testing by our third-party vendors and providers, current or future products may contain serious defects. Serious defects or errors could result in lost revenue or a delay in market acceptance of our products and could seriously harm our business and operating results. Errors in our products may be caused by defects in third-party hardware or software incorporated into our products. If so, we may be unable to fix these defects without the co-operation of these third-party providers. Because these defects may not be as significant to these providers as they are to us, we may not receive the rapid co-operation that we may require. Errors, defects or other performance problems with our products could also harm our customers' businesses or result in potential product liability claims. Even if unsuccessful, a product liability claim brought against us would likely be time-consuming, costly and harmful to our reputation. Nor can there be any assurance that our product liability insurance coverage will be sufficient to satisfy any successful claim.

 

Any loss of our personnel or inability to acquire new personnel could harm our business.

 

Our continued operations and future success is significantly reliant on the continued services and performance of our senior management. The loss of the services of any member of our senior management team could cause significant disruption in our business. We have no long-term employment agreements with senior management, do not currently maintain any "key person" life insurance and have no employees. As such, our future success depends on our ability to retain current senior management and to identify, attract, hire, train, retain and motivate other highly skilled technical, managerial, operations, customer service, and sales and marketing personnel. Competition for such personnel is intense, and we may not successfully attract, assimilate or retain sufficiently qualified personnel. The failure to retain and attract the necessary personnel could impede our future success.

 

Failure to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business and operating results and shareholders could lose confidence in our financial reporting.

 

Effective internal controls are necessary for the Company to provide reliable financial reports and effectively prevent fraud. If we cannot provide reliable financial reports or prevent fraud, our operating results could be harmed. Failure to achieve and maintain an effective internal control environment, regardless of whether the Company is required to maintain such controls, could also cause investors to lose confidence in our reported financial information, which could have a material adverse effect on the Company's share price. Although we are not aware of anything that would impact its ability to maintain effective internal controls, we have not obtained an independent audit of the Company's internal controls and, as a result, we are not aware of any deficiencies which would result from such an audit. Further, at such time as the Company is required to comply with the internal control requirements of the Sarbanes-Oxley Act, we may incur significant expenses in having its internal controls audited and in implementing any changes which are required.

 

 

We do not currently have any paying customers.

 

Our sales were $Nil in 2023 and 2022. We expect that a small number of customers will account for a substantial portion of our revenue in the foreseeable future. The inability to increase the number of customers could limit our ability to maintain or increase our market share or could cause revenue to drop quickly and unexpectedly.

 

Our business may suffer if we cannot protect our intellectual property.

 

We seek to protect our proprietary rights through a combination of patents, trade secrets, trademark laws, confidentiality procedures and contractual provisions with employees and third parties. Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy aspects of our products or obtain and use information that we have proprietary rights over. Litigation may be necessary to enforce our intellectual property rights, to protect our trade secrets and to determine the validity and scope of our proprietary rights. Any litigation could result in substantial costs and diversion of management and other resources with no assurance of success and could seriously harm our business and operating results.

 

Our products may infringe the intellectual property rights of others, causing us to incur significant costs or prevent us from licensing our products.

 

Other companies, including our competitors, may have or obtain patents or other proprietary rights that would prevent, limit or interfere with our ability to make, use or license our products. We cannot be certain that our products do not and will not infringe patents or the proprietary rights of others. We may be subject to legal proceedings, including claims of alleged infringement by others of the intellectual property rights of third parties. If a successful claim of infringement is brought against us and we fail to or are unable to license the infringed technology on commercially reasonable terms, our business and operating results could be significantly harmed. Companies in the technology sector are increasingly bringing suits alleging infringement of their proprietary rights, particularly patent rights. Although we are not currently subject to any litigation or claims, any future claims, whether or not valid, could result in substantial costs and diversion of resources with no assurance of success. Intellectual property litigation or claims could force us to do one or more of the following:

 

 

·

cease selling, incorporating or using products or services that incorporate the infringed intellectual property;

   

 

 

·

obtain a license from the rights-holder or owner of the infringed intellectual property, which license may not be available on commercially reasonable terms, or at all; or

   

 

 

·

re-design our products or services.

 

If we are forced to take any of these actions, our business could be substantially harmed.

 

Our success depends on the continued growth in demand for e-business applications.

 

Our primary business strategy involves the development of products and services that enable users to transmit video over the Internet. As a result, our future sales and any future profits will be substantially dependent upon the widespread acceptance and use of the Internet as an effective medium of business by consumers and businesses. To be successful, consumers and businesses that have historically used traditional means of commerce to transact business must continue to accept and utilize the Internet as a medium for conducting business and exchanging information. Consumers and businesses may reject the Internet as a viable commercial medium for a number of reasons, including potentially inadequate network infrastructure, slow development of enabling technologies, insufficient commercial support and privacy concerns. In addition, delays in the development or adoption of new standards and protocols required to handle increased levels of Internet activity or increased government regulation could cause the Internet to lose its viability as a commercial medium. If the demand for e-business applications does not grow or grows more slowly than anticipated, demand for our products and services would be reduced and our revenue would suffer.

 

 

Government regulation and legal uncertainties could add additional costs and risks to doing business on the Internet.

 

We are not currently subject to direct regulation by any governmental agency, other than regulations applicable to businesses generally, export control laws and laws or regulations directly applicable to electronic commerce. However, due to the increasing popularity and use of the Internet, it is possible that a number of laws and regulations may be adopted with respect to the Internet covering issues such as: user privacy, pricing, content, copyrights, distribution and characteristics and quality of products and services.

 

Furthermore, the growth and development of the market for electronic commerce may prompt calls for more stringent consumer protection laws that may impose additional burdens on companies conducting business online. The adoption of additional laws or regulations may decrease the growth of the Internet or other online services, which could, in turn, decrease the demand for our products and services and increase our cost of doing business.

 

The applicability of existing laws to the Internet, property ownership, copyrights, encryption and other intellectual property issues, taxation, libel, export or import matters, obscenity and personal privacy is uncertain. The vast majority of such laws were adopted prior to the advent of the Internet and related technologies. As a result, they do not contemplate or address the unique issues of the Internet and related technologies. Changes to such laws intended to address these issues, including some recently proposed changes, could create uncertainty in the Internet marketplace. Such uncertainty could reduce demand for our products and services or increase the cost of doing business due to increased costs of litigation or increased service delivery costs.

 

Our share price has been and could be highly volatile, which could result in substantial losses to investors.

 

The trading price of our common shares has been and is likely to continue to be highly volatile and could be subject to wide fluctuations in response to a number of factors including variations in quarterly operating results, new products or services offered by us or our competitors, conditions or trends in the Internet and online commerce industries, changes in the economic performance and/or market valuations of other Internet and online service companies, and other events or factors, many of which are beyond our control. In addition, the stock market in general, and the market for Internet-related and technology companies in particular, has experienced extreme price and volume fluctuations, including large price drops in 2017, 2015, 2011, 2010, 2009, 2008, 2003, 2002 and 2001, that have often been unrelated or disproportionate to the operating performance of such companies. These broad market and industry factors may materially adversely affect the market price of our common shares, regardless of our actual operating performance. In the past, following periods of volatility in the market price of a company's securities, securities class-action litigation has often been instituted against affected companies. Such litigation, if instituted, could result in substantial costs and a diversion of management's attention and resources.

 

We have not paid cash dividends in the past and does not expect to pay cash dividends in the foreseeable future. Any return on investment may be limited to the value of the Company's common shares.

 

We have never paid cash dividends on its capital stock and does not anticipate paying cash dividends on its capital stock in the foreseeable future. The payment of dividends on the Company's capital stock will depend on its earnings, financial condition and other business and economic factors affecting the Company at such time as the board of directors may consider relevant. If we do not pay dividends, its common shares may be less valuable because a return on your investment will only occur if the common shares price appreciates.

 

Securities analysts may not initiate coverage or continue to cover the Company's common shares, and this may have a negative impact on its market price.

 

The trading market for the Company's securities could depend in part on the research and reports that securities analysts publish about Oculus' business and the Company. We do not have any control over these analysts. There is no guarantee that securities analysts will cover the Company's securities. If securities analysts do not cover the Company, the lack of research coverage may adversely affect the market prices of the Company's common shares. If the Company is covered by securities analysts, and its securities are the subject of an unfavorable report, the prices for the Company's securities would likely decline. If one or more of these analysts ceases to cover the Company or fails to publish regular reports on the Company, the Company could lose visibility in the financial markets, which could cause its share price and/or trading volume to decline.

 

Anti-takeover provisions in our charter documents could prevent or delay a change in control of the company.

 

Our articles of continuance and bylaws contain anti-takeover provisions that could discourage, delay or even prevent an acquisition of our company at a premium price or at all. Any of these provisions might prevent the market price of our common shares from increasing in response to takeover attempts and could prevent our shareholders from realizing a premium over the then-prevailing market price for the common shares. 

 

 

We intend to issue additional equity securities, which may dilute the interests of current shareholders or carry rights or preferences senior to the common shares.

 

We intend to issue additional equity securities in order to raise working capital. Accordingly, existing shareholders may experience additional dilution of their percentage ownership interest in our company. In addition, the new equity securities may have rights, preferences or privileges senior to those of our existing common shares.

 

The exercise of options and warrants and other issuances of common shares or securities convertible into or exercisable for common shares will dilute the ownership interests of the Company's current shareholders and may adversely affect the future market price of the Company's common shares.

 

We may use stock options, stock grants and other equity-based incentives, to provide motivation and compensation to our officers, employees and key independent consultants. The award of any such incentives will result in an immediate and potentially substantial dilution to our existing shareholders and could result in a decline in the value of the Company's share price. The exercise of these options and the sale of the underlying common shares and the sale of common shares issued pursuant to stock grants may have an adverse effect upon the price of the Company's common shares.

 

Limited liability of executive officers and directors may discourage shareholders from bringing a lawsuit against them.

 

Our bylaws contain provisions that limit the liability of directors for monetary damages and provide for indemnification of officers and directors. These provisions may discourage shareholders from bringing a lawsuit against officers and directors for breaches of their fiduciary duty and may also reduce the likelihood of derivative litigation against officers and directors even though such action, if successful, might otherwise have benefited the shareholders. In addition, a shareholder's investment in Oculus may be adversely affected to the extent that costs of settlement and damage awards against officers or directors are paid by Oculus pursuant to the indemnification provisions of the bylaws.

 

Requirements of the SEC with regard to low-priced "penny stocks" may adversely affect the ability of shareholders to sell their shares in the secondary market.

 

"Penny stocks" are low-priced, and usually highly speculative, stock selling at less than $5.00 per share. Our securities are subject to Rule 15g-9 under the Exchange Act, which imposes additional sales practice requirements on broker-dealers who sell such securities to persons other than established customers and "accredited investors" (generally, an individual with a net worth in excess of $1,000,000 or an annual income exceeding $200,000, or $300,000 together with his or her spouse). For transactions covered by this rule, a broker-dealer must make a special suitability determination for the purchaser and have received the purchaser's written consent to the transaction prior to sale. The rule also requires the delivery, prior to the transaction, of a risk disclosure document mandated by the SEC relating to the penny stock market. The broker-dealer must also disclose the commissions payable for the transaction, current quotations for the stock, and, if applicable, the fact that it is the sole market maker in the stock. Consequently, the rule may adversely affect the ability of broker-dealers to sell our securities and may adversely affect the ability of shareholders to sell their shares in the secondary market

 

We do not anticipate paying dividends to shareholders in the foreseeable future.

 

We have not paid dividends on our common shares and we intend, for the foreseeable future, to invest any earnings in the further development of our business. Accordingly, shareholders should not expect to receive any dividends on their shares.

 

We may be exposed to adverse currency exchange rate fluctuations, which could harm our financial results and cash flows.

 

Substantially all of our assets and operations are located and conducted in the United States and Canada. As a result, our primary exposure to movements in foreign currency rates relate to Canadian dollar operating expenses, assets and liabilities. A decline in the Canadian dollar would decrease the U.S. dollar value of our Canadian assets while a rise in the Canadian dollar would increase the U.S. dollar value of Canadian operating expenses and liabilities.

 

International transactions are settled in U.S. dollars. As a result, weaknesses in foreign currencies could adversely affect demand for our products.

 

Service outages and disruption of our infrastructure may harm our adversely impact business operations and injure reputation.

 

We may experience outages or disruptions to our services or infrastructure before, during or after the transition to a cloud platform, including information technology system failures and network disruptions. Such events could interrupt our customers' access to our services, adversely affect their perception of our services' reliability and consequently reduce our revenue. 

 

 

Security vulnerabilities in our products and services or any breach of our security measures may injure our reputation and disrupt our business.

 

We intend to host a digital Cloud platform with various features including document storage. While this Cloud service will have security features, Cloud-based content has been, and continues to be, targeted by malicious cyber-attacks. Should our security features be breached as a result of third-party attacks or due any error, negligence, product defect or otherwise, and should such a breach compromise the confidentiality, integrity or availability of our cloud services, the business may suffer and its reputation may be injured. In addition, if an actual or perceived security breach occurs, we may become subject to significant liability through lawsuits or claims and lose future sales and customers and there is no assurance that our product liability insurance coverage will be sufficient to satisfy any successful claims.

 

Techniques used to defeat online security measures are constantly evolving and may not be discovered until after the secured information has already been compromised. Therefore, we may be unable to anticipate these techniques, react in a timely manner, or implement adequate preventative measures.

 

The financial reporting obligations of being a public company in the United States are expensive, time consuming, and may place significant demands on the Company's management.

 

The obligations of being a public company in the United States require significant expenditures and place certain demands on our management, including costs resulting from public company reporting obligations under the Exchange Act and the rules and regulations regarding corporate governance practices, including those under the Sarbanes-Oxley Act of 2002, and the Dodd-Frank Wall Street Reform and Consumer Protection Act. Our management and other personnel devote a substantial amount of time to ensure that the Company complies with all of these requirements. Moreover, despite recent reforms made possible by the Jumpstart Our Business Startups Act, the reporting requirements, rules and regulations increase the Company's legal and financial compliance costs and will make some activities more time-consuming and costly. Any changes that the Company makes to comply with these obligations may not be sufficient to allow it to satisfy its obligations as a public company on a timely basis, or at all.

 

We also expect these rules and regulations to make it more difficult and more expensive for it to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. These factors also could make it more difficult for us to attract and retain qualified persons to serve on its board of directors, particularly to serve on its audit and compensation committees, or as executive officers.

 

Our failure to manage or adequately address any one or more of these risks could result in our business suffering a material adverse effect.

 

 

Item 1B.

Unresolved Staff Comments.

 

None.

 

Item 2.

Description of Properties.

 

The Company's corporate headquarters are located at Suite 507, 837 West Hastings Street, Vancouver, British Columbia and are subject to an office space lease on a month-to-month basis. The monthly base rent is $4,645 CAD (Canadian Dollars).

 

Item 3.

Legal Proceedings.

 

From time to time the Company may be a defendant or plaintiff in various legal proceedings arising in the normal course of the Company's business. The Company is unaware of any material, active, pending or threatened proceeding against the Company, nor is the Company involved as a plaintiff or defendant in any material proceeding or pending litigation.

 

Item 4.

Mine Safety Disclosures.

 

Not applicable.

 

 

 

PART II

 

Item 5.

Market for Registrant's Common Equity and Related Stockholder Matters.

 

There is a limited public market for our common shares. Our common shares trade on the TSX Venture Exchange (the “TSXV”) under the trading symbol "OVT", and on the OTCQB under the symbol "OVTZ".

 

The following table shows the high and low sales prices (in Canadian dollars) of our common shares as reported by the TSXV for the periods indicated.

 

TSX (Symbol OVT)

 

Period

 

High

(CAD $)

   

Low

(CAD $)

 

First Quarter 2022

  0.60     0.55  

Second Quarter 2022

  0.34     0.31  

Third Quarter 2022

  0.28     0.26  

Fourth Quarter 2022

  0.15     0.14  

First Quarter 2023

  0.20     0.13  

Second Quarter 2023

  0.15     0.085  

Third Quarter 2023

  0.115     0.07  

Fourth Quarter 2023

  0.08     0.035  

 

The following table shows the high and low prices of our common shares on the OTCQB. The following quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions:

 

OTC Bulletin Board (Symbol OVTZ)

 

Period

 

High

(US $)

   

Low

(US $)

 

First Quarter 2022

  0.60     0.36  

Second Quarter 2022

  0.35     0.19  

Third Quarter 2022

  0.27     0.15  

Fourth Quarter 2022

  0.17     0.08  

First Quarter 2023

  0.14     0.08  

Second Quarter 2023

  0.12     0.04  

Third Quarter 2023

  0.10     0.05  

Fourth Quarter 2023

  0.06     0.02  

 

Transfer Agent

 

The Registrar and Transfer Agent for our shares of common stock is Computershare Trust Company of Canada located at 324 - 8th Avenue SW, Suite 800, Calgary, Alberta, T2P 2Z2.

 

Holders

 

As of March 19th, 2024, there were 91,422,569 common shares outstanding, held by 1,285 shareholders of record. However, beneficial holders of the Company's common shares who hold their shares in an account with an investment dealer or broker are represented by one nominee. Therefore, although the number of registered shareholders is 1,285, the number of registered holders may not be representative of the number of beneficial owners.

 

 

Options

 

Details of options outstanding as at date of the report are as follows:

 

 

Exercise price

(CAD)

   

Number of

options

outstanding

 

Expiry date

 

Number of options

exercisable

   

Remaining

contractual life (years)

 
                               
$ 1.200       500,000  

January 29, 2024*

    500,000       0.08  
$ 0.800       375,000  

June 10, 2024

    375,000       0.44  
$ 0.600       590,000  

October 14, 2024

    472,000       0.79  
$ 0.800       100,000  

January 31, 2025

    60,000       1.09  
                               
          1,565,000         1,407,000          

* subsequently expired

 

Warrants

 

Details of warrants outstanding as at date of the report are as follows:

 

Exercise price

     

Number of

warrants

outstanding

 

Expiry date

 

Number of

warrants

exercisable

   

Remaining

contractual life

(years)

 
                                 
$ 0.001 (1) (US)  

 

    12,500,000  

June 4, 2025

    -       1.43  
                                 
            12,500,000         -          

 

 

(1)

No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) targeted revenue sales projections met, or 2) listing on a major US exchange, or 3) change of control.

 

Dividends

 

The Company has not declared or paid any dividends in the previous two years. The Company currently intends to retain future earnings, if any, for use in its business. The Company does not anticipate paying dividends on the common shares in the foreseeable future. Any determination to pay any future dividends will remain at the discretion of the board of directors of the Company (the “Board of Directors”) and will be made taking into account the Company’s financial condition and other factors deemed relevant by the Board of Directors.

 

 

Securities Authorized For Issuance Under Equity Compensation Plans

 

As at December 31, 2023 there were 9,142,257 Options and 9,142,247 Share Units authorized for issuance under the under the Company’s Omnibus Equity Incentive Plan approved by the Board on July 19,2023 and by Stockholders at the Company’s annual stockholder meeting held on September 15, 2023 (the “Omnibus Plan”). Since the last financial year end of December 31, 2023, as at March 19th, 2024, the following securities were authorized for issuance under the Omnibus Plan:

 

   

Number of securities to be

   

Weighted-average exercise

   

Number of securities

 
   

issued upon exercise of

   

price of outstanding

   

remaining available for

 

Plan Category

 

outstanding options,

   

options, warrants and

   

future issuance under

 
   

warrants and rights

   

rights

   

equity compensation plans

 
                   

(excluding securities

 
                   

reflected in column (a))

 

Equity compensation plans approved by security holders

   

1,065,000

     

$0.50 

     

8,077,247 (Options)

9,142,247 (Share Units)

 

Equity compensation plans not approved by security holders

   

N/A

     

N/A

     

N/A

 

Total

   

1,065,000

     

$0.50 

     

8,077,247 (Options)

 9,142,247 (Share Units)

 

 

Equity Incentive Compensation Plan

 

The Omnibus Plan approved by stockholders at the Company’s annual stockholder meeting held on September 15, 2023 supersedes and replaces the Company’s 2020 Share Option Plan, dated as originally adopted by the Board of Directors on August 28, 2020, and ratified by the stockholders of the Company at the Company’s annual meeting held on November 23, 2020.

 

The purpose of the Omnibus Plan is to promote the interests of the Company and its stockholders by aiding the Company in attracting and retaining employees, officers, consultants, advisors and non-employee directors capable of assuring the future success of the Company, to offer such persons incentives to put forth maximum efforts for the success of the Company’s business and to compensate such persons through various stock and cash-based arrangements and provide them with opportunities for stock ownership in the Company, thereby aligning the interests of such persons with the Company’s stockholders.

 

The following is a summary of certain provisions of the Omnibus Plan. This summary is intended as a summary only and is qualified in its entirety by reference to the Omnibus Plan attached as Schedule “C” to the proxy statement prepared for the company’s annual stockholder meeting held on September 15, 2023.

 

Summary of Material Terms

 

The Omnibus Plan, in respect of options to purchase shares of common stock (“Common Shares”), serves as the successor to the Company’s stock option plan adopted on August 28, 2020 (the “Original Stock Option Plan”), and no further options to purchase Common Shares have been or will be granted under the Original Stock Option Plan from and after the effective date of the Omnibus Plan.

 

The purposes of the Omnibus Plan is to: (i) provide the Company with a mechanism to attract, retain and motivate highly qualified directors, officers, employees and consultants; (ii) align the interests of eligible participants in the Omnibus Plan (“Participants”) with that of other Shareholders of the Company generally; and (iii) enable and encourage Participants to participate in the long-term growth of the Company through the acquisition of Common Shares as long-term investments.

 

The Omnibus Plan is administered by the Board and provides that the Board may, from time to time, in its discretion, and in accordance with TSXV requirements or any other stock exchange on which the Common Shares are listed (the “Exchange”), grant to eligible Participants, non-transferable awards (the “Awards”). Such Awards include stock options (“Options”), restricted share units (“RSUs”), deferred share units (“DSUs”) and performance share units (“PSUs”).

 

 

Under the Omnibus Plan, the maximum number of Shares issuable at any time pursuant to outstanding Awards will be equal to: (a) 10% of the outstanding Common shares issued pursuant to Options; and (b) 9,142,257 issued pursuant to Share Units (which represents 10% of the outstanding Common Shares as of the date the Plan was approved by the Board), or such other number as may be approved by the Exchange and the shareholders of the Company from time to time. For so long as the Company is listed on the Exchange or on another exchange that requires the Company to fix the number of Common Shares to be issued pursuant to Share Units, the maximum number of Common Shares available for issuance pursuant to the settlement of RSUs, DSUs and PSUs together will be an aggregate of 9,142,257 Common Shares.

 

The Omnibus Plan is an “evergreen” plan, as Common Shares covered by Awards which have been exercised or settled, as applicable, and Awards which expire or are forfeited, cancelled or otherwise terminated or lapse for any reason without having been exercised, will be available for subsequent grant under the Omnibus Plan.

 

The maximum number of Common Shares for which Awards may be issued to any one Participant in any 12-month period shall not exceed 5% of the outstanding Common Shares, unless the Company obtains disinterested shareholder approval as required by the policies of the Exchange. The aggregate number of Common Shares for which Awards may be issued to any one consultant within any 12-month period shall not exceed 2% of the outstanding Common Shares, calculated on the date an Award is granted to the consultant. The aggregate number of Common Shares for which Options may be issued to any persons retained to provide Investor Relations Activities (as defined by the Exchange) within any 12-month period shall not exceed 2% of the outstanding Shares, calculated on the date an Option is granted to such persons.

 

Further, unless disinterested shareholder approval as required by the policies of the Exchange is obtained: (i) the maximum number of Common Shares for which Awards may be issued to insiders of the Company (as a group) at any point in time shall not exceed 10% of the outstanding Common Shares; and (ii) the aggregate number of Awards granted to insiders of the Company (as a group), within any 12-month period, shall not exceed 10% of the outstanding Common Shares, calculated at the date an Award is granted to any insider.

 

The Omnibus Plan provides for customary adjustments or substitutions, as applicable, in the number of Common Shares that may be issued under the Omnibus Plan in the event of a merger, arrangement, amalgamation, consolidation, reorganization, recapitalization, separation, stock dividend, extraordinary dividend, stock split, reverse stock split, split up, spin-off or other distribution of stock or property of the Company, combination of securities, exchange of securities, dividend in kind, or other like change in capital structure or distribution (other than normal cash dividends) to shareholders of the Company, or any similar corporate event or transaction.

 

In the event of an actual or potential Change of Control (as is defined in the Omnibus Plan) of the Company, the Board shall have discretion as to the treatment of Awards, including whether to (i) accelerate, conditionally or otherwise, on such terms as it sees fit, the vesting date of any Awards; (ii) permit the conditional redemption or exercise of any Awards, on such terms as it sees fit; (iii) otherwise amend or modify the terms of any Awards; and (iv) terminate, following the successful completion of a Change of Control, on such terms as it sees fit, the Awards not exercised prior to the successful completion of such Change of Control. If there is a Change of Control, any Awards held by a Participant shall automatically vest following such Change of Control, if the Participant is an employee, officer or a director and their employment, or officer or director position is terminated within 12 months following the Change of Control, provided that no acceleration of Awards shall occur in the case of a Participant that was retained to provide Investor Relations Activities unless the approval of the Exchange is either obtained or not required.

 

Neither the Awards nor the securities which may be acquired pursuant to the exercise of the Awards have been registered under the United States Securities Act of 1933 (the “U.S. Securities Act”) or under any securities law of any state of the United States of America and are considered “restricted securities” (as such term is defined in Rule 144(a)(3) under the U.S. Securities Act) and any Common Shares will be affixed with an applicable restrictive legend as set forth in the Award Agreement. Provisions of the Omnibus Plan relating to U.S. Taxpayers can be found in Article 17 of the Omnibus Plan, which is attached as Schedule “C” to this Proxy Statement.

 

Options

 

Subject to the terms and conditions of the Omnibus Plan, the Board may grant Options to Participants in such amounts and upon such terms (including the exercise price, duration of the Options, the number of Common Shares to which the Option pertains, and the conditions, if any, upon which an Option shall become vested and exercisable) as the Board shall determine.

 

The exercise price of the Options will be determined by the Board at the time any Option is granted. In no event will such exercise price be lower than the last closing price of the Common Shares on the Exchange less any discount permitted by the rules or policies of the Exchange at the time the Option is granted. Such price upon exercise of any Option shall be payable to the Company in full in cash, by certified cheque or by wire transfer, by a cashless exercise or a net exercise.

 

 

In connection with a cashless exercise, the Participant shall elect, on a notice of exercise, to receive a loan from a brokerage firm, which the Company has an arrangement with, to purchase the underlying Common Shares. Upon the sale by the brokerage firm of an equivalent number of Common Shares received from the exercise of the Options to repay the loan made to the Participant, the Participant shall elect to receive either the balance of the Common Shares following the sale or the cash proceeds from the balance of the Common Shares.

 

In connection with a net exercise, the Participant shall elect on a notice of exercise to receive an amount equal to the number of underlying Common Shares listed on the Exchange that is the equal to the quotient obtained by dividing: (a) the product of the number of Options being exercised multiplied by the difference between the five-day volume weighted average price of the underlying Common Shares so listed and the exercise price of the subject Options; by (b) the five-day volume weighted average price of the underlying Common Shares so listed; provided, however, that persons retained to provide investor relations activities shall not be permitted to exercise an Option using the net exercise method.

 

Unless otherwise specified in an Award agreement granting Options, Options shall vest subject to Exchange policies, and the Board may in its sole discretion, determine the time during which an Option shall vest and the method of vesting, or that no vesting restriction shall exist.

 

Subject to any requirements of the Exchange, the Board may determine the expiry date of each Option. Subject to a limited extension if an Option expires during a black out period, Options may be exercised for a period of up to ten years after the grant date, provided that: (i) upon a Participant’s termination for cause, all Options, whether vested or not, as at the date on which a Participant ceases to be eligible to participate under the Omnibus Plan(the “Termination Date”) as a result of termination of employment, will automatically and immediately expire and be forfeited; (ii) upon the death of a Participant, all unvested Options as at the Termination Date shall automatically and immediately vest, and all vested Options will continue to be subject to the Omnibus Plan and be exercisable for a period of 12 months after the Termination Date; (iii) in the case of the disability of a Participant, all Options shall remain and continue to vest (and are exercisable) in accordance with the terms of the Omnibus Plan for a period of 12 months after the Termination Date, provided that any Options that have not been exercised (whether vested or not) within 12 months after the Termination Date shall automatically and immediately expire and be forfeited on such date; (iv) in the case of the retirement of a Participant, the Board shall have discretion, with respect to such Options, to determine whether to accelerate the vesting of such Options, cancel such Options with or without payment and determine how long, if at all, such Options may remain outstanding following the Termination Date, provided, however, that in no event shall such Options be exercisable for more than 12 months after the Termination Date; and; (v) in all other cases where a Participant ceases to be eligible under the Omnibus Plan, including a termination without cause or a voluntary resignation, unless otherwise determined by the Board, all unvested Options shall automatically and immediately expire and be forfeited as of the Termination Date, and all vested Options will continue to be subject to the Omnibus Plan and be exercisable for a period of 90 days after the Termination Date.

 

RSUs

 

Subject to the terms and conditions of the Omnibus Plan, the Board may grant RSUs to Participants in such amounts and upon such terms (including time-based restrictions on vesting, restrictions under applicable laws or under the requirements of the Exchange) as the Board shall determine.

 

No RSU may vest before one year following the date it is granted or issued. The vesting of RSUs may be accelerated in limited circumstances, in the case of the death of Participant or upon a Participant ceasing to be an eligible participant under the Omnibus Plan in connection with a change of control, take-over bid, Reverse Take-Over or other similar transaction.

 

Unless otherwise specified in an Award agreement granting RSUs, RSUs shall vest at the discretion of the Board, subject to the policies of the Exchange, provided that, and subject to the Board’s discretion: (i) upon a Participant’s termination for cause, all RSUs, whether vested (if not yet paid out) or not as at the Termination Date will automatically and immediately expire and be forfeited; (ii) upon the death of a Participant, all unvested RSUs as at the Termination Date shall automatically and immediately vest and be paid out; (iii) in the case of the disability of a Participant, all RSUs shall remain and continue to vest in accordance with the terms of the Omnibus Plan for a period of 12 months after the Termination Date, provided that any RSUs that have not been vested within 12 months after the Termination Date shall automatically and immediately expire and be forfeited on such date; (iv) in the case of the retirement of a Participant, the Board shall have discretion, with respect to such RSUs, to determine whether to cancel such RSUs with or without payment and determine how long, if at all, such RSUs may remain outstanding following the Termination Date, provided, however, that in no event shall such RSUs be exercisable for more than 12 months after the Termination Date; and (v) in all other cases where a Participant ceases to be eligible under the Omnibus Plan, including a termination without cause or a voluntary resignation, unless otherwise determined by the Board, all unvested RSUs shall automatically and immediately expire and be forfeited as of the Termination Date, and all vested RSUs will be paid out in accordance with the Omnibus Plan.

 

 

When and if RSUs become payable, the Participant issued such RSUs shall be entitled to receive payment from the Company in settlement of such RSU: (i) in a number of Common Shares (issued from treasury) equal to the number of RSUs being settled, or (ii) in any other form, all as determined by the Board at its sole discretion. The Board’s determination regarding the form of payout shall be set forth or reserved for later determination in the Award agreement for the grant of the RSUs.

 

Participants holding RSUs may, if the Board so determines, be credited with dividends paid with respect of the underlying Common Shares or dividend equivalents while they are so held in a manner determined by the Board in its sole discretion.

 

DSUs

 

Subject to the terms and conditions of the Omnibus Plan, the Board may grant DSUs to Participants in such amounts and upon such terms (including the requirement that Participants pay a stipulated purchase price for each DSU, restrictions based upon the achievement of specific performance criteria, time-based restrictions, restrictions under applicable laws or under the requirements of the Exchange, or holding or sale restrictions placed on the Common Shares by the Company upon vesting of such DSUs) as the Board shall determine.

 

When and if DSUs become payable, the Participant issued such DSUs shall be entitled to receive payment from the Company in settlement of such DSU: (i) in a number of Common Shares (issued from treasury) equal to the number of DSUs being settled, or (ii) in any other form, all as determined by the Board at its sole discretion. The Board’s determination regarding the form of payout shall be set forth or reserved for later determination in the Award agreement for the grant of the DSUs. Participants holding DSUs may, if the Board so determines, be credited with dividends paid with respect of the underlying Common Shares or dividend equivalents while they are so held in a manner determined by the Board in its sole discretion.

 

The extent to which a Participant shall have the right to retain DSUs following termination of the Participant’s employment or other relationship with the Company, shall be set out in each DSU award agreement and determined in the sole discretion of the Board, and need not be uniform among all DSUs issued pursuant to the Omnibus Plan, and may reflect distinctions based on the reasons for termination, provided that the provisions shall comply with the applicable rules of the Exchange.

 

No DSU may vest before one year following the date it is granted or issued. The vesting of DSUs may be accelerated in limited circumstances, in the case of the death of Participant or upon a Participant ceasing to be an eligible participant under the Omnibus Plan in connection with a change of control, take-over bid, Reverse Take-Over or other similar transaction, provided, however, that in the event that a Participant ceases to be an eligible Participant under the Omnibus Plan, no DSU granted to that Participant shall remain outstanding for a period of more than 12 months following the Termination Date, provided that any DSUs that have not been settled within 12 months after the Termination Date shall automatically and immediately expire and be forfeited on such date.

 

Performance Awards

 

Subject to the terms and conditions of the Omnibus Plan, the Board may grant PSUs to Participants in such amounts and upon such terms (including the performance criteria applicable to such PSUs) as the Board shall determine. Each PSU shall have an initial value equal to the fair market value of a Common Share on the date of grant. After the applicable performance period has ended, the holder of a PSU shall be entitled to receive payout on the value and number of PSUs, determined as a function of the extent to which the corresponding performance criteria have been achieved.

 

Subject to the terms of the Omnibus Plan, the Board, in its sole discretion, may pay earned PSUs in the form of a number of Common Shares issued from treasury equal to the number of earned PSUs at the end of the applicable performance period. Any Common Shares may be granted subject to any restrictions deemed appropriate by the Board.

 

Participants holding PSUs may, if the Board so determines, be credited with dividends paid with respect of the underlying Common Shares or dividend equivalents while they are so held in a manner determined by the Board in its sole discretion.

 

The extent to which a Participant shall have the right to retain PSUs following termination of the Participant’s employment or other relationship with the Company, shall be set out in each PSU award agreement and determined in the sole discretion of the Board, and need not be uniform among all PSUs issued pursuant to the Omnibus Plan, and may reflect distinctions based on the reasons for termination, provided that the provisions shall comply with the applicable rules of the Exchange.

 

No PSU may vest before one year following the date it is granted or issued. The vesting of PSUs may be accelerated in limited circumstances, in the case of the death of Participant or upon a Participant ceasing to be an eligible participant under the Omnibus Plan in connection with a change of control, take-over bid, Reverse Take-Over or other similar transaction, provided, however, that in the event that a Participant ceases to be an eligible Participant under the Omnibus Plan, no PSU granted to that Participant shall remain outstanding for a period of more than 12 months following the Termination Date, provided that any PSUs that have not been settled within 12 months after the Termination Date shall automatically and immediately expire and be forfeited on such date.

 

 

Stock Option Plan

 

Previous plans adopted by the Company dated for reference October 15, 2021 (the “2021 Share Option Plan”). The 2021 Share Option Plan, supersedes and replaced the 2020 Stock Option Plan, which was approved by shareholders at the Company’s annual general and special meeting on October 15, 2021. The purpose of the 2020 Share Option Plan is to provide incentive to qualified parties to increase their proprietary interest in the Company and thereby encourage their continuing association with the Company.

 

Previous grants will be taken into account when considering new grants under the 2020 Share Option Plan and a maximum of 10% of the number of the issued and outstanding common shares of the Company are available for issuance under the 2020 Share Option Plan. There are currently NIL options issued under the 2020 Stock Option Plan and 1,065,000 option issued under the 2021 Stock Option Plan for a total of 1,065,000.

 

The additional terms and conditions attached to the Option represented by this Option Commitment are as follows:

 

1.

The Options will not be exercisable unless and until they have vested and then only to the extent that they have vested. The Options will vest in accordance with the following:

 

Vesting Provisions (Previous Stock Option Plans)

 

To vest as to 20% on the date that is six months from the date of grant, and a further 20% on each successive date that is six months from the date of the previous vesting in accordance with the conditions below:

 

All options will be considered vested if one of the following criteria are met by the Company:

 

 

i.

Meeting sales forecasts:

 

 

-

The greater of either the 20% vesting every six months or the pro rata percentage of revenue earned by the Company’s subsidiary, Comply Trust (“CTI”) in years 1, 2, 3

 

 

-

(100V/$125,000,000) of the warrants shall vest on June 4, 2021 (2022 and 2023), wherein “V” is the Gross Revenue of the business (as hereinafter defined) between the period June 4, 2020 – June 4, 2025;

 

 

-

“Gross Revenue” means all monetary sums earned less any credits issued for returns and allowances, and, for certainty, Gross Revenue does not include Deferred Revenue;

 

 

-

eg: if the CT warrant holders earn 60% of projected revenue in Year 1 then all option holders would also vest 60% .

 

 

ii.

the listing of the Company on any national securities exchange registered with the United States Securities and Exchange Commission under section 6 of the United States Securities Exchange Act of 1934, as amended, such as, but not limited to, the New York Stock Exchange, the NYSE American, and NASDAQ Stock Market; or

 

 

iii.

a Change of Control Event meaning, with reference to the Company: (a) the acquisition of a sufficient number of voting securities in the capital of the Company so that the acquirer (as referenced in the CT Share Purchase Agreement dated for reference June 5, 2020) becomes entitled, directly or indirectly, to exercise more than 50% of the voting rights attaching to the outstanding voting securities in the capital of the Company (provided that, prior to the acquisition, the acquirer was not entitled to exercise more than 50% of the voting rights attaching to the outstanding voting securities in the capital of the Company); (b) an occurrence when a majority of the directors elected at any annual or extraordinary general meeting of shareholders of the Company are not individuals nominated by the Company’s then-incumbent board; or (c) sale of one or more assets of the Company (but for certainty excludes sales made in the normal course of Business) after the Closing Date (as defined in the CTI Share Purchase Agreement) resulting in the collection of monetary sums that is collectively more than 50% of the Gross Revenue of the Company during the twelve (12) month period immediately preceding the Closing Date (as defined in the CT Share Purchase Agreement).

 

 

Performance Graph

 

The graph below matches Oculus VisionTech Inc.'s cumulative 5-Year total shareholder return on common stock with the cumulative total returns of the Russell 2500 index and the Dow Jones US Software index. The graph tracks the performance of a $100 investment in our common stock and in each index (with the reinvestment of all dividends) from 12/31/2017 to 12/31/2023.

 

ovtz20231231_10kimg002.jpg

 

 

 

The stock price performance included in this graph is not necessarily indicative of future stock price performance.

 

 

 

Begin:

12/31/2016

 

Period End:

12/31/2023

Oculus Visiontech Inc

   

OVTZ

   

 

 

Beginning

                                         
                                                           

Date*

Transaction

Type

 

Closing

Price**

   

No. Of

Shares***

   

Dividend

per Share

   

Dividend

Paid

   

Shares

Reinvested

   

Ending

Shares

   

Cum. Tot.

Return

 
                                                           

31-Dec-16

Begin

    0.161       256.41       -       -       -       256.410       100.00  
                                                           

31-Dec-17

Year End

    0.067       256.41       -       -       -       256.410       41.28  
                                                           

31-Dec-18

Year End

    0.080       256.41       -       -       -       256.410       17.15  
                                                           

31-Dec-19

Year End

    0.120       256.41       -       -       -       256.410       20.51  
                                                           

31-Dec-20

Year End

    0.410       256.41       -       -       -       256.410       30.77  
                                                           

31-Dec-21

Year End

    0.980       256.41       -       -       -       256.410       30.77  
                                                           

31-Dec-22

Year End

    0.145       256.41       -       -       -       256.410       30.77  
                                                           

31-Dec-23

Year End

    0.05       256.41       -       -       -       256.410       30.77  

 

*  Specified ending dates or ex-dividends dates.

** All Closing Prices and Dividends are adjusted for stock splits and stock dividends.

***'Begin Shares' based on $100 investment.

 

Recent Sales of Unregistered Securities

 

Not applicable. 

 

Issuer Purchases of Equity Securities

 

Not applicable.

 

Item 6.

Selected Financial Data.

 

Not applicable.

 

 

 

Item 7.

Management's Discussion and Analysis of Financial Conditions and Results of Operation.

 

You should read the following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and related notes appearing elsewhere in this annual report on Form 10-K. This discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. The actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors, including, but not limited to, those set forth under ‘‘Risk Factors’’ and elsewhere in this annual report on Form 10-K.

 

Overview

 

We design and market to business customers digital watermarking, streaming video and video-on-demand (VOD) systems, services and source-to-destination digital media delivery solutions that allow live or recorded digitized and compressed video to be transmitted through Internet, intranet, satellite or wireless connectivity. The Company’s systems, services and delivery solutions include digital watermark solutions and video content production, content encoding, media asset management, media and application hosting, multi-mode content distribution, transaction data capture and reporting, e-commerce, specialized engineering services, and Internet streaming hardware.

 

The Company’s products and services are based on its data privacy, data protection and media delivery infrastructure, software and services. It has developed a number of specific products and services that include Cloud-DPS, CTSS and Forget-Me-Yes™.

 

As more fully discussed below we have not been profitable, and our revenues for 2023 and 2022 were $Nil. We cannot predict our revenue levels for the next 12 months, or thereafter, nor when, or if, our operations will become profitable. We will require additional financing, both for the remainder of fiscal 2021 and thereafter, to continue to operate and expand our business. There is no assurance that such financing will be available on commercially reasonable terms, if at all.

 

CRITICAL ACCOUNTING POLICIES

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.  On an ongoing basis, we evaluate these estimates, including those related to bad debts, intangible assets, income taxes, impairment or disposal of long-lived assets, contingencies and litigation.  We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions.

 

We have identified the policies below as critical to our business operations and to the understanding of our financial results. The impact and any associated risks related to these policies on our business operations is discussed throughout management’s discussion and analysis of financial condition and results of operations where such policies affect our reported and expected financial results:

 

 

Impairment or disposal of long-lived assets;

 

Deferred taxes;

 

Accounting for stock-based compensation; and

 

Commitments and contingencies.

 

IMPAIRMENT OR DISPOSAL OF LONG-LIVED ASSETS.  Long-lived assets are reviewed in accordance with ASC Topic 360-10-05.  Impairment or disposal of long-lived assets losses are recognized in the period the impairment or disposal occurs.  

 

DEFERRED TAXES.  We record a valuation allowance to reduce deferred tax assets when it is more likely than not that some portion of the amount may not be realized.  

 

ACCOUNTING FOR STOCK-BASED COMPENSATION.    Under ASC Topic 718, Stock Compensation, the Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value for awards that are expected to vest is then amortized on a straight-line basis over the requisite service period of the award, which is generally the option vesting term. The amount of expense attributed is based on estimated forfeiture rate, which is updated based on actual forfeitures as appropriate. This option pricing model requires the input of highly subjective assumptions, including the expected volatility of the Company’s common stock, pre-vesting forfeiture rate and an option’s expected life. The financial statements include amounts that are based on the Company’s best estimates and judgments. 

 

 

COMMITMENTS AND CONTINGENCIES.    We account for commitments and contingencies in accordance with ASC Topic 450 Contingencies. We record a liability for commitments and contingencies when the amount is both probable and reasonably estimable.

 

Results of Operations

 

For the Year Ended December 31, 2023

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses, consisting of product marketing expenses, consulting fees, office, professional fees and other expenses to execute our business plan and for our day-to-day operations, increased in the year ended December 31, 2023.  We continue to develop and market C-DPS – Cloud Document Protection System and the “Right-to-be-Forgotten” and “Right-to-Erase” platform. Administrative expenses have decreased/increased moderately as a result of insignificant fluctuations in general costs.

 

Selling, general and administrative expenses for the year ended December 31, 2023 decreased by $124,969 to $274,498 from $399,467 for the year ended December 31, 2022. This included professional expenses for the year ended December 31, 2023 which decreased to $78,089 from $104,801 for the comparable year in 2022. We incurred decreased costs in 2023 due to minimal corporate and filing activities during the fiscal year.

 

Research and development for the year ended December 31, 2023 decrease to $95,884 from $1,137,883 for the comparable period in 2022. We incurred decreased costs in 2023 due to minimal activities during the fiscal year.

 

We have arranged for additional staff and consultants to engage in marketing activities in an effort to identify and assess appropriate market segments, develop business arrangements with prospective partners, create awareness of new products and services, and communicate to the industry and potential customers. Other components of selling, general and administrative expenses did not change significantly.

 

Research and Development

 

Research and development costs for the three months ended December 31, 2023, decreased to $2,323 from $224,991 for the comparable year in 2022. We incurred comparable costs in 2023 as the management maintain its decision in 2022, to develop CTSS (ComplyScan®) as well as the on-going development of our subsidiary’s Forget-Me-Yes® zero trust data privacy platform. (“Right-to-be-Forgotten” and “Right-to-Erase”).

 

Net Losses

 

To date, we have not achieved profitability and expect to incur substantial losses for the foreseeable future. Our net loss for fiscal 2023 was $591,212, compared with a net loss of $1,649,589 for fiscal 2022. Our total comprehensive loss for fiscal 2023 was $589,218 which includes currency translation differences of $1,993, compared with a comprehensive loss of $1,608,543 for fiscal 2022.

 

 

Liquidity and Capital Resources

 

At December 31, 2023 our cash position was $156,574, a decrease from $687,602 at December 31, 2022. We had a working capital deficiency of $89,768 and an accumulated deficit of $48,386,646 at December 31, 2023.

 

We have historically satisfied our capital needs primarily by shareholders’ loans and issuing equity securities to our officers, directors, employees and a small group of investors, and from short-term bridge loans from members of management.

 

As of December 31, 2023, we had $156,574 in cash. Management has forecasted the Company will not have sufficient working capital to operate for the ensuing 12 months. We will require an additional $3 million to $5 million to finance operations for the fiscal 2024 and we intend to obtain such financing through sales of our equity securities. While the Company has been successful in the past in obtaining financing, there can be no assurance that the Company will be able to obtain adequate financing, or that such financing will be on terms acceptable to the Company, to meet future operational needs which may result in the delay, reduction, or discontinuation of ongoing development programs.

 

Assuming the aforementioned $3 million to $5 million in financing is obtained, continuing operations for the longer-term will be supported through anticipated growth in revenues and through additional sales of our securities. Although longer-term financing requirements may vary depending upon our sales performance, management expects that we will require additional financing of $3 million to $5 million for fiscal 2024. We have no binding commitments or arrangements for additional financing, and there is no assurance that management will be able to obtain any additional financing on terms acceptable to us, if at all.

 

Statement of Cash Flows

 

The Company had cash and cash equivalents of $156,574 (2022 - $687,602) as of December 31, 2023.

 

The decrease in cash and cash equivalents during the year ended December 31, 2023 was primarily due to cash used in operating activities during the fiscal year.

 

Cash Flow used in Operating Activities

 

Cash and cash equivalents used in operating activities were $533,021 (2022 - $1,479,216) for the year ended December 31, 2023. Operating activities were affected by the change in non-cash working capital balances because of a decrease in prepaid expense and other current assets of $2,857, an increase in accounts payable and accrued expenses of $2,452 and an increase in accounts payable and accrued expenses due to related parties of $31,152.

 

Off-Balance Sheet Arrangements

 

As of fiscal 2023 we have no off-balance sheet arrangements.

 

Item 7A.

Quantitative and Qualitative Disclosure About Market Risk.

 

As a smaller reporting issuer, the Company is not required to provide the information under this Item.

 

Item 8.

Financial Statements and Supplementary Data.

 

The financial statements and supplementary financial information required to be filed under this item are presented on pages F-1 through F-14 of this Report and are included. 

 

 

 

 

OCULUS VISIONTECH, INC AND SUBSIDIARY

 

 

CONSOLIDATED FINANCIAL STATEMENTS

 

DECEMBER 31, 2023 AND 2022

 

 

 

 

 

 

 

 

 

 

OCULUS VISIONTECH, INC. AND SUBSIDIARY

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2023 AND 2022

 

 


 

 

 

Index – Consolidated Financial Statements

36

Report of Independent Registered Public Accounting Firm - [Davidson & Company LLP / Vancouver, BC. Canada /  Auditor Firm ID#: 731]

37

  

Consolidated Financial Statements:

 
  

Consolidated Balance Sheets

39

Consolidated Statements of Operations and Comprehensive Loss

40

Consolidated Statements of Stockholder’s Equity

41

Consolidated Statements of Cash Flows

42

Notes to Consolidated Financial Statements

43-53

 

  

 

AUDITOR INDEPENENCE REPORT

dcllp01.jpg

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

To the Shareholders and Directors of

Oculus VisionTech Inc.

 

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated balance sheets of Oculus VisionTech Inc. (the “Company”) as of December 31, 2023 and 2022, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity (deficiency), and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for the years ended December 31, 2023 and 2022, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As

 

discussed in Note 2 to the financial statements, the Company has incurred losses from inception and does not currently have

 

the financial resources to sustain operations in the long-term. As shown in the financial statements, the Company has incurred a loss of $591,212 for the year ended December 31, 2023 and as of December 31, 2023, the Company had an accumulated deficit of $48,386,646 and a working capital deficiency of $89,768. These matters raise substantial doubt about the Company’s ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

 
dcllp02.jpg

 

 

Critical Audit Matters

 

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

We have determined that there are no critical audit matters to communicate in our auditor’s report.

 

We have served as the Company’s auditor since 2022.

 

 

  /s/ DAVIDSON & COMPANY LLP

 

 

Vancouver, Canada Chartered Professional Accountants

 

March 19, 2024

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

(Stated in US Dollars)

 

 

 

  

December 31,

2023

  

December 31,

2022

 
         

ASSETS

        
         

Current Assets:

        

Cash and cash equivalents

 $156,574  $687,602 

Prepaid expenses and other current assets (Note 4)

  27,381   30,238 

Total Assets

 $183,955  $717,840 
         

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICENCY)

        
         

Current Liabilities:

        

Accounts payable and accrued expenses (Note 5)

 $136,248  $133,796 

Accounts payable and accrued expenses – related parties

  137,475   168,627 

Total Current Liabilities

  273,723   302,423 
         

Stockholders’ Equity (Deficiency):

        

Preferred stock - no par value; authorized 250,000,000 shares, none issued

  -   - 

Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 91,422,569

  46,850,710   46,850,710 

Additional paid-in capital

  1,479,031   1,394,997 

Accumulated other comprehensive income (loss)

  (32,863)  (34,856)

Accumulated deficit

  (48,386,646)  (47,795,434)

Stockholders' Equity (Deficiency):

  (89,768)  415,417 

Total Liabilities and Stockholders' Equity (Deficiency):

 $183,955  $717,840 

 

The accompanying notes form an integral part of these consolidated financial statements.

 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Stated in US Dollars)

 

 

 

For the Years Ended December 31,

 

2023

  

2022

 
         

Expenses:

        

Consulting (Note 13)

 $148,500  $135,000 

Research and development (Note 10)

  95,884   1,137,883 

Selling, general and administrative (Notes 9 and 13)

  274,498   399,467 

Share-based compensation (Notes 7 and 13)

  84,034   396,520 
         

Loss from operations

  (602,916)  (2,068,870)

Interest income

  11,704   5,153 

Gain on reduction of commitment to issue shares (Note 6)

  -   414,128 
         

Net loss

  (591,212)  (1,649,589)
         

Other comprehensive income (loss)

        

Currency translation differences

  1,993   41,046 
         

Total comprehensive loss

 $(589,219) $(1,608,543)
         

Net loss per share – basic and diluted

 $(0.01) $(0.02)
         

Weighted average number of common shares outstanding – basic and diluted

  91,422,569   91,422,569 

 

The accompanying notes form an integral part of these consolidated financial statements.

 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIENCY)

(Stated in US Dollars)

 

 

 

  

Common Stock and Additional

Paid in Capital

                     
  

Shares

  

Amount

  

Additional

Paid In

Capital

  

Commitment to

Issue Shares

  

Accumulated

Other

Comprehensive

Income (Loss)

  

Accumulated

Deficit

  

Stockholders’

Equity

(Deficiency)

 
                             

Balance at December 31, 2021

  91,422,569  $46,850,710  $998,477  $414,128  $6,190  $(46,145,845) $2,123,660 
                             

Share-based compensation

  -   -   396,520   -   -   -   396,520 

Reduction of commitment to issue shares

  -   -   -   (414,128)  -   -   (414,128)

Currency translation differences

  -   -   -   -   (41,046)  -   (41,046)

Net loss

  -   -   -   -   -   (1,649,589)  (1,649,589)
                             

Balance at December 31, 2022

  91,422,569   46,850,710   1,394,997   -   (34,856)  (47,795,434)  415,417 
                             

Share-based compensation

  -   -   84,034   -   -   -   84,034 

Currency translation differences

  -   -   -   -   1,993   -   1,993 

Net loss

  -   -   -   -   -   (591,212)  (591,212)
                             

Balance at December 31, 2023

  91,422,569  $46,850,710  $1,479,031  $-  $(32,863) $(48,386,646) $(89,768)

 

The accompanying notes form an integral part of these consolidated financial statements.

 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Stated in US Dollars)

 

 

 

Years ended December 31,

 

2023

  

2022

 
         

Cash flows from operating activities:

        

Net loss

 $(591,212) $(1,649,589)

Add back non-cash share-based compensation

  84,034   396,520 

 

        

Gain on reduction of commitment to issue shares

  -   (414,128)

Adjustments to reconcile net loss to net cash used in operating activities:

        

Changes in operating assets and liabilities:

        

Decrease in prepaid expenses and other current assets

  2,857   7,594 

Increase in accounts payable and accrued expenses

  2,452   180,387 

Decrease in accounts payable and accrued expenses due to related parties

  (31,152)  - 

Net cash used in operating activities

  (533,021)  (1,479,216)
         

Effect of foreign currency translation on cash

  1,993   (41,633)
         

Net decrease in cash and cash equivalents

  (531,028)  (1,520,849)

Cash and cash equivalents at beginning of year

  687,602   2,208,451 

Cash and cash equivalents at end of year

 $156,574  $687,602 
         
         

Supplemental disclosures of cash flow information:

        
         

Cash paid during the year for interest

 $-  $- 

Cash paid during the year for income taxes

 $-  $- 

 

The accompanying notes form an integral part of these consolidated financial statements. 

 

 
42

OCULUS VISIONTECH INC. AND SUBSIDIARY
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2023 and 2022
(Stated in US Dollars)

 

1.

BASIS OF PRESENTATION AND BUSINESS

 

The accompanying consolidated financial statements include the accounts of Oculus Visiontech Inc. (“Oculus”) and its wholly-owned subsidiary, ComplyTrust Inc. (“CTI”), (together “the Company”). All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included.

 

The Company is a designer of digital watermarking services and solutions. At December 31, 2023 and for the two-year period then ended, substantially all of the Company's assets and substantially all its operations are located and conducted in the United States and Canada.

  

 

2.

GOING CONCERN

 

These consolidated financial statements are prepared on a going concern basis which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses from inception and does not currently have the financial resources to sustain operations in the long-term. As shown in the financial statements, the Company has incurred a loss of $591,212 for the year ended December 31, 2023 and, in addition the Company incurred losses of $1,649,589 for the year ended December 31, 2022. As of December 31, 2023, the Company had an accumulated deficit of $48,386,646 and a working capital deficiency of $89,768. As a result of the Company’s current financial position and challenging access to capital, there can be no assurance that the Company will be able to raise additional funds in the future, in which case the Company will be unable to meet its financial obligations. These material uncertainties raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include adjustments to amounts and classifications of assets and liabilities that might be necessary should the Company be unable to continue operations. The Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company’s management will continue to be available to the Company when needed.  

 

There are many external factors that can adversely affect general workforces, economies and financial markets globally. Examples include, but are not limited to, the COVID-19 global pandemic and political conflict in other regions. It is not possible for the Company to predict the duration or magnitude of adverse results of such external factors and their effect on the Company’s business or ability to raise funds.

  

 

3.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of consolidation

 

These consolidated financial statements are presented in United States dollars and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). On March 19th, 2024, the Board approved the consolidated financial statements dated December 31, 2023.

 

These consolidated financial statements include the financial statements of the Company and the entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases.

 

Control is defined as the exposure, or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee. Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly affect the investee’s returns. This control is generally evidenced through owning more than 50% of the voting rights or currently exercisable potential voting rights of a Company’s capital stock. All significant intercompany transactions and balances have been eliminated.

 

43

OCULUS VISIONTECH INC. AND SUBSIDIARY
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2023 and 2022
(Stated in US Dollars)
 

The controlled entities are listed in the following table:

 

Name of Subsidiary

Country of

Incorporation

 

Ownership

Interest at

December 31,

2023

  

Ownership

Interest at

December 31,

2022

 

Principal Activity

           

ComplyTrust Inc.

US/Delaware

  

100%

   

100%

 

Software Development

 

Significant judgments, estimates and assumptions

 

The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows.

 

The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are not limited to the following:

 

Significant judgments

 

the determination of functional currencies; and

 

share-based compensation and warrants issued in connection with private placements, using the fair value method. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based compensation. This estimate also requires determining the most appropriate inputs to the valuation model. The main factor affecting the estimates of the fair value of stock options is the stock price, expected volatility used and the expected duration of the instrument. The Company currently estimates the expected volatility of its common shares based on historical stock price information. The Company recognizes the commitment to issue shares, based on the trading price at the date of the commitment on a percentage basis on the likelihood of the completion of the event.

 

Cash and cash equivalents

 

Cash equivalents include highly liquid investments with original maturities of twelve months or less, and which are subject to an insignificant risk of change in value. Cash equivalents are held for the purpose of meeting short-term cash commitments rather than for investment or other purposes.

 

Impairment of long-lived assets and long-lived assets to be disposed of

 

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount and the fair value less costs to sell.

 

Research and development

 

Expenditure on research activities is recognized on the consolidated statements of operations and comprehensive loss as incurred. Development expenditures are capitalized as part of the cost of the resulting intangible asset only if the expenditures can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. Management determined that as at December 31, 2023 it was not yet able to demonstrate with sufficient certainty that it is probable that any economic benefits will flow to the Company. Accordingly, all research and development costs incurred to date have been expensed. 

 

44

OCULUS VISIONTECH INC. AND SUBSIDIARY
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2023 and 2022
(Stated in US Dollars)
 

Intangible asset

 

Identifiable intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is valued at fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses.

 

The useful lives of intangible assets are assessed as either finite or indefinite.

 

Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment annually whenever there is an indication that the intangible asset may be impaired. The amortization period and method for an intangible asset with a finite useful life are reviewed at least at each financial year-end. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in profit or loss.

 

Intangible assets with indefinite lives are measured at cost less any accumulated impairment losses. These intangible assets are tested for impairment on an annual basis and more frequently if there are indicators that intangible assets may be impaired.

 

Income taxes

 

The Company accounts for income taxes under the asset and liability method. Current income taxes are the expected taxes payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to taxes payable in respect of previous years. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under the asset and liability method, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion or the entire deferred tax asset will not be recognized.

 

Net loss per share

 

Basic loss per share is calculated using the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or contracts that may require the issuance of common shares in the future were converted, unless the impact is anti-dilutive. For the year ended December 31, 2023 and 2022, this calculation proved to be anti-dilutive, and therefore the Company’s 1,565,000 (2022: 5,415,000) stock options and 12,500,000 (2022: 17,400,000) warrants were excluded from the calculation.

 

Stock-based compensation

 

The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Section 718 “Compensation - Stock Compensation”, which establishes accounting for equity-based compensation awards to be accounted for using the fair value method. Equity-settled share-based payment arrangements are initially measured at fair value at the date of grant and recorded within shareholders’ equity. Arrangements considered to be cash-settled are initially recorded at fair value and classified as accrued liabilities, and subsequently re-measured at fair value at each reporting date. The Company’s stock option plan is an equity-settled arrangement.

 

The fair value at grant date of all share-based payments is recognized as compensation expense over the period for which benefits of services are expected to be derived, with a corresponding credit to shareholders’ equity or accrued liabilities depending on whether they are equity-settled or cash-settled. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and estimate the expected forfeiture rate at the date of grant.

 

45

OCULUS VISIONTECH INC. AND SUBSIDIARY
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2023 and 2022
(Stated in US Dollars)
 

Functional currency

 

The Company’s consolidated financial statements are presented in U.S. dollars, which is the Company’s reporting currency. The functional currency of Oculus is the Canadian (“CAD” or “C”) dollar and the functional currency of CTI is the U.S. dollar.

 

In accordance with ASC 830, Foreign Currency Matters, for companies that have a functional currency other than the US dollar, the Company translates the assets and liabilities into U.S. dollars using the rate of exchange prevailing at the balance sheet date and the statements of operations and comprehensive loss and cash flows are translated at an average rate during the reporting period. Adjustments resulting from the translation from CAD into U.S. dollars are recorded in shareholders' equity as part of accumulated other comprehensive (income) loss.

 

Foreign currency transactions are translated into the functional currency of the respective currency of the entity or division, using the exchange rates prevailing at the dates of the transactions (spot exchange rate). Foreign exchange gains and losses resulting from the settlement of such transactions and from the re-measurement of monetary items denominated in foreign currency at period-end exchange rates are recognized in profit or loss. Non-monetary items that are not re-translated at period end are measured at historical cost (translated using the exchange rates at the transaction date), except for non-monetary items measured at fair value, which are translated using the exchange rates as at the date when fair value was determined. Gains and losses are recorded in the statement of operations and comprehensive loss.

 

Recently adopted accounting pronouncements

 

The Company has reviewed new and revised accounting pronouncements that have been issued but are not yet effective. The Company does not expect any material impact from future accounting pronouncements.

  

 

4.

PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

Prepaid expenses and other current assets consist of the following:

 

   

December 31,

   

December 31,

 
   

2023

   

2022

 
                 

Prepaid expenses

  $ 16,014     $ 28,028  

Tax Receivable – Canadian GST

    11,367       2,210  
    $ 27,381     $ 30,238  

 

46

OCULUS VISIONTECH INC. AND SUBSIDIARY
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2023 and 2022
(Stated in US Dollars)
  
 

5.

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consist of the following:

 

   

December 31,

   

December 31,

 
   

2023

   

2022

 
                 

Accounts payable

  $ 87,422     $ 81,927  

Accrued fees and expenses

    48,826       51,869  
    $ 136,248     $ 133,796  

  

 

6.

COMMON STOCK 

 

The Company has no par value common stock with 500,000,000 authorized shares and 91,422,569 outstanding on December 31, 2023 and 2022.

 

The Company has authorized the issuance of 250,000,000 non-voting preferred shares without par value, none issued.

 

As of December 31, 2023, there were Nil common shares held in escrow.

 

During the year ended December 31, 2022, the Company wrote-off the commitment to issue shares of $414,128 due to the uncertainty in the Company meeting the required performance conditions.

  

 

7.

STOCK OPTIONS  

 

During the year ended December 31, 2023 and 2022, the Company adopted a Rolling Stock Option Plan. Up to 10% of the Company’s issued and outstanding common shares may be reserved for granting of stock options. All of the options granted vest 20% every six months.

 

However, all options will be considered vested if one of the following criteria are met by the Company:

 

 

i.

Meeting sales forecasts:

 

 

-

The greater of either the 20% vesting every six months or based on a pro rata percentage of revenue earned by the Company’s subsidiary.

 

 

ii.

the listing of the Company on any national securities exchange.

 

iii.

a Change of Control Event.

 

During the year ended December 31, 2023, the Company did not grant any stock options and recorded $84,034 (2022: $396,520) of share-based compensation for vested portion of options that were previously granted.

 

47

OCULUS VISIONTECH INC. AND SUBSIDIARY
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2023 and 2022
(Stated in US Dollars)
 

The changes in options are as follows:

 

  

Number of

options

  

Weighted

average exercise price

(CAD)

  

Aggregate

Intrinsic Value

 
             

Options outstanding, December 31, 2021

  5,315,000  $0.49  $3,910,950 

Granted

  100,000   0.80   - 

Options outstanding, December 31, 2022

  5,415,000   0.50   - 

Expired

  (3,850,000)  0.36   - 

Options outstanding, December 31, 2023

  1,565,000  $0.85  $- 

 

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for the options that were in-the-money at December 31, 2023.

 

Details of options outstanding as at December 31, 2023 are as follows: 

 

Exercise price

(CAD)

  

Number of

options

outstanding

 

Expiry date

 

Number of options

exercisable

  

Remaining

contractual life (years)

 
                
$1.200   500,000 

January 29, 2024*

  500,000   0.08 
$0.800   375,000 

June 10, 2024

  375,000   0.44 
$0.600   590,000 

October 14, 2024

  472,000   0.79 
$0.800   100,000 

January 31, 2025

  60,000   1.09 
                
     1,565,000    1,407,000     

* expires subsequent to December 31, 2023

 

The following weighted average assumptions were used for the Black-Scholes valuation of stock options granted:

 

  

December 31, 2023

  

December 31, 2022

 
         

Risk-free interest rate

  -   1.24%

Exercise price (CAD)

  -  $0.80 

Expected life of options (in years)

  -   3.00 

Expected annualized volatility

  -   119.10%

Fair value of options granted (CAD)

  -  $0.55 

Expected dividend rate

  -   - 

 

48

OCULUS VISIONTECH INC. AND SUBSIDIARY
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2023 and 2022
(Stated in US Dollars)
  
 

8.

WARRANTS  

 

The changes in warrants are as follows:

 

  

Number of

warrants

  

Weighted

average exercise

price

(CAD)

  

Aggregate

Intrinsic Value

 
             

Warrants outstanding, December 31, 2021 and 2022

  17,400,000  $0.28  $- 

Expired

  (4,900,000)  (1.00)  - 

Warrants outstanding, December 31, 2023

  12,500,000  $0.001  $- 

 

Details of warrants outstanding as at December 31, 2023 are as follows:

 

Exercise price

   

Number of

warrants

outstanding

 

Expiry date

 

Number of

warrants

exercisable

  

Remaining

contractual life

(years)

 
                 
$0.001 

(1) (USA)

  12,500,000 

June 4, 2025

  -   1.43 
                 
      12,500,000    -     

 

 

(1)

No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) targeted revenue sales projections met, or 2) listing on a major US exchange, or 3) change of control.

  

 

9.

SELLING, GENERAL AND ADMINISTRATIVE  

 

The breakdown of selling, general and administrative for the years ended December 31, 2023 and 2022 is as follows:

 

   

2023

   

2022

 
                 

Filing and regulatory fees

  $ 32,862     $ 40,158  

Marketing

    -       76,459  

Professional fees

    78,089       104,801  

Rent

    43,269       38,922  

Office and administration

    120,278       139,127  
                 
    $ 274,498     $ 399,467  

 

49

OCULUS VISIONTECH INC. AND SUBSIDIARY
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2023 and 2022
(Stated in US Dollars)
  
 

10.

RESEARCH AND DEVELOPMENT  

 

The breakdown of research and development for the years ended December 31, 2023 and 2022 is as follows:

 

   

2023

   

2022

 
                 

Project management

  $ -     $ 11,990  

Software development

    61,446       820,996  

Business development

    3,952       133,588  

Payroll

    30,486       171,309  
                 
    $ 95,884     $ 1,137,883  

  

 

11.

FINANCIAL INSTRUMENTS AND RISKS  

 

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are described below.

 

Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2 – inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and

Level 3 - inputs for the asset or liability that are not based on observable market data (unobservable inputs).

 

Fair value of financial instruments

 

The Company has various financial instruments including cash, receivables, accounts payable and accrued liabilities and accounts payable and accrued liabilities - related parties. The carrying values of cash and cash equivalents, receivables, accounts payable and accrued liabilities, and accounts payable and accrued liabilities - related parties approximate their fair values due to the short-term nature of these financial instruments.

 

Cash is carried at a level 1 fair value measurement.

 

The Company’s risk exposures and the impact on the Company’s financial instruments are summarized below:

 

Credit risk

The Company is exposed to credit risk only with respect to uncertainties as to timing and amount of collectability of receivables. The Company believes its credit risk is low because a portion of receivables are comprised of goods and services tax (GST) and other government refunds, which is recoverable from the governing body in Canada. Management does not believe the receivables are impaired. The Company doesn’t believe there is significant credit risk associated with cash as these amounts are held with major Canadian banks.

 

Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company’s approach to managing liquidity risk is to ensure that it will have sufficient liquidity to meet liabilities when due. As at December 31, 2023, the Company had a cash balance of $156,574 (2022 – $687,602) to settle current liabilities of $273,723 (2022 – $302,423). All of the Company’s financial liabilities have contractual maturities of 30 days or due on demand and are subject to normal trade terms.

 

50

OCULUS VISIONTECH INC. AND SUBSIDIARY
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2023 and 2022
(Stated in US Dollars)
 

Interest rate risk

Interest rate risk is the risk that the future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The risk that the Company will realize such a loss is limited as it does not have any significant interest-bearing financial instruments.

 

Foreign currency risk

As at December 31, 2023 and 2022, the Company is exposed to foreign currency risk as certain monetary financial instruments are denominated in Canadian currency. The Company’s sensitivity analysis suggests that reasonably expected changes in the rates of exchange in United States would change foreign exchange gain or loss by an insignificant amount.

  

 

12.

INCOME TAXES  

 

A reconciliation of income taxes at statutory rates with the reported taxes is as follows:

 

  

December 31,

2023

  

December 31,

2022

 
         

Loss before taxes for the year

 $(591,212) $(1,649,589)
         

Expected income tax (recovery)

 $(165,000) $(461,000)

Effect of change in tax rates

  -   37,000 

Permanent differences

  23,000   (5,000)

Adjustment to prior years provision

  (7,000)  (5,000)

Change in unrecognized deductible temporary

  135,000   434,000 
         

Total income taxes

 $-  $- 
         

Current income tax

 $-  $- 

Deferred tax recovery

 $-  $- 

 

The significant components of the Company’s deferred tax assets that have not been included on the consolidated statement of financial position are as follows:

 

  

December 31,

2023

  

December 31,

2022

 
         

Research and development

 $213,000  $- 

Non-capital losses

 $6,936,120  $5,445,227 
         
  $7,149,120  $5,445,227 

Unrecognized deferred tax assets

  (7,149,120)  (5,445,227)

Net deferred tax assets

 $-  $- 

 

51

OCULUS VISIONTECH INC. AND SUBSIDIARY
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2023 and 2022
(Stated in US Dollars)
 

The significant components of the Company’s temporary differences, unused tax credits and unused tax losses that have not been included on the consolidated statement of financial position are as follows: 

 

  

2023

  

Expiry Date

Range

  

2022

  

Expiry Date

Range

 

Temporary Differences

                

Research and development

 $760,000  

 

No expiry date  $-     

Non-capital losses available for future periods

 $24,787,000  

 

2023 to indefinite  $25,155,000  

 

2023 to indefinite 

Canada

 $18,610,000   2023 to 2037  $18,334,000   2023 to 2037 

USA

 $5,350,000  

 

No expiry date  $6,821,000  

 

No expiry date 

  

 

13.

RELATED PARTIES  

 

Related parties include the Board of Directors, officers, close family members and enterprises that are controlled by these individuals as well as certain persons performing similar functions.

 

The Company defines its key management as the Board of Directors, Chief Executive Officer, President, and Chief Financial Officer. Remuneration of directors and key management personnel of the Company was as follows:

 

  

Years ended

December 31,

 
  

2023

  

2022

 
         

Consulting

 $148,500  $135,000 

Selling general and administrative

  94,356   80,331 

Share-based compensation to directors and officers

  1,442   47,062 
  $244,298  $262,393 

 

The Company for the years ended December 31, 2023 and 2022 reimbursed a related party $94,356 and $80,331, respectively, for selling, general and administrative expenses paid on behalf of the Company. The Company incurred $148,500 (2022 - $135,000) of consulting fees accrued to a company controlled by a director of the Company for the years ended December 31, 2023 and 2022.

 

The Company also recorded share-based compensation of $1,442 (2022 - $47,062) for options vested to related parties during the years ended December 31, 2023 and 2022.

 

52

OCULUS VISIONTECH INC. AND SUBSIDIARY
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2023 and 2022
(Stated in US Dollars)
  
 

14.

OPERATING LEASES  

 

The Company has one operating lease with unrelated third parties for office space at Vancouver, Canada.

 

The lease at the Vancouver, Canada location is on a month-to-month basis with monthly rental payments of $4,645 (CAD). For the years ended December 31, 2023 and 2022 rent expense was $41,241 and $36,894, respectively.

  

 

15.

SEGMENTED INFORMATION  

 

The Company currently operates in a single reportable operating segment. All of the Company’s assets and expenditures are located in the United States. Since the Company does not have any revenue producing activities, there is no segment information by revenues.

 

 

 
53

    
 

Item 9A

Control and Procedures

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures, as defined in Exchange Act Rules 13a-15(e) and 15d-15(e), as of the end of the period covered by this report.

 

In designing and evaluating our disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

 

No system of controls can prevent errors and fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur. Controls can also be circumvented by individual acts of some people, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with its policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

Subject to the limitations above, management believes that the consolidated financial statements and other financial information contained in this report, fairly present in all material respects our financial condition, results of operations, and cash flows for the periods presented.

 

Based on the evaluation of the effectiveness of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) were not effective as a result of the weaknesses in the design of our internal control over financial reporting.

 

Based upon their evaluation of our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer have concluded that our internal controls over financial reporting are ineffective.  The material weaknesses in our internal controls related to a lack of segregation of duties due to inadequate staffing within our accounting department and upper management, the assignment of authority and responsibility, lack of consistent policies and procedures, inadequate monitoring controls and inadequate disclosure controls.

 

There were no changes in our internal controls that occurred during the period covered by this report that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

 

We are committed to improving our financial organization.  As part of this commitment, we will create a position to segregate duties consistent with control objectives and will increase our personnel resources and technical accounting expertise within the accounting function when funds are available to our company.

 

In addition, management believes that preparing and implementing sufficient written policies and checklists will remedy the following material weaknesses (i) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements; and (ii) ineffective controls over period end financial close and reporting processes. Further, management believes that the hiring of additional personnel who have the technical expertise and knowledge will result in proper segregation of duties and provide more checks and balances within the department. Additional personnel will also provide the cross training needed to support our company if personnel turn over issues within the department occur.

 

We will continue to monitor and evaluate the effectiveness of our internal controls and procedures and our internal controls over financial reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.  

 

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting.  Management's report was not subject to attestation by our registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit our company to provide only management's report in this annual report.

 

Item 9B.

Other Information

 

Not applicable

  

 

Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 

Not applicable

 

 

PART III

 

Item 10.

Directors and Executive Officers of the Registrant.

 

Our current directors and executive officers and their respective ages as of March 19th, 2024, are as follows:

 

Name and Province or State
  and Country of Residence

Age

Position

Period of

Service

Rowland Perkins
Alberta, Canada

71

Director, President and Chief Executive Officer

Since 2005

Anton J. Drescher 1
British Columbia, Canada

67

Director, Chief Financial Officer and Corporate Secretary

Since 1994

Fabrice Helliker,
Broadstone, UK

56

Director

Since 2020

Maurice Loverso 1
Quebec, Canada

63

Director

Since 2003

Tom Perovic
Ontario, Canada

71

Director

Since 2011

Ron Wages 1
North Carolina, USA

61

Director

Since 2011

 

Note:

1

Member of audit committee.

 

Rowland Perkins President, Chief Executive Officer and Director

Mr. Perkins was formerly the President & Chief Executive Officer of ebackup Inc. (2001-2015) (a private corporation), a digital cloud data service provider specializing in cloud services, data backup and business continuity. Mr. Perkins has over 45 years of business experience and 30 years with various public companies. Mr. Perkins is a former director of one other publicly trade company: Corvus Gold Inc, since August 2010 to 2021. Mr. Perkins was also a former director of Xiana Mining Inc. (TSXV) from 2011 to 2018, of International Tower Hill Mines Ltd. from 2005 to 2010, of Blue Rhino Capital Corp. in 2020 to 2021, and of Lamaska Capital Corp in 2020 to 2021. Mr. Perkins has a degree in Economics from the University of Manitoba.

 

Anton J. Drescher - Chief Financial Officer, Secretary and Director

Mr. Drescher has been a Chartered Professional Accountant, Certified Management Accountant since 1981. He is currently involved with several public companies including as: a director (since 1991) of International Tower Hill Mines Ltd., a public mining company listed on the TSX and the NYSE-MKT; a director (since 1996) and Chief Financial Officer (since 2012) of Xiana Mining Inc., a public mineral exploration company listed on the TSXV/NEX; a director (since 2007) and the Chief Financial Officer of Oculus VisionTech Inc., a public company involved in watermarking of film and data listed on the TSXV and the OTC Bulletin Board; a director (since 2014) of CENTR Brands Corp., a public company listed on the CSE; a former director (since 2020 -2023) of Zeb Nickle Corp. (formerly Blue Rhino Capital Corp.), a public company listed on the TSXV; a former director (2020-2021) of Lamaska Capital Corp., a public company listed on the TSXV. Mr. Drescher is also the President (since 1979) of Westpoint Management Consultants Limited, a private company engaged in tax and accounting consulting for business reorganizations, and the President (since 1998) of Harbour Pacific Capital Corp., a private company involved in regulatory filings for businesses in Canada.

 

Fabrice Helliker Director

Mr. Helliker is currently an advisor to ComplyTrust Inc. (formerly OCL Technologies Corp.), and a long time executive and entrepreneur in the data protection and compliance market. He is currently the head of a software engineering division responsible for data protection automation and orchestration solutions for Hitachi Vantara, where he joined in 2012 upon the acquisition of a company he co-founded, Cofio Software. He was also a co-founder of BakBone Software, which was traded on the Toronto Exchange and later acquired by Quest Software Corp.

 

Maurice Loverso Director

Mr. Loverso has been an independent director of Oculus since May 2003. He has been President of 3336298 Canada Inc. since 1996, providing financial consultation services to small capital public and private companies and has been a director of Group Intercapital Inc. since 1996, assisting a small cap venture capital firm with financial advice.

 

 

Tom Perovic Director

Mr. Perovic has over 30 years of experience in high technology management, from research and development to high-level and top development and executive positions in businesses including automotive industry, in particular in developing and releasing autonomous driving AD Perception products , and ADAS (Advanced Driver Assistance Systems), based on AI - Machine/Deep learning models, for major OEMs, including Daimler, BMW, Toyota, Honda Ford and GM, electronics (embedded hardware, imaging/video processing based products), real-time automotive grade, functional safety compliant embedded software development, running on intelligent RTOS (Real Time Operating System), sensor fusion (camera, LiDAR, Radar, ultrasonic) data capture, and real-time processed by deep learning Neural Networks, Internet centric streaming video content (movies) watermarking products for the entertainment industry, machine vision, IP based video communications, PCB production/development equipment, professional video (TV broadcasting), Internet imaging, security video surveillance, contract manufacturing, material handling/logistics and production/distribution. He has been a co-founder, President and CTO of ASPRO Technologies, a digital security/surveillance technology start-up from 1992-2002, General Manager of Magna International Inc. and Global Director of Engineering at Magna Electronics (Magna Vectrics) from 2002 to 2018 where he was responsible for restructuring since a takeover, P/L, development strategy, operational team building and leadership, and since 2018 till present Sr. Director, Toronto Automotive Center of Excellence (TACoE), LeddarTech Inc, LiDAR high technology company. He established TACoE AI based AD/ADAS/Perception division of LeddarTech from scratch, including building the scientific, engineering, and vehicle integration and quality teams, OPEX and CAPEX. Tom has been instrumental in several technology companies M&A process.

 

Ron Wages Director

Mr. Wages is an innovative and results-driven corporate professional with an impressive 30 year record of success in delivering record profit growth and solid project performance in multiple markets worldwide. He is the Director, Transmission Project Controls at Duke Energy where he leads a team of project management professionals that manage a $9B portfolio of Transmission Capital Projects. Previously, he was the founder and Chief Executive Officer of Vagues Solid State Lighting, a manufacturer of LED based lighting. He was President and General Manager of MEMScAP Inc./JDS Uniphase, a public company in the semiconductors industry. He managed the day-to-day operations for sales, marketing, manufacturing, legal and finance. Mr. Wages has a B.S. in Electrical Engineering from the University of Maryland College Park and an MBA (Honors) from the University of Houston Executive MBA Program.

 

The Board of Directors has no reason to believe that any nominee will not serve if elected. If any nominee is unable to serve as a director, the shares represented by all valid proxies may be voted for the election for such other person(s) as the Board may recommend, unless the Board chooses to reduce the number of directors serving on the Board. Proxies will be voted FOR each nominee unless the shareholder specifies otherwise.

 

The Board of Directors unanimously recommends a vote FOR the election of each of the nominees named in this Proxy Statement. Proxies solicited by the Board of Directors will be so voted unless shareholders specify otherwise on the accompanying Proxy.

 

Term of Office

All of our directors, when elected, hold office until the next annual meeting of our stockholders or until their successors are elected and qualified. Our officers are appointed by our Board of Directors and hold office until their successors are appointed and qualified.

 

Significant Employees

 

There are no significant employees of the Company other than our executive officers. However, our subsidiary, ComplyTrust Inc. (“CTI”), formerly OCL Technologies Corp. (“OCL”), had entered into an employment contract with Mike Johnson (age 65), who was the co-founder, President and a director of CTI, effective February 1, 2022, whereby Mr. Johnson provided product manager services for product development based on proprietary ideas developed by CTI. The term of the employment contract ended on January 31, 2023, as agreed to in writing by CTI and Mr. Johnson. Mr. Johnson was a director and officer of CTI from June 12, 2020 to January 31, 2023. From March 2017 to February 2020, Mr. Johnson was a Business Development Director with the Archival Solutions Division at Sony Electronics where he provided clarity and thought-leadership for introduction of PetaByte-class enterprise storage solutions to the autonomous vehicle/IoT, big data and high-performance compute markets worldwide. Mr. Johnson obtained and undergraduate degree in Audio Engineering from SoundMaster Institute located in Hollywood, California in 1980, and obtained undergraduate degrees in Business and Computer Science from Fullerton College located in Fullerton, California in 1984. Subsequent to Mr. Johnson’s resignation, Anton J. Drescher will act as the interim President and CEO while the Company initiates plans to build out a new CTI executive leadership team focused on continued software development, new customers acquisition and revenue generation.

 

Family Relationships

There is no family relationship between any of our executive officers or directors.

 

 

Involvement in Certain Legal Proceedings

 

Except as disclosed in this proxy statement, during the past ten years none of the following events have occurred with respect to any of our directors and officers:

 

 

1.

A petition under any legislation relating to bankruptcy laws or insolvency laws was filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court for the business or property of such person, or any partnership in which he was a general partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at or within two years before the time of such filing;

 

 

2.

Such person was convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses);

 

 

3.

Such person was the subject of any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from, or otherwise limiting, the following activities:

 

 

i.

Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity;

 

 

ii.

Engaging in any type of business practice; or

 

 

iii.

Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of applicable securities legislation, whether federal, state or provincial or any applicable commodities legislation;

 

 

4.

Such person was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any Federal or State authority barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in paragraph (3)(i) above, or to be associated with persons engaged in any such activity;

 

 

5.

Such person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;

 

 

6.

Such person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;

 

 

7.

Such person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:

 

 

i.

Any Federal or State securities or commodities law or regulation; or

 

 

ii.

Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or

 

 

iii.

Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

 

 

8.

Such person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the U.S. Securities Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

There are currently no legal proceedings to which any of our directors or officers is a party adverse to us or in which any of our directors or officers has a material interest adverse to us. 

 

 

Code of Business Conduct and Ethics

 

The company has adopted and operates under a strict code to conduct its affairs in accordance with all applicable laws, rules and regulations of the countries in which it does business. This Code of Business Conduct (“Code”) applies to the Company’s officers, directors, non-employee directors and contractors, and includes the Company’s principal executive officer, principal financial officer, principal accounting officer or controller, and persons performing similar functions. This Code is the Company’s “code of ethics” and is designed to promote:

 

 

honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

 

 

full, fair, accurate, timely and understandable disclosure in the reports and documents the Company files with, or submits to, the U.S. Securities and Exchange Commission and in other public communications made by the Company;

 

 

compliance with applicable governmental laws, rules and regulations;

 

 

the prompt internal reporting to the appropriate person of violations of this Code; and

 

 

accountability for adherence to this Code.

 

The company has established standards for behavior that affects the Company, officers, directors, contractors and future employees that should pattern their daily performance in compliance with those standards.

 

This Code covers a wide range of business practices and procedures. It does not cover every issue that may arise, but it sets out basic principles to guide you. Corporate policies and procedures provide details pertinent to many of the provisions of the Code.

 

For more details, please refer to Exhibit A, Code of Business Conduct and Ethics.

 

Executive Officers and Directors of the Company:

 

Audit Committee

 

The Audit Committee of the Board of Directors consists of Maurice Loverso, Anton J. Drescher and Ron Wages, who serves as Chairman. The Board of Directors had determined that each Audit Committee member has sufficient knowledge in financial and accounting matters to serve on the Committee and that Anton J. Drescher is an “audit committee financial expert” as defined by SEC rules.

 

The Audit Committee meets with our independent auditors at least quarterly to discuss the results of the annual audit or interim periodic reviews and to review the financial statements; appoints the independent auditors to be retained; oversees the independence of the independent accountants; evaluates the independent auditors’ performance; approves fees paid to independent auditors and receives and considers the independent auditors’ comments as to controls, adequacy of staff and management performance and procedures in connection with audit and financial controls. The Audit Committee met informally by telephone conference during fiscal 2023.

 

The Audit Committee is primarily concerned with the effectiveness of our audits by our internal audit staff and by our independent auditors. Its duties include: (1) recommending the selection of independent auditors; (2) reviewing the scope of the audit to be conducted by them, as well as the results of their audit; (3) reviewing the organization and scope of our internal system of audit and financial controls; (4) appraising our financial reporting activities (including our Proxy Statement and Annual Report) and the accounting standards and principles followed; and (5) examining other reviews relating to compliance by employees with important policies and applicable laws. The Audit Committee operates under a written Charter adopted by the Board of Directors, a copy of which is attached to this Proxy Statement as Schedule “A”.

 

Compensation Committee

 

At present, the company does not have a formal Compensation Committee. All compensation is controlled, managed, and reviewed by the company Board of Directors. As of December 31, 2023, company executives or directors received no compensation for services rendered other than granted stock options.

 

 

 

Item 11.

Executive Compensation

 

The following table sets forth compensation awarded to, earned by or paid to Oculus's Chief Executive Officer (CEO), and to other persons serving as executive officers for the last three completed fiscal years, whose salary and bonus for such year exceeded $100,000 (collectively, the "Named Executive Officers").

 

                             

Long Term Compensation

 
 

Summary Compensation

Annual Compensation

   

Awards

   

Payouts

 

Name and

Principal

Position

Year

 

Salary

   

Bonus

   

Other

Annual

Compen-

sation

   

Restricted

Stock

Award(s)

   

Securities

Underlying

Options/SARs

(#)1

   

LTIP

Payouts

   

All Other

Compen-

sation

 
     

$

   

$

   

$

   

$

           

$

   

$

 
                                                           

Drescher,

2023

   

-0-

     

-0-

     

148,500

     

-0-

     

-0-

     

-0-

     

-0-

 

Anton

2022

   

-0-

     

-0-

     

135,000

     

-0-

     

-0-

     

-0-

     

-0-

 

CFO

2021

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 
                                                           

Perkins,

2023

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 

Rowland

2022

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 

CEO

2021

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 

 

The following table sets forth certain information concerning exercises of stock options by the Named Executive Officers during the year ended December 31, 2023 and stock options held at year end.

 

Aggregated Option / SAR Exercises in Last Fiscal Year and FY-End Option / SAR Values

 
             

Number of Securities

Underlying Unexercised

Options / SARs at Fiscal year End

December 31, 2023

 

Value of Unexercised In-the-

Money Options / SARs at

Fiscal Year End ($)

 

Name

Shares

Acquired on

Exercise (#)1

 

Value

Realized ($)

 

Exercisable/ Unexercisable

 

Exercisable/ Unexercisable

 

Drescher, Anton

 

Nil

   

-0-

 

Nil / Nil

   

-0-

/

-0-

 

Perkins, Rowland

 

Nil

   

-0-

 

Nil / Nil

   

-0-

/

-0-

 

 

1 The additional terms and conditions attached to the Option represented by this Option Commitment are as follows:

 

 

1.

The Options will not be exercisable unless and until they have vested and then only to the extent that they have vested. The Options will vest in accordance with the following:

 

 

Vesting Provisions

 

To vest as to 20% on the date that is six months from the date of grant, and a further 20% on each successive date that is six months from the date of the previous vesting in accordance with the table below:

 

All options will be considered vested if one of the following criteria are met by the Company:

 

 

i.

Meeting sales forecasts:

 

 

-

The greater of either the 20% vesting every six months or the pro rata percentage of warrants earned by the Company’s subsidiary, ComplyTrust Inc. (“CTI”) in years 1, 2 and 3

 

 

-

(100V/$125,000,000) of the warrants shall vest on June 4, 2021 (2022 and 2023), wherein “V” is the Gross Revenue of the business (as hereinafter defined) between the period June 4, 2020 – June 4, 2025;

 

 

-

“Gross Revenue” means all monetary sums earned less any credits issued for returns and allowances, and, for certainty, Gross Revenue does not include Deferred Revenue;

 

 

-

eg: if the CTI warrant holders earn 60% of projected revenue in Year 1 then all option holders would also vest 60% .

 

 

ii.

the listing of the Company on any national securities exchange registered with the United States Securities and Exchange Commission under section 6 of the United States Securities Exchange Act of 1934, as amended, such as, but not limited to, the New York Stock Exchange, the NYSE American, and NASDAQ Stock Market; or

 

 

iii.

a Change of Control Event meaning, with reference to the Company: (a) the acquisition of a sufficient number of voting securities in the capital of the Company so that the acquirer (as referenced in the CTI Share Purchase Agreement dared for reference June 5, 2020) becomes entitled, directly or indirectly, to exercise more than 50% of the voting rights attaching to the outstanding voting securities in the capital of the Company (provided that, prior to the acquisition, the acquirer was not entitled to exercise more than 50% of the voting rights attaching to the outstanding voting securities in the capital of the Company); (b) an occurrence when a majority of the directors elected at any annual or extraordinary general meeting of shareholders of the Company are not individuals nominated by the Company’s then-incumbent board; or (c) sale of one or more assets of the Company (but for certainty excludes sales made in the normal course of Business) after the Closing Date (as defined in the CTI Share Purchase Agreement) resulting in the collection of monetary sums that is collectively more than 50% of the Gross Revenue of the Company during the twelve (12) month period immediately preceding the Closing Date (as defined in the CTI Share Purchase Agreement).

 

 

Compensation of Directors

 

Directors receive no compensation for their service as such.

 

The following table sets forth compensation awarded to, earned by or paid to Oculus's directors for the last three completed fiscal years.

 

                             

Long Term Compensation

 
 

Summary Compensation

Annual Compensation

   

Awards

   

Payouts

 

Name and

Principal

Position

Year

 

Salary

   

Bonus

   

Other

Annual

Compen-

sation

   

Restricted

Stock

Award(s)

   

Securities

Underlying

Options/SARs

(#)1

   

LTIP

Payouts

   

All Other

Compen-

sation

 
     

$

   

$

   

$

   

$

           

$

   

$

 
                                                           

Loverso,

2023

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 

Maurice

2022

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 

Director

2021

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 
                                                           

Pervic,

2023

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 

Tom

2022

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 

Director

2021

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 
                                                           

Wages

2023

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 

Ron

2022

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 

Director

2021

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 
                                                           

Helliker

2023

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 

Fabrice

2022

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 

Director

2021

   

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

     

-0-

 

 

The following table sets forth certain information concerning exercises of stock options by directors during the year ended December 31, 2023 and stock options held at year end.

 

Aggregated Option / SAR Exercises in Last Fiscal Year and FY-End Option / SAR Values

 
                 

Number of Securities

Underlying Unexercised

Options / SARs at Fiscal year End

December 31, 2022

 

Value of Unexercised In-the-

Money Options / SARs at

Fiscal Year End ($)

 

Name

 

Shares

Acquired on

Exercise (#)1

   

Value

Realized ($)

 

Exercisable/ Unexercisable

 

Exercisable/ Unexercisable

 

Loverso, Maurice

   

Nil

     

-0-

 

Nil / Nil

   

-0-

/

-0-

 

Pervic, Tom

   

Nil

     

-0-

 

Nil / Nil

   

-0-

/

-0-

 

Wages, Ron

   

Nil

     

-0-

 

Nil / Nil

   

-0-

/

-0-

 

Helliker, Fabrice

   

Nil

     

-0-

 

Nil / Nil

   

-0-

/

-0-

 

 

Employment Contracts

 

We do not have an employment contract with Mr. Rowland Perkins and Anton Drescher. We have no obligation to provide any compensation to Mr. Perkins or any other Named Executive Officer in the event of his resignation, retirement or termination, or a change in control of our company, or a change in any Named Executive Officers' responsibilities following a change in control.

 

We may in the future create retirement, pension, profit sharing and medical reimbursement plans covering our Executive Officers and Directors.

 

 

 

Item 12.

Security Ownership of Certain Beneficial Owners and Management.

 

The following table sets forth information regarding the beneficial ownership of our common stock as of March 19th, 2024, by:

 

 

each person who is known by us to beneficially own more than 5% of our shares of common stock; and

 

 

each executive officer, each director and all of our directors and executive officers as a group.

 

The number of shares beneficially owned and the related percentages are based on 91,422,569 shares of common stock outstanding as of March 19th, 2024.

 

For the purposes of the information provided below, Common Shares that may be issued upon the exercise or conversion of stock options, warrants and other rights to acquire shares of our common stock that are exercisable or convertible within 60 days following December 31, 2023, when there were deemed to be 91,422,569 shares of common stock (“Common Shares”) of the Company outstanding and beneficially owned by the stockholders for the purpose of computing the number of Common Shares and percentage ownership of each holder are reported below, but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person.

 

Name and Address of Beneficial Owner (1)

Amount and Nature of
Beneficial Ownership (1)

Percentage of
Beneficial Ownership

Directors and Officers:

   
     

Anton J. Drescher, Chief Financial Officer, Corporate Secretary and Director
c/o #507, 837 West Hastings Street
Vancouver, British Columbia, Canada, V6C 3N6

13,804,540(2)

15.10%

     

Maurice Loverso, Director
c/o #507, 837 West Hastings Street
Vancouver, British Columbia, Canada, V6C 3N6

Nil

Nil

     

Rowland Perkins, President, Chief Executive Officer and Director
c/o #507, 837 West Hastings Street
Vancouver, British Columbia, Canada, V6C 3N6

8,600,000(3)

9.41%

     

Tom Perovic, Director
c/o #057, 837 West Hastings Street
Vancouver, British Columbia, Canada, V6C 3N6

1,895,000(4)

2.07%

     

Ron Wages, Director
c/o #507, 837 West Hastings Street
Vancouver, British Columbia, Canada, V6C 3N6

200,000(5)

.222

     

Fabrice Helliker, Director

c/o #507, 837 West Hastings Street
Vancouver, British Columbia, Canada, V6C 3N6

325,000(6)

.352

     

All directors and executive officers as a group (6 persons)

24,840,540

27.15%

 

 

Notes:

*

Less than one percent.

(1)

Under Rule 13d-3 of the Exchange Act, a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares: (i) voting power, which includes the power to vote, or to direct the voting of such security; and (ii) investment power, which includes the power to dispose or direct the disposition of the security. Certain shares of common stock may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares of common stock are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares of common stock outstanding is deemed to include the amount of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of common stock of any person as shown in this table does not necessarily reflect the person’s actual ownership or voting power with respect to the number of shares of common stock actually outstanding as of the date of this Proxy Statement. As of March 15, 2021, there were 86,522,569 shares of common stock of the Company issued and outstanding.

(2)

This figure represents 13,804,540 shares of common stock held directly by Anton J. Drescher.

(3)

This figure represents 8,600,000 shares of common stock held directly by Rowland Perkins.

(4)

This figure represents (i) 1,800,000 shares of common stock held by 4C Inc., an entity controlled by Tom Perovic, and (ii) 95,000 shares of common stock held directly by Mr. Perovic.

(5)

This figure represents 200,000 shares of common stock held directly by Ron Wages.

(6)

This figure represents 325,000 shares of common stock help by 14D9OCL LLC, an entity in which Fabrice Helliker has a 20% ownership interest.

 

Name

   

Shares Owned

   

Percentage of Class

 

N/A

     

-0-

     

0.00%

 

Person known to us to beneficial own more than 5%

     

-0-

     

0.00%

 

 

Item 13.

Certain Relationships and Related Transactions.

 

The Company for the years ended December 31, 2023 and 2022 reimbursed a related party $94,356 and $80,331, respectively, for selling, general and administrative expenses paid on behalf of the Company. The Company incurred $148,500 (2022 - $135,000) of consulting fees accrued to a company controlled by a director of the Company for the years ended December 31, 2023 and 2022.

 

The Company also recorded share-based compensation of $1,442 (2022 - $47,062) for options vested to related parties during the years ended December 31, 2023 and 2022.

 

Item 14.

Principle Accountant Fees and Services

 

Audit and Non-Audit Fees

 

The following table presents fees for the professional audit services rendered by Davidson and Company LLP, for the audit of our annual financial statements for the years ended December 31, 2023 and 2022.

 

Year ended December 31

 

2023

   

2022

 

Audit fees

  $ 22,400     $ 22,400  

Audit-related fees

    -       -  

Tax fees

    8,500       8,500  

All other fees

    -       -  

Total

  $ 30,900     $ 30,900  

 

The Audit Committee reviews all audit and non-audit related fees at least annually. The Audit Committee pre-approved all audit and non-audit related services in fiscal 2023 and 2022.

 

 

PART IV

 

Item 15.

Exhibits and Financial Statements Schedules

 

 

3.1

Articles of Amendment (Wyoming) filed January 26, 2012.

 

3.2

Articles of Continuance (Wyoming) filed February 16, 1995 (incorporated by reference from Exhibit 3.1 to the registrant's Form 10).

 

 

The following exhibits are filed as part of this Annual Report.

 

3.3

Articles of Amendment (Alberta) filed January 3, 1995 (incorporated by reference from Exhibit 3.2 to the registrant's Form 10).

 

3.4

Articles of Amendment (Alberta) filed June 28, 1993 (incorporated by reference from Exhibit 3.3 to the registrant's Form 10).

 

3.5

Articles of Amendment (Alberta) filed April 6, 1992 (incorporated by reference from Exhibit 3.3 to the registrant's Form 10).

 

3.6

Articles of Amendment (Alberta) filed September 1, 1989 (incorporated by reference from Exhibit 3.5 to the registrant's Form 10).

 

3.7

Articles of Incorporation (Alberta) filed April 18, 1986 (incorporated by reference from Exhibit 3.6 to the registrant's Form 10).

 

3.8

Bylaws (incorporated by reference from Exhibit 3.7 to the registrant's Form 10).

 

4.3

Share Option Plan (incorporated by reference from Exhibit 4.3 to the registrant's Form 10).

 

10.4

Alliance Partner Agreement dated November 11, 1999, between Exodus Communications, Inc. and registrant (incorporated by reference from Exhibit 10.4 to the registrant's Form 10).

 

21.

Subsidiaries of the Registrant:

 

Name

State of Incorporation

Status

USA Video (California) Corporation

Nevada

Dissolved

USA Video Corporation

Texas

Dissolved

Old Lyme Video Productions Inc.

Wyoming

Dissolved

USA Video Technology Corporation

Wyoming

Dissolved

USVO, Inc.

Connecticut

Dissolved

ComplyTrust® Inc. (Formerly OCL Technologies Corp.)

Delaware

Active

 

31.1

Certification of the Chief Executive Officer Pursuant To Rule 13a-14 Or 15d-14 of the Securities Exchange Act Of 1934,as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

31.2

Certification of the Chief Financial Officer Pursuant To Rule 13a-14 Or 15d-14 of the Securities Exchange Act of 1934,as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

32.1

Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

32.2

Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

101.INS

Inline XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)

 

Item 16.

Form 10-K Summary

 

None. 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

OCULUS VISIONTECH, INC.

 

 

Dated: March 19th, 2024

By: /s/ Rowland Perkins         

Rowland Perkins

Chief Executive Officer

(Principal Executive Officer)

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

         

/s/ Rowland Perkins

 

Chief Executive Officer (Principal

Executive Officer), Director

 

March 19th, 2024

Rowland Perkins

       
         

/s/ Anton J. Drescher

 

Chief Financial Officer, (Principal

financial officer and principal

accounting officer), Director

 

March 19th, 2024

Anton J. Drescher

       
         

/s/ Maurice Loverso

 

Director

 

March 19th, 2024

Maurice Loverso

       
         

/s/ Tom Perovic

 

Director

 

March 19th, 2024

Tom Perovic

       
         

/s/ Ron Wages

 

Director

 

March 19th, 2024

Ron Wages

       
         

/s/ Fabrice Helliker

 

Director

 

March 19th, 2024

Fabrice Helliker

       

 

66
EX-31.1 2 ex_638660.htm EXHIBIT 31.1 ex_638660.htm

 

EXHIBIT 31.1

 

CERTIFICATION

 

I, Rowland Perkins, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Oculus VisionTech Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

       
       

Date: March 19th, 2024

By:

/s/ Rowland Perkins

 
   

Rowland Perkins

 
   

Chief Executive Officer

 
   

(Principal Executive Officer)

 

 

 
EX-31.2 3 ex_638661.htm EXHIBIT 31.2 ex_638661.htm

 

EXHIBIT 31.2

 

CERTIFICATIONS

 

I, Anton J. Drescher, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Oculus VisionTech Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

       
       

Date: March 19th, 2024

By:

/s/ Anton J. Drescher

 
   

Anton J. Drescher

 
   

Chief Financial Officer

 
   

(Principal Financial and Accounting Officer)

 

 

 
EX-32.1 4 ex_638662.htm EXHIBIT 32.1 ex_638662.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of Oculus VisionTech Inc. (the “Company”), for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Rowland Perkins, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

       
       

Date: March 19th, 2024

By:

/s/ Rowland Perkins

 
   

Rowland Perkins

 
   

Chief Executive Officer

 
   

(Principal Executive Officer)

 

 

 
EX-32.2 5 ex_638663.htm EXHIBIT 32.2 ex_638663.htm

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of Oculus VisionTech Inc. (the “Company”), for the period ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Anton J. Drescher of Oculus VisionTech Inc., Chief Financial Officer for the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

       
       

Date: March 19th, 2024

By:

/s/ Anton J. Drescher

 
   

Chief Financial Officer

 
   

(Principal Financial and Accounting Officer)

 

 

 
EX-101.SCH 6 ovtz-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Stockholders' Equity (Deficiency) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Basis of Presentation and Business link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Going Concern link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Common Stock link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Stock Options link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Warrants link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Selling, General and Administrative link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Research and Development link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 11 - Financial Instruments and Risks link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 12 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 13 - Related Parties link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 14 - Operating Leases link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 15 - Segmented Information link:calculationLink link:definitionLink link:presentationLink 995467 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 995468 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 995469 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses (Tables) link:calculationLink link:definitionLink link:presentationLink 995470 - Disclosure - Note 7 - Stock Options (Tables) link:calculationLink link:definitionLink link:presentationLink 995471 - Disclosure - Note 8 - Warrants (Tables) link:calculationLink link:definitionLink link:presentationLink 995472 - Disclosure - Note 9 - Selling, General and Administrative (Tables) link:calculationLink link:definitionLink link:presentationLink 995473 - Disclosure - Note 10 - Research and Development (Tables) link:calculationLink link:definitionLink link:presentationLink 995474 - Disclosure - Note 12 - Income Taxes (Tables) link:calculationLink link:definitionLink link:presentationLink 995475 - Disclosure - Note 13 - Related Parties (Tables) link:calculationLink link:definitionLink link:presentationLink 995476 - Disclosure - Note 2 - Going Concern (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995477 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995478 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) link:calculationLink link:definitionLink link:presentationLink 995479 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) link:calculationLink link:definitionLink link:presentationLink 995480 - Disclosure - Note 6 - Common Stock (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995481 - Disclosure - Note 7 - Stock Options (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995482 - Disclosure - Note 7 - Stock Options - Changes in Options (Details) link:calculationLink link:definitionLink link:presentationLink 995483 - Disclosure - Note 7 - Stock Options - Details of Options Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink 995484 - Disclosure - Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details) link:calculationLink link:definitionLink link:presentationLink 995485 - Disclosure - Note 8 - Warrants - Schedule of Warrants (Details) link:calculationLink link:definitionLink link:presentationLink 995486 - Disclosure - Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) link:calculationLink link:definitionLink link:presentationLink 995487 - Disclosure - Note 10 - Research and Development - Research and Development (Details) link:calculationLink link:definitionLink link:presentationLink 995488 - Disclosure - Note 11 - Financial Instruments and Risks (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995489 - Disclosure - Note 12 - Income Taxes - Reconciliation of Income Taxes (Details) link:calculationLink link:definitionLink link:presentationLink 995490 - Disclosure - Note 12 - Income Taxes - Net Deferred Tax Assets (Details) link:calculationLink link:definitionLink link:presentationLink 995491 - Disclosure - Note 12 - Income Taxes - Components of Temporary Difference (Details) link:calculationLink link:definitionLink link:presentationLink 995492 - Disclosure - Note 13 - Related Parties (Details Textual) link:calculationLink link:definitionLink link:presentationLink 995493 - Disclosure - Note 13 - Related Parties - Related Party Expenses (Details) link:calculationLink link:definitionLink link:presentationLink 995494 - Disclosure - Note 14 - Operating Leases (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 7 ovtz-20231231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 ovtz-20231231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 ovtz-20231231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Note To Financial Statement Details Textual Exercise price (CAD) (in CAD per share) Significant Accounting Policies Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Note 4 - Prepaid Expenses and Other Current Assets Note 5 - Accounts Payable and Accrued Expenses Risk-free interest rate Note 7 - Stock Options Note 8 - Warrants Note 9 - Selling, General and Administrative Note 10 - Research and Development Expected annualized volatility Note 12 - Income Taxes Note 13 - Related Parties Accumulated other comprehensive income (loss) Income Tax Disclosure [Text Block] Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Foreign Currency Transactions and Translations Policy [Policy Text Block] Note 7 - Stock Options - Changes in Options (Details) Note 7 - Stock Options - Details of Options Outstanding (Details) Add back non-cash share-based compensation us-gaap_LiabilitiesCurrent Liabilities, Current Total Current Liabilities Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details) Note 8 - Warrants - Schedule of Warrants (Details) Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) Note 10 - Research and Development - Research and Development (Details) Note 12 - Income Taxes - Reconciliation of Income Taxes (Details) Expected life of options (in years) (Year) Earnings Per Share, Policy [Policy Text Block] Note 12 - Income Taxes - Net Deferred Tax Assets (Details) Note 12 - Income Taxes - Components of Temporary Difference (Details) Note 13 - Related Parties - Related Party Expenses (Details) Notes To Financial Statements Notes To Financial Statements [Abstract] Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Income Tax, Policy [Policy Text Block] Share-Based Payment Arrangement, Option, Activity [Table Text Block] Currency translation differences Currency translation differences Currency translation differences Research and Development Expense, Policy [Policy Text Block] Other comprehensive income (loss) us-gaap_SharesIssued Balance (in shares) Balance (in shares) Share-Based Payment Arrangement [Policy Text Block] Equity [Text Block] Granted, aggregate intrinsic value (in dollars per share) Expired, aggregate intrinsic value (in dollars per share) Exercisable (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Remaining contractual life (Year) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 Options outstanding, aggregate intrinsic value Fair value of options granted (CAD) (in dollars per share) Tax Receivable – Canadian GST Interest income Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 91,422,569 us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Options outstanding, weighted average exercise price (in dollars per share) Options outstanding, weighted average exercise price (in dollars per share) Common stock, shares authorized (in shares) Common Stock, Shares Authorized (in shares) Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Common stock, shares issued (in shares) Expired, weighted average exercise price (in dollars per share) Common stock, no par value (in dollars per share) Common Stock, No Par Value (in dollars per share) us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Granted, weighted average exercise price (in dollars per share) us-gaap_DeferredTaxAssetsValuationAllowance Unrecognized deferred tax assets Lessee, Operating Leases [Text Block] us-gaap_AccountsPayableCurrent Accounts payable Number of options outstanding (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Options outstanding (in shares) Options outstanding (in shares) us-gaap_DeferredTaxAssetsNet Net deferred tax assets us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Expired, options (in shares) Preferred stock - no par value; authorized 250,000,000 shares, none issued Preferred stock, issued (in shares) Preferred Stock, Shares Issued (in shares) Cash paid during the year for interest us-gaap_PolicyTextBlockAbstract Accounting Policies Cash paid during the year for income taxes Prepaid expenses Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Preferred stock, par value (in dollars per share) Goodwill and Intangible Assets, Policy [Policy Text Block] us-gaap_DeferredTaxAssetsGross Deferred Tax Assets, Gross Preferred stock, authorized (in shares) Preferred Stock, Shares Authorized (in shares) Accrued fees and expenses Expiry date us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Financial Instruments Disclosure [Text Block] Current Liabilities: Vesting [Axis] Vesting [Domain] Share-Based Payment Arrangement, Tranche One [Member] us-gaap_Assets Total Assets Supplemental disclosures of cash flow information: Plan Name [Axis] Plan Name [Domain] Consulting (Note 13) The aggregate costs incurred for consultation. Other Assets Disclosure [Text Block] Rent Operating Lease, Expense ovtz_WorkingCapitalDeficit Working Capital (Deficit) Represents the amount of difference between Current Assets and Current Liabilities. Statement [Line Items] Commitment to Issue Shares [Member] Represents commitment to issue shares. Additional paid-in capital Share-Based Payment Arrangement [Text Block] AOCI Attributable to Parent [Member] Stockholders’ Equity (Deficiency): Segment Reporting Disclosure [Text Block] Non-capital losses Award Type [Domain] Net loss us-gaap_NetIncomeLoss Net Income (Loss) Attributable to Parent Net loss Award Type [Axis] us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year ASSETS Effect of foreign currency translation on cash us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Net decrease in cash and cash equivalents Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Share-Based Payment Arrangement, Option [Member] us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities Warrant [Member] us-gaap_PrepaidExpenseAndOtherAssetsCurrent Prepaid expenses and other current assets (Note 4) Prepaid Expense and Other Assets, Current Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Canada Revenue Agency [Member] Range Six [Member] Represents the range six. Expired (in dollars per share) Per share or per unit weighted average exercise price of warrants or rights expired during the period. Nonrelated Party [Member] us-gaap_CostsAndExpenses Loss from operations Expenses: Retained Earnings [Member] Consulting Fees [Member] Represents consulting fees paid. Increase in accounts payable and accrued expenses Related party transactions Related Party Transaction, Amounts of Transaction Additional Paid-in Capital [Member] Common Stock [Member] Related Party Transactions Disclosure [Text Block] Schedule of Related Party Transactions [Table Text Block] us-gaap_IncomeTaxExpenseBenefit Total income taxes Equity Components [Axis] Equity Component [Domain] Current income tax Exercise price (in dollars per share) us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Number of warrants outstanding (in shares) us-gaap_ClassOfWarrantOrRightOutstanding Warrants outstanding (in shares) Warrants outstanding (in shares) us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Loss before taxes for the year Reimbursement [Member] Represents the related party transaction for reimbursement. ovtz_ClassOfWarrantOrRightExpiredDuringPeriod Expired (in shares) The number of warrants or rights expired during period. ICFR Auditor Attestation Flag Office and administration Vancouver, CA Operating Lease [Member] Represents the operating lease for the Vancouver, Candada location. ovtz_OperatingLeasesMonthlyRentExpense Operating Leases, Monthly Rent Expense Amount of monthly rent expense incurred under the operating lease. Decrease in accounts payable and accrued expenses due to related parties Vesting Every Six Months [Member] Represents the options vested every 6 months. Cash and cash equivalents us-gaap_CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value Income Tax Authority, Name [Axis] Income Tax Authority, Name [Domain] Internal Revenue Service (IRS) [Member] Income Tax Authority [Axis] Income Tax Authority [Domain] Share-based compensation (Notes 7 and 13) Share-Based Payment Arrangement, Expense Domestic Tax Authority [Member] Foreign Tax Authority [Member] Document Annual Report Cash and Cash Equivalents, Policy [Policy Text Block] Amendment Flag Entity Incorporation, State or Country Code Accounting Policies [Abstract] Significant Accounting Policies [Text Block] us-gaap_ComprehensiveIncomeNetOfTax Total comprehensive loss Document Transition Report City Area Code Document Financial Statement Error Correction [Flag] Use of Estimates, Policy [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] Selling, General and Administrative Expenses [Member] Entity Interactive Data Current Related Party [Member] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding, Ending Balance (in shares) Title of 12(g) Security Current Fiscal Year End Date us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Decrease in prepaid expenses and other current assets Selling, General and Administrative Disclosure [Text Block] The entire disclosure for selling, general and administrative expenses. Document Fiscal Period Focus Document Fiscal Year Focus Consolidation, Policy [Policy Text Block] Schedule of Selling, General and Administrative Expenses [Table Text Block] Tabular disclosure of selling, general and administrative expenses. Document Period End Date Income Statement Location [Axis] Income Statement Location [Domain] Entity File Number Entity Emerging Growth Company Document Type Filing and regulatory fees Expenditures for filing and regulatory. Entity Small Business Entity Shell Company Auditor Name Document Information [Line Items] Document Information [Table] Research and Development Represents research and development operating loss carryforwards. Research and development Represents capitalized research and development related to deferred tax assets. Entity Public Float Entity Filer Category Auditor Firm ID Entity Current Reporting Status Entity Voluntary Filers Auditor Location Entity Well-known Seasoned Issuer Non-capital losses available for future periods Represents non-capital losses available for future periods related to operating loss carryforwards. us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue Share-based compensation Entity Tax Identification Number Entity Central Index Key Operatinting loss Entity Registrant Name Entity [Domain] Legal Entity [Axis] Summary of Operating Loss Carryforwards [Table Text Block] Statement [Table] Entity Address, Address Line One Statement of Financial Position [Abstract] Weighted average number of common shares outstanding – basic and diluted (in shares) Accounts Payable and Accrued Liabilities Disclosure [Text Block] ecd_NonRule10b51ArrTrmntdFlag Non-Rule 10b5-1 Arrangement Terminated [Flag] Entity Address, City or Town ecd_Rule10b51ArrTrmntdFlag Rule 10b5-1 Arrangement Terminated [Flag] ecd_Rule10b51ArrAdoptedFlag Rule 10b5-1 Arrangement Adopted [Flag] Entity Address, Postal Zip Code Net loss per share – basic and diluted (in dollars per share) Entity Address, State or Province ecd_NonRule10b51ArrAdoptedFlag Non-Rule 10b5-1 Arrangement Adopted [Flag] Material Terms of Trading Arrangement [Text Block] Statement of Cash Flows [Abstract] Entity Common Stock, Shares Outstanding Lease Contractual Term [Domain] Statement of Stockholders' Equity [Abstract] Lease Contractual Term [Axis] Income Statement [Abstract] Professional fees Marketing Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Local Phone Number Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] us-gaap_TableTextBlock Notes Tables Related Party, Type [Axis] Related Party, Type [Domain] ovtz_CommonStockSharesHeldInEscrow Common Stock, Shares Held in Escrow (in shares) Number of common stock held in escrow. Selling, general and administrative (Notes 9 and 13) Selling, General and Administrative Expense Granted, options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) Effect of change in tax rates Range Five [Member] Represents range five. Class of Warrant or Right [Text Block] The entire disclosure for warrant or right. us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes Adjustment to prior years provision Schedule of Warrants or Right [Table Text Block] Tabular disclosure of an entity's warrants or rights. Range Three [Member] Represents range three. Range Four [Member] Represents range four. us-gaap_LiabilitiesAndStockholdersEquity Total Liabilities and Stockholders' Equity (Deficiency): Class of Warrant or Right, Remaining Contractual Term ovtz_ClassOfWarrantOrRightRemainingContractualTerm Remaining contractual term of class of warrant or right. Warrants Expiring on June 4, 2025 [Member] Represents warrants expiring on June 4, 2025. Related Party Transaction [Axis] Related Party Transaction [Domain] ovtz_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice Warrants outstanding, weighted average exercise price (in dollars per share) Warrants outstanding, weighted average exercise price (in dollars per share) Weighted average price of class of warrant or right outstanding. Payroll Research and development expense during the period related to payroll. Accumulated deficit Retained Earnings (Accumulated Deficit) Share-based Compensation [Member] Represents share-based compensation. Research and development (Note 10) Research and Development Expense Schedule of Research and Development Expenses [Table Text Block] Tabular disclosure of research and development expenses. Project management Research and development expense during the period related to project management. Research, Development, and Computer Software Disclosure [Text Block] Software development Business development Research and development expense during the period related to business development. Expected income tax (recovery) Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to expected income tax (recovery). Changes in operating assets and liabilities: us-gaap_StockholdersEquity Stockholders' Equity (Deficiency): Balance Balance ovtz_SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved The percent of issued and outstanding common shares reserved in a share-based compensation. ovtz_ReductionOfCommitmentToIssueShares Reduction of commitment to issue shares Represents a reduction of the commitment to issue shares. us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Substantial Doubt about Going Concern [Text Block] Permanent differences Change in unrecognized deductible temporary Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to change in unrecognized deductible temporary. Class of Stock [Axis] Gain on reduction of commitment to issue shares (Note 6) Gains (Losses) on Commitment to Issue Shares Gain on reduction of commitment to issue shares Gain (loss) related to the commitment to issue shares. Rolling Stock Option Plan [Member] Related to the Rolling Stock Option Plan. Deferred tax recovery Exercise Price Range [Axis] Exercise Price Range [Domain] EX-101.PRE 10 ovtz-20231231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 11 dcllp01.jpg begin 644 dcllp01.jpg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dcllp02.jpg begin 644 dcllp02.jpg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ovtz20231231_10kimg001.jpg begin 644 ovtz20231231_10kimg001.jpg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ovtz20231231_10kimg002.jpg begin 644 ovtz20231231_10kimg002.jpg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htm IDEA: XBRL DOCUMENT v3.24.1
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2023
Mar. 19, 2024
Jun. 30, 2023
Document Information [Line Items]      
Entity Central Index Key 0001107280    
Entity Registrant Name OCULUS VISIONTECH INC.    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Document Transition Report false    
Entity File Number 000-29651    
Entity Incorporation, State or Country Code WY    
Entity Tax Identification Number 06-1576391    
Entity Address, Address Line One #507, 837 West Hastings Street    
Entity Address, City or Town Vancouver    
Entity Address, State or Province BC    
Entity Address, Postal Zip Code V6C 3N6    
City Area Code 604    
Local Phone Number 685-1017    
Title of 12(g) Security Common Stock, no par value    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 4,000,000
Entity Common Stock, Shares Outstanding   91,422,569  
Auditor Name Davidson & Company LLP    
Auditor Location Vancouver, BC. Canada    
Auditor Firm ID 731    
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
ASSETS    
Cash and cash equivalents $ 156,574 $ 687,602
Prepaid expenses and other current assets (Note 4) 27,381 30,238
Total Assets 183,955 717,840
Current Liabilities:    
Total Current Liabilities 273,723 302,423
Stockholders’ Equity (Deficiency):    
Preferred stock - no par value; authorized 250,000,000 shares, none issued 0 0
Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 91,422,569 46,850,710 46,850,710
Additional paid-in capital 1,479,031 1,394,997
Accumulated other comprehensive income (loss) (32,863) (34,856)
Accumulated deficit (48,386,646) (47,795,434)
Stockholders' Equity (Deficiency): (89,768) 415,417
Total Liabilities and Stockholders' Equity (Deficiency): 183,955 717,840
Nonrelated Party [Member]    
Current Liabilities:    
Accounts payable and accrued expenses 136,248 133,796
Related Party [Member]    
Current Liabilities:    
Accounts payable and accrued expenses $ 137,475 $ 168,627
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets (Parentheticals) - $ / shares
$ / shares in Thousands
Dec. 31, 2023
Dec. 31, 2022
Preferred stock, par value (in dollars per share) $ 0 $ 0
Preferred stock, authorized (in shares) 250,000,000 250,000,000
Preferred stock, issued (in shares) 0 0
Common stock, no par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 91,422,569 91,422,569
Common stock, shares outstanding (in shares) 91,422,569 91,422,569
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Expenses:    
Consulting (Note 13) $ 148,500 $ 135,000
Research and development (Note 10) 95,884 1,137,883
Selling, general and administrative (Notes 9 and 13) 274,498 399,467
Share-based compensation (Notes 7 and 13) 84,034 396,520
Loss from operations (602,916) (2,068,870)
Interest income 11,704 5,153
Gain on reduction of commitment to issue shares (Note 6) 0 414,128
Net loss (591,212) (1,649,589)
Other comprehensive income (loss)    
Currency translation differences 1,993 41,046
Total comprehensive loss $ (589,219) $ (1,608,543)
Net loss per share – basic and diluted (in dollars per share) $ (0.01) $ (0.02)
Weighted average number of common shares outstanding – basic and diluted (in shares) 91,422,569 91,422,569
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Stockholders' Equity (Deficiency) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Commitment to Issue Shares [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2021 91,422,569          
Balance at Dec. 31, 2021 $ 46,850,710 $ 998,477 $ 414,128 $ 6,190 $ (46,145,845) $ 2,123,660
Share-based compensation 0 396,520 0 0 0 396,520
Reduction of commitment to issue shares 0 0 (414,128) 0 0 (414,128)
Currency translation differences 0 0 0 (41,046) 0 (41,046)
Net loss 0 0 0 0 (1,649,589) (1,649,589)
Currency translation differences (0) (0) (0) 41,046 (0) 41,046
Net Income (Loss) Attributable to Parent $ 0 0 0 0 (1,649,589) (1,649,589)
Balance (in shares) at Dec. 31, 2022 91,422,569          
Balance at Dec. 31, 2022 $ 46,850,710 1,394,997 0 (34,856) (47,795,434) 415,417
Share-based compensation 0 84,034 0 0 0 84,034
Currency translation differences 0 0 0 (1,993) 0 (1,993)
Net loss 0 0 0 0 (591,212) (591,212)
Currency translation differences 0 0 0 1,993 0 1,993
Net Income (Loss) Attributable to Parent $ 0 0 0 0 (591,212) (591,212)
Balance (in shares) at Dec. 31, 2023 91,422,569          
Balance at Dec. 31, 2023 $ 46,850,710 $ 1,479,031 $ 0 $ (32,863) $ (48,386,646) $ (89,768)
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Net loss $ (591,212) $ (1,649,589)
Add back non-cash share-based compensation 84,034 396,520
Gain on reduction of commitment to issue shares 0 (414,128)
Changes in operating assets and liabilities:    
Decrease in prepaid expenses and other current assets 2,857 7,594
Increase in accounts payable and accrued expenses 2,452 180,387
Decrease in accounts payable and accrued expenses due to related parties (31,152) 0
Net cash used in operating activities (533,021) (1,479,216)
Effect of foreign currency translation on cash 1,993 (41,633)
Net decrease in cash and cash equivalents (531,028) (1,520,849)
Cash and cash equivalents at beginning of year 687,602 2,208,451
Cash and cash equivalents at end of year 156,574 687,602
Supplemental disclosures of cash flow information:    
Cash paid during the year for interest 0 0
Cash paid during the year for income taxes $ 0 $ 0
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Note 1 - Basis of Presentation and Business
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

1.

BASIS OF PRESENTATION AND BUSINESS

 

The accompanying consolidated financial statements include the accounts of Oculus Visiontech Inc. (“Oculus”) and its wholly-owned subsidiary, ComplyTrust Inc. (“CTI”), (together “the Company”). All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included.

 

The Company is a designer of digital watermarking services and solutions. At December 31, 2023 and for the two-year period then ended, substantially all of the Company's assets and substantially all its operations are located and conducted in the United States and Canada.

  

XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.1
Note 2 - Going Concern
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Substantial Doubt about Going Concern [Text Block]

2.

GOING CONCERN

 

These consolidated financial statements are prepared on a going concern basis which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses from inception and does not currently have the financial resources to sustain operations in the long-term. As shown in the financial statements, the Company has incurred a loss of $591,212 for the year ended December 31, 2023 and, in addition the Company incurred losses of $1,649,589 for the year ended December 31, 2022. As of December 31, 2023, the Company had an accumulated deficit of $48,386,646 and a working capital deficiency of $89,768. As a result of the Company’s current financial position and challenging access to capital, there can be no assurance that the Company will be able to raise additional funds in the future, in which case the Company will be unable to meet its financial obligations. These material uncertainties raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include adjustments to amounts and classifications of assets and liabilities that might be necessary should the Company be unable to continue operations. The Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company’s management will continue to be available to the Company when needed.  

 

There are many external factors that can adversely affect general workforces, economies and financial markets globally. Examples include, but are not limited to, the COVID-19 global pandemic and political conflict in other regions. It is not possible for the Company to predict the duration or magnitude of adverse results of such external factors and their effect on the Company’s business or ability to raise funds.

  

XML 24 R9.htm IDEA: XBRL DOCUMENT v3.24.1
Note 3 - Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Significant Accounting Policies [Text Block]

3.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of consolidation

 

These consolidated financial statements are presented in United States dollars and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). On March 19th, 2024, the Board approved the consolidated financial statements dated December 31, 2023.

 

These consolidated financial statements include the financial statements of the Company and the entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases.

 

Control is defined as the exposure, or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee. Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly affect the investee’s returns. This control is generally evidenced through owning more than 50% of the voting rights or currently exercisable potential voting rights of a Company’s capital stock. All significant intercompany transactions and balances have been eliminated.

 

The controlled entities are listed in the following table:

 

Name of Subsidiary

Country of

Incorporation

 

Ownership

Interest at

December 31,

2023

  

Ownership

Interest at

December 31,

2022

 

Principal Activity

           

ComplyTrust Inc.

US/Delaware

  

100%

   

100%

 

Software Development

 

Significant judgments, estimates and assumptions

 

The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows.

 

The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are not limited to the following:

 

Significant judgments

 

the determination of functional currencies; and

 

share-based compensation and warrants issued in connection with private placements, using the fair value method. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based compensation. This estimate also requires determining the most appropriate inputs to the valuation model. The main factor affecting the estimates of the fair value of stock options is the stock price, expected volatility used and the expected duration of the instrument. The Company currently estimates the expected volatility of its common shares based on historical stock price information. The Company recognizes the commitment to issue shares, based on the trading price at the date of the commitment on a percentage basis on the likelihood of the completion of the event.

 

Cash and cash equivalents

 

Cash equivalents include highly liquid investments with original maturities of twelve months or less, and which are subject to an insignificant risk of change in value. Cash equivalents are held for the purpose of meeting short-term cash commitments rather than for investment or other purposes.

 

Impairment of long-lived assets and long-lived assets to be disposed of

 

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount and the fair value less costs to sell.

 

Research and development

 

Expenditure on research activities is recognized on the consolidated statements of operations and comprehensive loss as incurred. Development expenditures are capitalized as part of the cost of the resulting intangible asset only if the expenditures can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. Management determined that as at December 31, 2023 it was not yet able to demonstrate with sufficient certainty that it is probable that any economic benefits will flow to the Company. Accordingly, all research and development costs incurred to date have been expensed. 

 

Intangible asset

 

Identifiable intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is valued at fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses.

 

The useful lives of intangible assets are assessed as either finite or indefinite.

 

Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment annually whenever there is an indication that the intangible asset may be impaired. The amortization period and method for an intangible asset with a finite useful life are reviewed at least at each financial year-end. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in profit or loss.

 

Intangible assets with indefinite lives are measured at cost less any accumulated impairment losses. These intangible assets are tested for impairment on an annual basis and more frequently if there are indicators that intangible assets may be impaired.

 

Income taxes

 

The Company accounts for income taxes under the asset and liability method. Current income taxes are the expected taxes payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to taxes payable in respect of previous years. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under the asset and liability method, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion or the entire deferred tax asset will not be recognized.

 

Net loss per share

 

Basic loss per share is calculated using the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or contracts that may require the issuance of common shares in the future were converted, unless the impact is anti-dilutive. For the year ended December 31, 2023 and 2022, this calculation proved to be anti-dilutive, and therefore the Company’s 1,565,000 (2022: 5,415,000) stock options and 12,500,000 (2022: 17,400,000) warrants were excluded from the calculation.

 

Stock-based compensation

 

The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Section 718 “Compensation - Stock Compensation”, which establishes accounting for equity-based compensation awards to be accounted for using the fair value method. Equity-settled share-based payment arrangements are initially measured at fair value at the date of grant and recorded within shareholders’ equity. Arrangements considered to be cash-settled are initially recorded at fair value and classified as accrued liabilities, and subsequently re-measured at fair value at each reporting date. The Company’s stock option plan is an equity-settled arrangement.

 

The fair value at grant date of all share-based payments is recognized as compensation expense over the period for which benefits of services are expected to be derived, with a corresponding credit to shareholders’ equity or accrued liabilities depending on whether they are equity-settled or cash-settled. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and estimate the expected forfeiture rate at the date of grant.

 

Functional currency

 

The Company’s consolidated financial statements are presented in U.S. dollars, which is the Company’s reporting currency. The functional currency of Oculus is the Canadian (“CAD” or “C”) dollar and the functional currency of CTI is the U.S. dollar.

 

In accordance with ASC 830, Foreign Currency Matters, for companies that have a functional currency other than the US dollar, the Company translates the assets and liabilities into U.S. dollars using the rate of exchange prevailing at the balance sheet date and the statements of operations and comprehensive loss and cash flows are translated at an average rate during the reporting period. Adjustments resulting from the translation from CAD into U.S. dollars are recorded in shareholders' equity as part of accumulated other comprehensive (income) loss.

 

Foreign currency transactions are translated into the functional currency of the respective currency of the entity or division, using the exchange rates prevailing at the dates of the transactions (spot exchange rate). Foreign exchange gains and losses resulting from the settlement of such transactions and from the re-measurement of monetary items denominated in foreign currency at period-end exchange rates are recognized in profit or loss. Non-monetary items that are not re-translated at period end are measured at historical cost (translated using the exchange rates at the transaction date), except for non-monetary items measured at fair value, which are translated using the exchange rates as at the date when fair value was determined. Gains and losses are recorded in the statement of operations and comprehensive loss.

 

Recently adopted accounting pronouncements

 

The Company has reviewed new and revised accounting pronouncements that have been issued but are not yet effective. The Company does not expect any material impact from future accounting pronouncements.

  

XML 25 R10.htm IDEA: XBRL DOCUMENT v3.24.1
Note 4 - Prepaid Expenses and Other Current Assets
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Other Assets Disclosure [Text Block]

4.

PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

Prepaid expenses and other current assets consist of the following:

 

   

December 31,

   

December 31,

 
   

2023

   

2022

 
                 

Prepaid expenses

  $ 16,014     $ 28,028  

Tax Receivable – Canadian GST

    11,367       2,210  
    $ 27,381     $ 30,238  

 

XML 26 R11.htm IDEA: XBRL DOCUMENT v3.24.1
Note 5 - Accounts Payable and Accrued Expenses
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

5.

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consist of the following:

 

   

December 31,

   

December 31,

 
   

2023

   

2022

 
                 

Accounts payable

  $ 87,422     $ 81,927  

Accrued fees and expenses

    48,826       51,869  
    $ 136,248     $ 133,796  

  

XML 27 R12.htm IDEA: XBRL DOCUMENT v3.24.1
Note 6 - Common Stock
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Equity [Text Block]

6.

COMMON STOCK 

 

The Company has no par value common stock with 500,000,000 authorized shares and 91,422,569 outstanding on December 31, 2023 and 2022.

 

The Company has authorized the issuance of 250,000,000 non-voting preferred shares without par value, none issued.

 

As of December 31, 2023, there were Nil common shares held in escrow.

 

During the year ended December 31, 2022, the Company wrote-off the commitment to issue shares of $414,128 due to the uncertainty in the Company meeting the required performance conditions.

  

XML 28 R13.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Stock Options
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

7.

STOCK OPTIONS  

 

During the year ended December 31, 2023 and 2022, the Company adopted a Rolling Stock Option Plan. Up to 10% of the Company’s issued and outstanding common shares may be reserved for granting of stock options. All of the options granted vest 20% every six months.

 

However, all options will be considered vested if one of the following criteria are met by the Company:

 

 

i.

Meeting sales forecasts:

 

 

-

The greater of either the 20% vesting every six months or based on a pro rata percentage of revenue earned by the Company’s subsidiary.

 

 

ii.

the listing of the Company on any national securities exchange.

 

iii.

a Change of Control Event.

 

During the year ended December 31, 2023, the Company did not grant any stock options and recorded $84,034 (2022: $396,520) of share-based compensation for vested portion of options that were previously granted.

 

The changes in options are as follows:

 

  

Number of

options

  

Weighted

average exercise price

(CAD)

  

Aggregate

Intrinsic Value

 
             

Options outstanding, December 31, 2021

  5,315,000  $0.49  $3,910,950 

Granted

  100,000   0.80   - 

Options outstanding, December 31, 2022

  5,415,000   0.50   - 

Expired

  (3,850,000)  0.36   - 

Options outstanding, December 31, 2023

  1,565,000  $0.85  $- 

 

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for the options that were in-the-money at December 31, 2023.

 

Details of options outstanding as at December 31, 2023 are as follows: 

 

Exercise price

(CAD)

  

Number of

options

outstanding

 

Expiry date

 

Number of options

exercisable

  

Remaining

contractual life (years)

 
                
$1.200   500,000 

January 29, 2024*

  500,000   0.08 
$0.800   375,000 

June 10, 2024

  375,000   0.44 
$0.600   590,000 

October 14, 2024

  472,000   0.79 
$0.800   100,000 

January 31, 2025

  60,000   1.09 
                
     1,565,000    1,407,000     

* expires subsequent to December 31, 2023

 

The following weighted average assumptions were used for the Black-Scholes valuation of stock options granted:

 

  

December 31, 2023

  

December 31, 2022

 
         

Risk-free interest rate

  -   1.24%

Exercise price (CAD)

  -  $0.80 

Expected life of options (in years)

  -   3.00 

Expected annualized volatility

  -   119.10%

Fair value of options granted (CAD)

  -  $0.55 

Expected dividend rate

  -   - 

 

XML 29 R14.htm IDEA: XBRL DOCUMENT v3.24.1
Note 8 - Warrants
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Class of Warrant or Right [Text Block]

8.

WARRANTS  

 

The changes in warrants are as follows:

 

  

Number of

warrants

  

Weighted

average exercise

price

(CAD)

  

Aggregate

Intrinsic Value

 
             

Warrants outstanding, December 31, 2021 and 2022

  17,400,000  $0.28  $- 

Expired

  (4,900,000)  (1.00)  - 

Warrants outstanding, December 31, 2023

  12,500,000  $0.001  $- 

 

Details of warrants outstanding as at December 31, 2023 are as follows:

 

Exercise price

   

Number of

warrants

outstanding

 

Expiry date

 

Number of

warrants

exercisable

  

Remaining

contractual life

(years)

 
                 
$0.001 

(1) (USA)

  12,500,000 

June 4, 2025

  -   1.43 
                 
      12,500,000    -     

 

 

(1)

No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) targeted revenue sales projections met, or 2) listing on a major US exchange, or 3) change of control.

  

XML 30 R15.htm IDEA: XBRL DOCUMENT v3.24.1
Note 9 - Selling, General and Administrative
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Selling, General and Administrative Disclosure [Text Block]

9.

SELLING, GENERAL AND ADMINISTRATIVE  

 

The breakdown of selling, general and administrative for the years ended December 31, 2023 and 2022 is as follows:

 

   

2023

   

2022

 
                 

Filing and regulatory fees

  $ 32,862     $ 40,158  

Marketing

    -       76,459  

Professional fees

    78,089       104,801  

Rent

    43,269       38,922  

Office and administration

    120,278       139,127  
                 
    $ 274,498     $ 399,467  

 

XML 31 R16.htm IDEA: XBRL DOCUMENT v3.24.1
Note 10 - Research and Development
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Research, Development, and Computer Software Disclosure [Text Block]

10.

RESEARCH AND DEVELOPMENT  

 

The breakdown of research and development for the years ended December 31, 2023 and 2022 is as follows:

 

   

2023

   

2022

 
                 

Project management

  $ -     $ 11,990  

Software development

    61,446       820,996  

Business development

    3,952       133,588  

Payroll

    30,486       171,309  
                 
    $ 95,884     $ 1,137,883  

  

XML 32 R17.htm IDEA: XBRL DOCUMENT v3.24.1
Note 11 - Financial Instruments and Risks
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Financial Instruments Disclosure [Text Block]

11.

FINANCIAL INSTRUMENTS AND RISKS  

 

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are described below.

 

Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2 – inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and

Level 3 - inputs for the asset or liability that are not based on observable market data (unobservable inputs).

 

Fair value of financial instruments

 

The Company has various financial instruments including cash, receivables, accounts payable and accrued liabilities and accounts payable and accrued liabilities - related parties. The carrying values of cash and cash equivalents, receivables, accounts payable and accrued liabilities, and accounts payable and accrued liabilities - related parties approximate their fair values due to the short-term nature of these financial instruments.

 

Cash is carried at a level 1 fair value measurement.

 

The Company’s risk exposures and the impact on the Company’s financial instruments are summarized below:

 

Credit risk

The Company is exposed to credit risk only with respect to uncertainties as to timing and amount of collectability of receivables. The Company believes its credit risk is low because a portion of receivables are comprised of goods and services tax (GST) and other government refunds, which is recoverable from the governing body in Canada. Management does not believe the receivables are impaired. The Company doesn’t believe there is significant credit risk associated with cash as these amounts are held with major Canadian banks.

 

Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company’s approach to managing liquidity risk is to ensure that it will have sufficient liquidity to meet liabilities when due. As at December 31, 2023, the Company had a cash balance of $156,574 (2022 – $687,602) to settle current liabilities of $273,723 (2022 – $302,423). All of the Company’s financial liabilities have contractual maturities of 30 days or due on demand and are subject to normal trade terms.

 

Interest rate risk

Interest rate risk is the risk that the future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The risk that the Company will realize such a loss is limited as it does not have any significant interest-bearing financial instruments.

 

Foreign currency risk

As at December 31, 2023 and 2022, the Company is exposed to foreign currency risk as certain monetary financial instruments are denominated in Canadian currency. The Company’s sensitivity analysis suggests that reasonably expected changes in the rates of exchange in United States would change foreign exchange gain or loss by an insignificant amount.

  

XML 33 R18.htm IDEA: XBRL DOCUMENT v3.24.1
Note 12 - Income Taxes
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

12.

INCOME TAXES  

 

A reconciliation of income taxes at statutory rates with the reported taxes is as follows:

 

  

December 31,

2023

  

December 31,

2022

 
         

Loss before taxes for the year

 $(591,212) $(1,649,589)
         

Expected income tax (recovery)

 $(165,000) $(461,000)

Effect of change in tax rates

  -   37,000 

Permanent differences

  23,000   (5,000)

Adjustment to prior years provision

  (7,000)  (5,000)

Change in unrecognized deductible temporary

  135,000   434,000 
         

Total income taxes

 $-  $- 
         

Current income tax

 $-  $- 

Deferred tax recovery

 $-  $- 

 

The significant components of the Company’s deferred tax assets that have not been included on the consolidated statement of financial position are as follows:

 

  

December 31,

2023

  

December 31,

2022

 
         

Research and development

 $213,000  $- 

Non-capital losses

 $6,936,120  $5,445,227 
         
  $7,149,120  $5,445,227 

Unrecognized deferred tax assets

  (7,149,120)  (5,445,227)

Net deferred tax assets

 $-  $- 

 

The significant components of the Company’s temporary differences, unused tax credits and unused tax losses that have not been included on the consolidated statement of financial position are as follows: 

 

  

2023

  

Expiry Date

Range

  

2022

  

Expiry Date

Range

 

Temporary Differences

                

Research and development

 $760,000  

 

No expiry date  $-     

Non-capital losses available for future periods

 $24,787,000  

 

2023 to indefinite  $25,155,000  

 

2023 to indefinite 

Canada

 $18,610,000   2023 to 2037  $18,334,000   2023 to 2037 

USA

 $5,350,000  

 

No expiry date  $6,821,000  

 

No expiry date 

  

XML 34 R19.htm IDEA: XBRL DOCUMENT v3.24.1
Note 13 - Related Parties
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]

13.

RELATED PARTIES  

 

Related parties include the Board of Directors, officers, close family members and enterprises that are controlled by these individuals as well as certain persons performing similar functions.

 

The Company defines its key management as the Board of Directors, Chief Executive Officer, President, and Chief Financial Officer. Remuneration of directors and key management personnel of the Company was as follows:

 

  

Years ended

December 31,

 
  

2023

  

2022

 
         

Consulting

 $148,500  $135,000 

Selling general and administrative

  94,356   80,331 

Share-based compensation to directors and officers

  1,442   47,062 
  $244,298  $262,393 

 

The Company for the years ended December 31, 2023 and 2022 reimbursed a related party $94,356 and $80,331, respectively, for selling, general and administrative expenses paid on behalf of the Company. The Company incurred $148,500 (2022 - $135,000) of consulting fees accrued to a company controlled by a director of the Company for the years ended December 31, 2023 and 2022.

 

The Company also recorded share-based compensation of $1,442 (2022 - $47,062) for options vested to related parties during the years ended December 31, 2023 and 2022.

 

XML 35 R20.htm IDEA: XBRL DOCUMENT v3.24.1
Note 14 - Operating Leases
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Lessee, Operating Leases [Text Block]

14.

OPERATING LEASES  

 

The Company has one operating lease with unrelated third parties for office space at Vancouver, Canada.

 

The lease at the Vancouver, Canada location is on a month-to-month basis with monthly rental payments of $4,645 (CAD). For the years ended December 31, 2023 and 2022 rent expense was $41,241 and $36,894, respectively.

  

XML 36 R21.htm IDEA: XBRL DOCUMENT v3.24.1
Note 15 - Segmented Information
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

15.

SEGMENTED INFORMATION  

 

The Company currently operates in a single reportable operating segment. All of the Company’s assets and expenditures are located in the United States. Since the Company does not have any revenue producing activities, there is no segment information by revenues.

 

 

 
XML 37 R22.htm IDEA: XBRL DOCUMENT v3.24.1
Insider Trading Arrangements
12 Months Ended
Dec. 31, 2023
Insider Trading Arr Line Items  
Material Terms of Trading Arrangement [Text Block]

Item 9B.

Other Information

 

Not applicable

  

Rule 10b5-1 Arrangement Adopted [Flag] false
Non-Rule 10b5-1 Arrangement Adopted [Flag] false
Rule 10b5-1 Arrangement Terminated [Flag] false
Non-Rule 10b5-1 Arrangement Terminated [Flag] false
XML 38 R23.htm IDEA: XBRL DOCUMENT v3.24.1
Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Consolidation, Policy [Policy Text Block]

Basis of consolidation

 

These consolidated financial statements are presented in United States dollars and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). On March 19th, 2024, the Board approved the consolidated financial statements dated December 31, 2023.

 

These consolidated financial statements include the financial statements of the Company and the entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases.

 

Control is defined as the exposure, or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee. Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly affect the investee’s returns. This control is generally evidenced through owning more than 50% of the voting rights or currently exercisable potential voting rights of a Company’s capital stock. All significant intercompany transactions and balances have been eliminated.

 

The controlled entities are listed in the following table:

 

Name of Subsidiary

Country of

Incorporation

 

Ownership

Interest at

December 31,

2023

  

Ownership

Interest at

December 31,

2022

 

Principal Activity

           

ComplyTrust Inc.

US/Delaware

  

100%

   

100%

 

Software Development

 

Use of Estimates, Policy [Policy Text Block]

Significant judgments, estimates and assumptions

 

The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows.

 

The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are not limited to the following:

 

Significant judgments

 

the determination of functional currencies; and

 

share-based compensation and warrants issued in connection with private placements, using the fair value method. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based compensation. This estimate also requires determining the most appropriate inputs to the valuation model. The main factor affecting the estimates of the fair value of stock options is the stock price, expected volatility used and the expected duration of the instrument. The Company currently estimates the expected volatility of its common shares based on historical stock price information. The Company recognizes the commitment to issue shares, based on the trading price at the date of the commitment on a percentage basis on the likelihood of the completion of the event.

 

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and cash equivalents

 

Cash equivalents include highly liquid investments with original maturities of twelve months or less, and which are subject to an insignificant risk of change in value. Cash equivalents are held for the purpose of meeting short-term cash commitments rather than for investment or other purposes.

 

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

Impairment of long-lived assets and long-lived assets to be disposed of

 

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount and the fair value less costs to sell.

 

Research and Development Expense, Policy [Policy Text Block]

Research and development

 

Expenditure on research activities is recognized on the consolidated statements of operations and comprehensive loss as incurred. Development expenditures are capitalized as part of the cost of the resulting intangible asset only if the expenditures can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. Management determined that as at December 31, 2023 it was not yet able to demonstrate with sufficient certainty that it is probable that any economic benefits will flow to the Company. Accordingly, all research and development costs incurred to date have been expensed. 

 

Goodwill and Intangible Assets, Policy [Policy Text Block]

Intangible asset

 

Identifiable intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is valued at fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses.

 

The useful lives of intangible assets are assessed as either finite or indefinite.

 

Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment annually whenever there is an indication that the intangible asset may be impaired. The amortization period and method for an intangible asset with a finite useful life are reviewed at least at each financial year-end. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in profit or loss.

 

Intangible assets with indefinite lives are measured at cost less any accumulated impairment losses. These intangible assets are tested for impairment on an annual basis and more frequently if there are indicators that intangible assets may be impaired.

 

Income Tax, Policy [Policy Text Block]

Income taxes

 

The Company accounts for income taxes under the asset and liability method. Current income taxes are the expected taxes payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to taxes payable in respect of previous years. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under the asset and liability method, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion or the entire deferred tax asset will not be recognized.

 

Earnings Per Share, Policy [Policy Text Block]

Net loss per share

 

Basic loss per share is calculated using the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or contracts that may require the issuance of common shares in the future were converted, unless the impact is anti-dilutive. For the year ended December 31, 2023 and 2022, this calculation proved to be anti-dilutive, and therefore the Company’s 1,565,000 (2022: 5,415,000) stock options and 12,500,000 (2022: 17,400,000) warrants were excluded from the calculation.

 

Share-Based Payment Arrangement [Policy Text Block]

Stock-based compensation

 

The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Section 718 “Compensation - Stock Compensation”, which establishes accounting for equity-based compensation awards to be accounted for using the fair value method. Equity-settled share-based payment arrangements are initially measured at fair value at the date of grant and recorded within shareholders’ equity. Arrangements considered to be cash-settled are initially recorded at fair value and classified as accrued liabilities, and subsequently re-measured at fair value at each reporting date. The Company’s stock option plan is an equity-settled arrangement.

 

The fair value at grant date of all share-based payments is recognized as compensation expense over the period for which benefits of services are expected to be derived, with a corresponding credit to shareholders’ equity or accrued liabilities depending on whether they are equity-settled or cash-settled. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and estimate the expected forfeiture rate at the date of grant.

 

Foreign Currency Transactions and Translations Policy [Policy Text Block]

Functional currency

 

The Company’s consolidated financial statements are presented in U.S. dollars, which is the Company’s reporting currency. The functional currency of Oculus is the Canadian (“CAD” or “C”) dollar and the functional currency of CTI is the U.S. dollar.

 

In accordance with ASC 830, Foreign Currency Matters, for companies that have a functional currency other than the US dollar, the Company translates the assets and liabilities into U.S. dollars using the rate of exchange prevailing at the balance sheet date and the statements of operations and comprehensive loss and cash flows are translated at an average rate during the reporting period. Adjustments resulting from the translation from CAD into U.S. dollars are recorded in shareholders' equity as part of accumulated other comprehensive (income) loss.

 

Foreign currency transactions are translated into the functional currency of the respective currency of the entity or division, using the exchange rates prevailing at the dates of the transactions (spot exchange rate). Foreign exchange gains and losses resulting from the settlement of such transactions and from the re-measurement of monetary items denominated in foreign currency at period-end exchange rates are recognized in profit or loss. Non-monetary items that are not re-translated at period end are measured at historical cost (translated using the exchange rates at the transaction date), except for non-monetary items measured at fair value, which are translated using the exchange rates as at the date when fair value was determined. Gains and losses are recorded in the statement of operations and comprehensive loss.

 

New Accounting Pronouncements, Policy [Policy Text Block]

Recently adopted accounting pronouncements

 

The Company has reviewed new and revised accounting pronouncements that have been issued but are not yet effective. The Company does not expect any material impact from future accounting pronouncements.

XML 39 R24.htm IDEA: XBRL DOCUMENT v3.24.1
Note 4 - Prepaid Expenses and Other Current Assets (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]
   

December 31,

   

December 31,

 
   

2023

   

2022

 
                 

Prepaid expenses

  $ 16,014     $ 28,028  

Tax Receivable – Canadian GST

    11,367       2,210  
    $ 27,381     $ 30,238  
XML 40 R25.htm IDEA: XBRL DOCUMENT v3.24.1
Note 5 - Accounts Payable and Accrued Expenses (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
   

December 31,

   

December 31,

 
   

2023

   

2022

 
                 

Accounts payable

  $ 87,422     $ 81,927  

Accrued fees and expenses

    48,826       51,869  
    $ 136,248     $ 133,796  
XML 41 R26.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Stock Options (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

Number of

options

  

Weighted

average exercise price

(CAD)

  

Aggregate

Intrinsic Value

 
             

Options outstanding, December 31, 2021

  5,315,000  $0.49  $3,910,950 

Granted

  100,000   0.80   - 

Options outstanding, December 31, 2022

  5,415,000   0.50   - 

Expired

  (3,850,000)  0.36   - 

Options outstanding, December 31, 2023

  1,565,000  $0.85  $- 
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

Exercise price

(CAD)

  

Number of

options

outstanding

 

Expiry date

 

Number of options

exercisable

  

Remaining

contractual life (years)

 
                
$1.200   500,000 

January 29, 2024*

  500,000   0.08 
$0.800   375,000 

June 10, 2024

  375,000   0.44 
$0.600   590,000 

October 14, 2024

  472,000   0.79 
$0.800   100,000 

January 31, 2025

  60,000   1.09 
                
     1,565,000    1,407,000     
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

December 31, 2023

  

December 31, 2022

 
         

Risk-free interest rate

  -   1.24%

Exercise price (CAD)

  -  $0.80 

Expected life of options (in years)

  -   3.00 

Expected annualized volatility

  -   119.10%

Fair value of options granted (CAD)

  -  $0.55 

Expected dividend rate

  -   - 
XML 42 R27.htm IDEA: XBRL DOCUMENT v3.24.1
Note 8 - Warrants (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Warrants or Right [Table Text Block]
  

Number of

warrants

  

Weighted

average exercise

price

(CAD)

  

Aggregate

Intrinsic Value

 
             

Warrants outstanding, December 31, 2021 and 2022

  17,400,000  $0.28  $- 

Expired

  (4,900,000)  (1.00)  - 

Warrants outstanding, December 31, 2023

  12,500,000  $0.001  $- 

Exercise price

   

Number of

warrants

outstanding

 

Expiry date

 

Number of

warrants

exercisable

  

Remaining

contractual life

(years)

 
                 
$0.001 

(1) (USA)

  12,500,000 

June 4, 2025

  -   1.43 
                 
      12,500,000    -     
XML 43 R28.htm IDEA: XBRL DOCUMENT v3.24.1
Note 9 - Selling, General and Administrative (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Selling, General and Administrative Expenses [Table Text Block]
   

2023

   

2022

 
                 

Filing and regulatory fees

  $ 32,862     $ 40,158  

Marketing

    -       76,459  

Professional fees

    78,089       104,801  

Rent

    43,269       38,922  

Office and administration

    120,278       139,127  
                 
    $ 274,498     $ 399,467  
XML 44 R29.htm IDEA: XBRL DOCUMENT v3.24.1
Note 10 - Research and Development (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Research and Development Expenses [Table Text Block]
   

2023

   

2022

 
                 

Project management

  $ -     $ 11,990  

Software development

    61,446       820,996  

Business development

    3,952       133,588  

Payroll

    30,486       171,309  
                 
    $ 95,884     $ 1,137,883  
XML 45 R30.htm IDEA: XBRL DOCUMENT v3.24.1
Note 12 - Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
  

December 31,

2023

  

December 31,

2022

 
         

Loss before taxes for the year

 $(591,212) $(1,649,589)
         

Expected income tax (recovery)

 $(165,000) $(461,000)

Effect of change in tax rates

  -   37,000 

Permanent differences

  23,000   (5,000)

Adjustment to prior years provision

  (7,000)  (5,000)

Change in unrecognized deductible temporary

  135,000   434,000 
         

Total income taxes

 $-  $- 
         

Current income tax

 $-  $- 

Deferred tax recovery

 $-  $- 
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
  

December 31,

2023

  

December 31,

2022

 
         

Research and development

 $213,000  $- 

Non-capital losses

 $6,936,120  $5,445,227 
         
  $7,149,120  $5,445,227 

Unrecognized deferred tax assets

  (7,149,120)  (5,445,227)

Net deferred tax assets

 $-  $- 
Summary of Operating Loss Carryforwards [Table Text Block]
  

2023

  

Expiry Date

Range

  

2022

  

Expiry Date

Range

 

Temporary Differences

                

Research and development

 $760,000  

 

No expiry date  $-     

Non-capital losses available for future periods

 $24,787,000  

 

2023 to indefinite  $25,155,000  

 

2023 to indefinite 

Canada

 $18,610,000   2023 to 2037  $18,334,000   2023 to 2037 

USA

 $5,350,000  

 

No expiry date  $6,821,000  

 

No expiry date 
XML 46 R31.htm IDEA: XBRL DOCUMENT v3.24.1
Note 13 - Related Parties (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Related Party Transactions [Table Text Block]
  

Years ended

December 31,

 
  

2023

  

2022

 
         

Consulting

 $148,500  $135,000 

Selling general and administrative

  94,356   80,331 

Share-based compensation to directors and officers

  1,442   47,062 
  $244,298  $262,393 
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.24.1
Note 2 - Going Concern (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Net Income (Loss) Attributable to Parent $ (591,212) $ (1,649,589)
Retained Earnings (Accumulated Deficit) (48,386,646) $ (47,795,434)
Working Capital (Deficit) $ 89,768  
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.24.1
Note 3 - Summary of Significant Accounting Policies (Details Textual) - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 1,565,000 5,415,000
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 12,500,000 17,400,000
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.24.1
Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Prepaid expenses $ 16,014 $ 28,028
Tax Receivable – Canadian GST 11,367 2,210
Prepaid Expense and Other Assets, Current $ 27,381 $ 30,238
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.24.1
Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) - Nonrelated Party [Member] - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Accounts payable $ 87,422 $ 81,927
Accrued fees and expenses 48,826 51,869
Accounts Payable and Accrued Liabilities, Current $ 136,248 $ 133,796
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.24.1
Note 6 - Common Stock (Details Textual) - USD ($)
$ / shares in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Common Stock, No Par Value (in dollars per share) $ 0 $ 0
Common Stock, Shares Authorized (in shares) 500,000,000 500,000,000
Common Stock, Shares, Outstanding, Ending Balance (in shares) 91,422,569 91,422,569
Preferred Stock, Shares Authorized (in shares) 250,000,000 250,000,000
Preferred Stock, Shares Issued (in shares) 0 0
Common Stock, Shares Held in Escrow (in shares) 0  
Gains (Losses) on Commitment to Issue Shares $ 0 $ 414,128
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Stock Options (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)   100,000
Share-Based Payment Arrangement, Expense $ 84,034 $ 396,520
Rolling Stock Option Plan [Member]    
Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved 10.00%  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) 0  
Share-Based Payment Arrangement, Expense $ 84,034 $ 396,520
Rolling Stock Option Plan [Member] | Vesting Every Six Months [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage 20.00%  
Rolling Stock Option Plan [Member] | Share-Based Payment Arrangement, Tranche One [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage 20.00%  
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Stock Options - Changes in Options (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Options outstanding (in shares) 5,415,000 5,315,000  
Options outstanding, weighted average exercise price (in dollars per share) $ 0.5 $ 0.49  
Options outstanding, aggregate intrinsic value $ 0 $ 0 $ 3,910,950
Granted, options (in shares)   100,000  
Granted, weighted average exercise price (in dollars per share)   $ 0.8  
Granted, aggregate intrinsic value (in dollars per share)   $ 0  
Expired, options (in shares) (3,850,000)    
Expired, weighted average exercise price (in dollars per share) $ 0.36    
Expired, aggregate intrinsic value (in dollars per share) $ 0    
Options outstanding (in shares) 1,565,000 5,415,000  
Options outstanding, weighted average exercise price (in dollars per share) $ 0.85 $ 0.5  
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Stock Options - Details of Options Outstanding (Details) - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Number of options outstanding (in shares) 1,565,000 5,415,000 5,315,000
Exercisable (in shares) 1,407,000    
Range Three [Member]      
Number of options outstanding (in shares) 500,000    
Expiry date [1] Jan. 29, 2024    
Exercisable (in shares) 500,000    
Remaining contractual life (Year) 29 days    
Range Four [Member]      
Number of options outstanding (in shares) 375,000    
Expiry date Jun. 10, 2024    
Exercisable (in shares) 375,000    
Remaining contractual life (Year) 5 months 8 days    
Range Five [Member]      
Number of options outstanding (in shares) 590,000    
Expiry date Oct. 14, 2024    
Exercisable (in shares) 472,000    
Remaining contractual life (Year) 9 months 14 days    
Range Six [Member]      
Number of options outstanding (in shares) 100,000    
Expiry date Jan. 31, 2025    
Exercisable (in shares) 60,000    
Remaining contractual life (Year) 1 year 1 month 2 days    
[1] expires subsequent to December 31, 2023
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details) - Share-Based Payment Arrangement, Option [Member]
12 Months Ended
Dec. 31, 2022
$ / shares
$ / shares
Risk-free interest rate 1.24%
Exercise price (CAD) (in CAD per share) $ 0.8
Expected life of options (in years) (Year) 3 years
Expected annualized volatility 119.10%
Fair value of options granted (CAD) (in dollars per share) $ 0.55
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.24.1
Note 8 - Warrants - Schedule of Warrants (Details)
12 Months Ended
Dec. 31, 2023
$ / shares
shares
Warrants outstanding (in shares) 17,400,000
Warrants outstanding, weighted average exercise price (in dollars per share) | $ / shares $ 0.28
Expired (in shares) (4,900,000)
Expired (in dollars per share) | $ / shares $ (1)
Warrants outstanding (in shares) 12,500,000
Warrants outstanding, weighted average exercise price (in dollars per share) | $ / shares $ 0.001
Number of warrants outstanding (in shares) 12,500,000
Warrants Expiring on June 4, 2025 [Member]  
Warrants outstanding (in shares) 12,500,000 [1]
Number of warrants outstanding (in shares) 12,500,000 [1]
Class of Warrant or Right, Remaining Contractual Term 1 year 5 months 4 days
[1] No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) revenue sales projections per ComplyTrust Inc.’s 5-year proformas, or 2) listing on a major US exchange, or 3) change of control.
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.24.1
Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Filing and regulatory fees $ 32,862 $ 40,158
Marketing 0 76,459
Professional fees 78,089 104,801
Rent 43,269 38,922
Office and administration 120,278 139,127
Selling, General and Administrative Expense $ 274,498 $ 399,467
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.24.1
Note 10 - Research and Development - Research and Development (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Project management $ 0 $ 11,990
Software development 61,446 820,996
Business development 3,952 133,588
Payroll 30,486 171,309
Research and Development Expense $ 95,884 $ 1,137,883
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.24.1
Note 11 - Financial Instruments and Risks (Details Textual) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Cash and Cash Equivalents, at Carrying Value $ 156,574 $ 687,602
Liabilities, Current $ 273,723 $ 302,423
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.24.1
Note 12 - Income Taxes - Reconciliation of Income Taxes (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Loss before taxes for the year $ 591,212 $ 1,649,589
Expected income tax (recovery) (165,000) (461,000)
Effect of change in tax rates 0 37,000
Permanent differences 23,000 (5,000)
Adjustment to prior years provision 7,000 5,000
Change in unrecognized deductible temporary 135,000 434,000
Total income taxes 0 0
Current income tax 0 0
Deferred tax recovery $ 0 $ 0
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.24.1
Note 12 - Income Taxes - Net Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Research and development $ 213,000 $ 0
Non-capital losses 6,936,120 5,445,227
Deferred Tax Assets, Gross 7,149,120 5,445,227
Unrecognized deferred tax assets (7,149,120) (5,445,227)
Net deferred tax assets $ 0 $ 0
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.24.1
Note 12 - Income Taxes - Components of Temporary Difference (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Research and Development $ 760,000 $ 0
Non-capital losses available for future periods 24,787,000 25,155,000
Foreign Tax Authority [Member] | Canada Revenue Agency [Member]    
Operatinting loss 18,610,000 18,334,000
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]    
Operatinting loss $ 5,350,000 $ 6,821,000
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.24.1
Note 13 - Related Parties (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Related Party Transaction, Amounts of Transaction $ 244,298 $ 262,393
Share-based Compensation [Member]    
Related Party Transaction, Amounts of Transaction 1,442 47,062
Reimbursement [Member]    
Related Party Transaction, Amounts of Transaction 94,356 80,331
Consulting Fees [Member]    
Related Party Transaction, Amounts of Transaction $ 148,500 $ 135,000
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.24.1
Note 13 - Related Parties - Related Party Expenses (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Related party transactions $ 244,298 $ 262,393
Consulting Fees [Member]    
Related party transactions 148,500 135,000
Selling, General and Administrative Expenses [Member]    
Related party transactions 94,356 80,331
Share-based Compensation [Member]    
Related party transactions $ 1,442 $ 47,062
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.24.1
Note 14 - Operating Leases (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating Lease, Expense $ 43,269 $ 38,922
Vancouver, CA Operating Lease [Member]    
Operating Leases, Monthly Rent Expense 4,645  
Operating Lease, Expense $ 41,241 $ 36,894
EXCEL 66 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 67 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 68 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 70 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 73 181 1 true 28 0 false 7 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' Equity (Deficiency) Sheet http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency Consolidated Statements of Stockholders' Equity (Deficiency) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Basis of Presentation and Business Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-1-basis-of-presentation-and-business Note 1 - Basis of Presentation and Business Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Going Concern Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern Note 2 - Going Concern Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Summary of Significant Accounting Policies Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies- Note 3 - Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets Note 4 - Prepaid Expenses and Other Current Assets Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses Note 5 - Accounts Payable and Accrued Expenses Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Common Stock Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock Note 6 - Common Stock Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Stock Options Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options Note 7 - Stock Options Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Warrants Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants Note 8 - Warrants Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Selling, General and Administrative Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative Note 9 - Selling, General and Administrative Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Research and Development Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development Note 10 - Research and Development Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Financial Instruments and Risks Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks- Note 11 - Financial Instruments and Risks Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Income Taxes Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes Note 12 - Income Taxes Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Related Parties Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties Note 13 - Related Parties Notes 19 false false R20.htm 019 - Disclosure - Note 14 - Operating Leases Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases Note 14 - Operating Leases Notes 20 false false R21.htm 020 - Disclosure - Note 15 - Segmented Information Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-15-segmented-information Note 15 - Segmented Information Notes 21 false false R22.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 22 false false R23.htm 995467 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies- 23 false false R24.htm 995468 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables Note 4 - Prepaid Expenses and Other Current Assets (Tables) Tables http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets 24 false false R25.htm 995469 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses (Tables) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables Note 5 - Accounts Payable and Accrued Expenses (Tables) Tables http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses 25 false false R26.htm 995470 - Disclosure - Note 7 - Stock Options (Tables) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-tables Note 7 - Stock Options (Tables) Tables http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options 26 false false R27.htm 995471 - Disclosure - Note 8 - Warrants (Tables) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-tables Note 8 - Warrants (Tables) Tables http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants 27 false false R28.htm 995472 - Disclosure - Note 9 - Selling, General and Administrative (Tables) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-tables Note 9 - Selling, General and Administrative (Tables) Tables http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative 28 false false R29.htm 995473 - Disclosure - Note 10 - Research and Development (Tables) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-tables Note 10 - Research and Development (Tables) Tables http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development 29 false false R30.htm 995474 - Disclosure - Note 12 - Income Taxes (Tables) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-tables Note 12 - Income Taxes (Tables) Tables http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes 30 false false R31.htm 995475 - Disclosure - Note 13 - Related Parties (Tables) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-tables Note 13 - Related Parties (Tables) Tables http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties 31 false false R32.htm 995476 - Disclosure - Note 2 - Going Concern (Details Textual) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern-details-textual Note 2 - Going Concern (Details Textual) Details http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern 32 false false R33.htm 995477 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual Note 3 - Summary of Significant Accounting Policies (Details Textual) Details 33 false false R34.htm 995478 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Details 34 false false R35.htm 995479 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Details 35 false false R36.htm 995480 - Disclosure - Note 6 - Common Stock (Details Textual) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual Note 6 - Common Stock (Details Textual) Details http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock 36 false false R37.htm 995481 - Disclosure - Note 7 - Stock Options (Details Textual) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual Note 7 - Stock Options (Details Textual) Details http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-tables 37 false false R38.htm 995482 - Disclosure - Note 7 - Stock Options - Changes in Options (Details) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details Note 7 - Stock Options - Changes in Options (Details) Details 38 false false R39.htm 995483 - Disclosure - Note 7 - Stock Options - Details of Options Outstanding (Details) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details Note 7 - Stock Options - Details of Options Outstanding (Details) Details 39 false false R40.htm 995484 - Disclosure - Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details) Details 40 false false R41.htm 995485 - Disclosure - Note 8 - Warrants - Schedule of Warrants (Details) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details Note 8 - Warrants - Schedule of Warrants (Details) Details 41 false false R42.htm 995486 - Disclosure - Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) Details 42 false false R43.htm 995487 - Disclosure - Note 10 - Research and Development - Research and Development (Details) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details Note 10 - Research and Development - Research and Development (Details) Details 43 false false R44.htm 995488 - Disclosure - Note 11 - Financial Instruments and Risks (Details Textual) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-details-textual Note 11 - Financial Instruments and Risks (Details Textual) Details http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks- 44 false false R45.htm 995489 - Disclosure - Note 12 - Income Taxes - Reconciliation of Income Taxes (Details) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details Note 12 - Income Taxes - Reconciliation of Income Taxes (Details) Details 45 false false R46.htm 995490 - Disclosure - Note 12 - Income Taxes - Net Deferred Tax Assets (Details) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details Note 12 - Income Taxes - Net Deferred Tax Assets (Details) Details 46 false false R47.htm 995491 - Disclosure - Note 12 - Income Taxes - Components of Temporary Difference (Details) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details Note 12 - Income Taxes - Components of Temporary Difference (Details) Details 47 false false R48.htm 995492 - Disclosure - Note 13 - Related Parties (Details Textual) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual Note 13 - Related Parties (Details Textual) Details http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-tables 48 false false R49.htm 995493 - Disclosure - Note 13 - Related Parties - Related Party Expenses (Details) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-related-party-expenses-details Note 13 - Related Parties - Related Party Expenses (Details) Details 49 false false R50.htm 995494 - Disclosure - Note 14 - Operating Leases (Details Textual) Sheet http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases-details-textual Note 14 - Operating Leases (Details Textual) Details http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases 50 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 33 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, dei:EntityRegistrantName, ecd:NonRule10b51ArrAdoptedFlag, ecd:NonRule10b51ArrTrmntdFlag, ecd:Rule10b51ArrAdoptedFlag, ecd:Rule10b51ArrTrmntdFlag, ovtz:CommonStockSharesHeldInEscrow, us-gaap:ClassOfWarrantOrRightOutstanding, us-gaap:CommonStockNoParValue, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareBasic, us-gaap:PreferredStockNoParValue, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued, us-gaap:PreferredStockValue, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross - ovtz20231231_10k.htm 8, 10, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43 ovtz-20231231.xsd ovtz-20231231_cal.xml ovtz-20231231_def.xml ovtz-20231231_lab.xml ovtz-20231231_pre.xml ovtz20231231_10k.htm dcllp01.jpg dcllp02.jpg ovtz20231231_10kimg001.jpg ovtz20231231_10kimg002.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 73 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ovtz20231231_10k.htm": { "nsprefix": "ovtz", "nsuri": "http://www.oculusvisiontech.com/20231231", "dts": { "schema": { "local": [ "ovtz-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "ovtz-20231231_cal.xml" ] }, "definitionLink": { "local": [ "ovtz-20231231_def.xml" ] }, "labelLink": { "local": [ "ovtz-20231231_lab.xml" ] }, "presentationLink": { "local": [ "ovtz-20231231_pre.xml" ] }, "inline": { "local": [ "ovtz20231231_10k.htm" ] } }, "keyStandard": 156, "keyCustom": 25, "axisStandard": 13, "axisCustom": 0, "memberStandard": 14, "memberCustom": 12, "hidden": { "total": 37, "http://fasb.org/us-gaap/2023": 26, "http://xbrl.sec.gov/dei/2023": 6, "http://xbrl.sec.gov/ecd/2023": 4, "http://www.oculusvisiontech.com/20231231": 1 }, "contextCount": 73, "entityCount": 1, "segmentCount": 28, "elementCount": 279, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 307, "http://xbrl.sec.gov/dei/2023": 35, "http://xbrl.sec.gov/ecd/2023": 5 }, "report": { "R1": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "longName": "001 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:Assets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "unique": true } }, "R3": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)", "shortName": "Consolidated Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": null, "uniqueAnchor": null }, "R4": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "longName": "003 - Statement - Consolidated Statements of Operations and Comprehensive Loss", "shortName": "Consolidated Statements of Operations and Comprehensive Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:ConsultingExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:ConsultingExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency", "longName": "004 - Statement - Consolidated Statements of Stockholders' Equity (Deficiency)", "shortName": "Consolidated Statements of Stockholders' Equity (Deficiency)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "i_2021-12-31_StatementEquityComponentsAxis-CommonStockMember", "name": "us-gaap:SharesIssued", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2021-12-31_StatementEquityComponentsAxis-CommonStockMember", "name": "us-gaap:SharesIssued", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows", "longName": "005 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ShareBasedCompensation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "unique": true } }, "R7": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-1-basis-of-presentation-and-business", "longName": "006 - Disclosure - Note 1 - Basis of Presentation and Business", "shortName": "Note 1 - Basis of Presentation and Business", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern", "longName": "007 - Disclosure - Note 2 - Going Concern", "shortName": "Note 2 - Going Concern", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-", "longName": "008 - Disclosure - Note 3 - Summary of Significant Accounting Policies", "shortName": "Note 3 - Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets", "longName": "009 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets", "shortName": "Note 4 - Prepaid Expenses and Other Current Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses", "longName": "010 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses", "shortName": "Note 5 - Accounts Payable and Accrued Expenses", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock", "longName": "011 - Disclosure - Note 6 - Common Stock", "shortName": "Note 6 - Common Stock", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "longName": "012 - Disclosure - Note 7 - Stock Options", "shortName": "Note 7 - Stock Options", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants", "longName": "013 - Disclosure - Note 8 - Warrants", "shortName": "Note 8 - Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:ClassOfWarrantOrRightTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:ClassOfWarrantOrRightTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative", "longName": "014 - Disclosure - Note 9 - Selling, General and Administrative", "shortName": "Note 9 - Selling, General and Administrative", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development", "longName": "015 - Disclosure - Note 10 - Research and Development", "shortName": "Note 10 - Research and Development", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-", "longName": "016 - Disclosure - Note 11 - Financial Instruments and Risks", "shortName": "Note 11 - Financial Instruments and Risks", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes", "longName": "017 - Disclosure - Note 12 - Income Taxes", "shortName": "Note 12 - Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "longName": "018 - Disclosure - Note 13 - Related Parties", "shortName": "Note 13 - Related Parties", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases", "longName": "019 - Disclosure - Note 14 - Operating Leases", "shortName": "Note 14 - Operating Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-15-segmented-information", "longName": "020 - Disclosure - Note 15 - Segmented Information", "shortName": "Note 15 - Segmented Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R22": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ecd:MtrlTermsOfTrdArrTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ecd:MtrlTermsOfTrdArrTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies", "longName": "995467 - Disclosure - Significant Accounting Policies (Policies)", "shortName": "Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "23", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables", "longName": "995468 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets (Tables)", "shortName": "Note 4 - Prepaid Expenses and Other Current Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables", "longName": "995469 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses (Tables)", "shortName": "Note 5 - Accounts Payable and Accrued Expenses (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-tables", "longName": "995470 - Disclosure - Note 7 - Stock Options (Tables)", "shortName": "Note 7 - Stock Options (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-tables", "longName": "995471 - Disclosure - Note 8 - Warrants (Tables)", "shortName": "Note 8 - Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:ScheduleOfWarrantsOrRightTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ovtz:ClassOfWarrantOrRightTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:ScheduleOfWarrantsOrRightTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ovtz:ClassOfWarrantOrRightTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-tables", "longName": "995472 - Disclosure - Note 9 - Selling, General and Administrative (Tables)", "shortName": "Note 9 - Selling, General and Administrative (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-tables", "longName": "995473 - Disclosure - Note 10 - Research and Development (Tables)", "shortName": "Note 10 - Research and Development (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-tables", "longName": "995474 - Disclosure - Note 12 - Income Taxes (Tables)", "shortName": "Note 12 - Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-tables", "longName": "995475 - Disclosure - Note 13 - Related Parties (Tables)", "shortName": "Note 13 - Related Parties (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern-details-textual", "longName": "995476 - Disclosure - Note 2 - Going Concern (Details Textual)", "shortName": "Note 2 - Going Concern (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "ovtz:WorkingCapitalDeficit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "unique": true } }, "R33": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "longName": "995477 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details Textual)", "shortName": "Note 3 - Summary of Significant Accounting Policies (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "longName": "995478 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)", "shortName": "Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:PrepaidExpenseCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:PrepaidExpenseCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "longName": "995479 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details)", "shortName": "Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "i_2023-12-31_RelatedPartyTransactionsByRelatedPartyAxis-NonrelatedPartyMember", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31_RelatedPartyTransactionsByRelatedPartyAxis-NonrelatedPartyMember", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual", "longName": "995480 - Disclosure - Note 6 - Common Stock (Details Textual)", "shortName": "Note 6 - Common Stock (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:GainsLossesOnCommitmentToIssueShares", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true }, "uniqueAnchor": null }, "R37": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual", "longName": "995481 - Disclosure - Note 7 - Stock Options (Details Textual)", "shortName": "Note 7 - Stock Options (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "d_2022-01-01_2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31_PlanNameAxis-RollingStockOptionPlanMember", "name": "ovtz:SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "1", "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "unique": true } }, "R38": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details", "longName": "995482 - Disclosure - Note 7 - Stock Options - Changes in Options (Details)", "shortName": "Note 7 - Stock Options - Changes in Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "i_2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "b", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2021-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "unitRef": "USDPerShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "b", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "unique": true } }, "R39": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details", "longName": "995483 - Disclosure - Note 7 - Stock Options - Details of Options Outstanding (Details)", "shortName": "Note 7 - Stock Options - Details of Options Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "b", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "unique": true } }, "R40": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details", "longName": "995484 - Disclosure - Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details)", "shortName": "Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "d_2022-01-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2022-01-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details", "longName": "995485 - Disclosure - Note 8 - Warrants - Schedule of Warrants (Details)", "shortName": "Note 8 - Warrants - Schedule of Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "i_2022-12-31", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfWarrantsOrRightTableTextBlock", "ovtz:ClassOfWarrantOrRightTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2022-12-31", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfWarrantsOrRightTableTextBlock", "ovtz:ClassOfWarrantOrRightTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "longName": "995486 - Disclosure - Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details)", "shortName": "Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:FilingAndRegulatoryFee", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:FilingAndRegulatoryFee", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details", "longName": "995487 - Disclosure - Note 10 - Research and Development - Research and Development (Details)", "shortName": "Note 10 - Research and Development - Research and Development (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:ResearchAndDevelopmentExpenseProjectManagement", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "ovtz:ResearchAndDevelopmentExpenseProjectManagement", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-details-textual", "longName": "995488 - Disclosure - Note 11 - Financial Instruments and Risks (Details Textual)", "shortName": "Note 11 - Financial Instruments and Risks (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true }, "uniqueAnchor": null }, "R45": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details", "longName": "995489 - Disclosure - Note 12 - Income Taxes - Reconciliation of Income Taxes (Details)", "shortName": "Note 12 - Income Taxes - Reconciliation of Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details", "longName": "995490 - Disclosure - Note 12 - Income Taxes - Net Deferred Tax Assets (Details)", "shortName": "Note 12 - Income Taxes - Net Deferred Tax Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "ovtz:DeferredTaxAssetsCapitalizedResearchAndDevelopment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "ovtz:DeferredTaxAssetsCapitalizedResearchAndDevelopment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details", "longName": "995491 - Disclosure - Note 12 - Income Taxes - Components of Temporary Difference (Details)", "shortName": "Note 12 - Income Taxes - Components of Temporary Difference (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "i_2023-12-31", "name": "ovtz:OperatingLossCarryforwardsResearchAndDevelopment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-12-31", "name": "ovtz:OperatingLossCarryforwardsResearchAndDevelopment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual", "longName": "995492 - Disclosure - Note 13 - Related Parties (Details Textual)", "shortName": "Note 13 - Related Parties (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "b", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31_RelatedPartyTransactionAxis-ReimbursementMember", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "unique": true } }, "R49": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-related-party-expenses-details", "longName": "995493 - Disclosure - Note 13 - Related Parties - Related Party Expenses (Details)", "shortName": "Note 13 - Related Parties - Related Party Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "b", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31_IncomeStatementLocationAxis-ConsultingFeesMember", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "b", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "unique": true } }, "R50": { "role": "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases-details-textual", "longName": "995494 - Disclosure - Note 14 - Operating Leases (Details Textual)", "shortName": "Note 14 - Operating Leases (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "d_2023-01-01_2023-12-31", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-12-31_LeaseContractualTermAxis-VancouverCAOperatingLeaseMember", "name": "ovtz:OperatingLeasesMonthlyRentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ovtz20231231_10k.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 0.0 }, "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expenses", "totalLabel": "Accounts Payable and Accrued Liabilities, Current", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r15" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r14" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_AccountsPayableCurrent", "terseLabel": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r13", "r394" ] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details" ], "lang": { "en-us": { "role": { "label": "Accrued fees and expenses", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r16" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive income (loss)", "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r419" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r3", "r9", "r19", "r261", "r264", "r282", "r317", "r318", "r420", "r421", "r422", "r427", "r428", "r429" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r51", "r394", "r473" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r221", "r222", "r223", "r331", "r427", "r428", "r429", "r464", "r476" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency" ], "lang": { "en-us": { "role": { "label": "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "terseLabel": "Share-based compensation", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r37", "r38", "r186" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual" ], "lang": { "en-us": { "role": { "label": "Share-based compensation (Notes 7 and 13)", "terseLabel": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r217", "r228" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r132" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r25" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r25" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "us-gaap_Assets", "totalLabel": "Total Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r75", "r91", "r109", "r139", "r143", "r146", "r153", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r256", "r258", "r270", "r307", "r351", "r394", "r404", "r431", "r432", "r469" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r407", "r408", "r409" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r407", "r408", "r409" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r407", "r408", "r409" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r188", "r189", "r190", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r212", "r213", "r214", "r215", "r216" ] }, "us-gaap_CanadaRevenueAgencyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CanadaRevenueAgencyMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "lang": { "en-us": { "role": { "label": "Canada Revenue Agency [Member]", "documentation": "Designated tax department of the government of Canada." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-details-textual" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "terseLabel": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r22", "r90", "r388" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r23" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "periodStartLabel": "Cash and cash equivalents at beginning of year", "periodEndLabel": "Cash and cash equivalents at end of year", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r22", "r61", "r106" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "totalLabel": "Net decrease in cash and cash equivalents", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r61" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r31" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercise price (in dollars per share)", "label": "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r182" ] }, "ovtz_ClassOfWarrantOrRightExpiredDuringPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ClassOfWarrantOrRightExpiredDuringPeriod", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "lang": { "en-us": { "role": { "label": "ovtz_ClassOfWarrantOrRightExpiredDuringPeriod", "negatedLabel": "Expired (in shares)", "documentation": "The number of warrants or rights expired during period." } } }, "auth_ref": [] }, "ovtz_ClassOfWarrantOrRightExpiredDuringPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ClassOfWarrantOrRightExpiredDuringPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "lang": { "en-us": { "role": { "label": "Expired (in dollars per share)", "documentation": "Per share or per unit weighted average exercise price of warrants or rights expired during the period." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of warrants outstanding (in shares)", "label": "us-gaap_ClassOfWarrantOrRightOutstanding", "periodStartLabel": "Warrants outstanding (in shares)", "periodEndLabel": "Warrants outstanding (in shares)", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "ovtz_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "lang": { "en-us": { "role": { "label": "ovtz_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice", "periodStartLabel": "Warrants outstanding, weighted average exercise price (in dollars per share)", "periodEndLabel": "Warrants outstanding, weighted average exercise price (in dollars per share)", "documentation": "Weighted average price of class of warrant or right outstanding." } } }, "auth_ref": [] }, "ovtz_ClassOfWarrantOrRightRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ClassOfWarrantOrRightRemainingContractualTerm", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Class of Warrant or Right, Remaining Contractual Term", "label": "ovtz_ClassOfWarrantOrRightRemainingContractualTerm", "documentation": "Remaining contractual term of class of warrant or right." } } }, "auth_ref": [] }, "ovtz_ClassOfWarrantOrRightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ClassOfWarrantOrRightTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Text Block]", "documentation": "The entire disclosure for warrant or right." } } }, "auth_ref": [] }, "ovtz_CommitmentToIssueSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "CommitmentToIssueSharesMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency" ], "lang": { "en-us": { "role": { "label": "Commitment to Issue Shares [Member]", "documentation": "Represents commitment to issue shares." } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r395", "r396", "r397", "r399", "r400", "r401", "r402", "r427", "r428", "r464", "r472", "r476" ] }, "us-gaap_CommonStockNoParValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockNoParValue", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual" ], "lang": { "en-us": { "role": { "label": "Common stock, no par value (in dollars per share)", "terseLabel": "Common Stock, No Par Value (in dollars per share)", "documentation": "Face amount per share of no-par value common stock." } } }, "auth_ref": [ "r50" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized (in shares)", "terseLabel": "Common Stock, Shares Authorized (in shares)", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r50", "r339" ] }, "ovtz_CommonStockSharesHeldInEscrow": { "xbrltype": "sharesItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "CommonStockSharesHeldInEscrow", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual" ], "lang": { "en-us": { "role": { "label": "ovtz_CommonStockSharesHeldInEscrow", "terseLabel": "Common Stock, Shares Held in Escrow (in shares)", "documentation": "Number of common stock held in escrow." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued (in shares)", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r50" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding (in shares)", "terseLabel": "Common Stock, Shares, Outstanding, Ending Balance (in shares)", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r10", "r50", "r339", "r357", "r476", "r477" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 91,422,569", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r50", "r309", "r394" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "lang": { "en-us": { "role": { "label": "us-gaap_ComprehensiveIncomeNetOfTax", "totalLabel": "Total comprehensive loss", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r20", "r94", "r96", "r101", "r304", "r314" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r42", "r390" ] }, "ovtz_ConsultingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ConsultingExpense", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "lang": { "en-us": { "role": { "label": "Consulting (Note 13)", "documentation": "The aggregate costs incurred for consultation." } } }, "auth_ref": [] }, "ovtz_ConsultingFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ConsultingFeesMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-related-party-expenses-details" ], "lang": { "en-us": { "role": { "label": "Consulting Fees [Member]", "documentation": "Represents consulting fees paid." } } }, "auth_ref": [] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "lang": { "en-us": { "role": { "label": "us-gaap_CostsAndExpenses", "negatedTotalLabel": "Loss from operations", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r59" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "lang": { "en-us": { "role": { "label": "Expenses:" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "lang": { "en-us": { "role": { "label": "Current income tax", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r73", "r246", "r252", "r424" ] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables" ], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]", "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs." } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "lang": { "en-us": { "role": { "label": "Deferred tax recovery", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r6", "r73", "r85", "r251", "r252", "r424" ] }, "ovtz_DeferredTaxAssetsCapitalizedResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopment", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details" ], "lang": { "en-us": { "role": { "label": "Research and development", "documentation": "Represents capitalized research and development related to deferred tax assets." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_DeferredTaxAssetsGross", "totalLabel": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r241" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_DeferredTaxAssetsNet", "totalLabel": "Net deferred tax assets", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r462" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details" ], "lang": { "en-us": { "role": { "label": "Non-capital losses", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r41", "r463" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_DeferredTaxAssetsValuationAllowance", "negatedLabel": "Unrecognized deferred tax assets", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r242" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r185", "r187", "r218", "r219", "r220", "r393" ] }, "us-gaap_DisclosureTextBlockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureTextBlockAbstract", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development", "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20231231/role/statement-note-15-segmented-information", "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative" ], "lang": { "en-us": { "role": { "label": "us-gaap_DisclosureTextBlockAbstract", "terseLabel": "Notes to Financial Statements" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r407", "r408", "r409" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r407", "r408", "r409", "r411" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r410" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticCountryMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "lang": { "en-us": { "role": { "label": "Domestic Tax Authority [Member]", "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "lang": { "en-us": { "role": { "label": "Net loss per share \u2013 basic and diluted (in dollars per share)", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r102", "r118", "r119", "r120", "r121", "r122", "r126", "r127", "r129", "r130", "r131", "r133", "r268", "r269", "r305", "r315", "r391" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r25", "r26" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Effect of foreign currency translation on cash", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r466" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r405" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information", "http://www.oculusvisiontech.com/20231231/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-", "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-related-party-expenses-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-15-segmented-information", "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-tables", "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r405" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r405" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r414" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r405" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r405" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r405" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r405" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r415" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r10", "r87", "r98", "r99", "r100", "r113", "r114", "r115", "r117", "r123", "r125", "r134", "r154", "r155", "r183", "r221", "r222", "r223", "r247", "r248", "r260", "r261", "r262", "r263", "r264", "r265", "r267", "r275", "r276", "r277", "r278", "r279", "r280", "r282", "r317", "r318", "r319", "r331", "r379" ] }, "ovtz_FilingAndRegulatoryFee": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "FilingAndRegulatoryFee", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "lang": { "en-us": { "role": { "label": "Filing and regulatory fees", "documentation": "Expenditures for filing and regulatory." } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentsDisclosureTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-" ], "lang": { "en-us": { "role": { "label": "Financial Instruments Disclosure [Text Block]", "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures." } } }, "auth_ref": [] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "lang": { "en-us": { "role": { "label": "Foreign Tax Authority [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r271" ] }, "ovtz_GainsLossesOnCommitmentToIssueShares": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "GainsLossesOnCommitmentToIssueShares", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual" ], "lang": { "en-us": { "role": { "label": "Gain on reduction of commitment to issue shares (Note 6)", "terseLabel": "Gains (Losses) on Commitment to Issue Shares", "negatedLabel": "Gain on reduction of commitment to issue shares", "documentation": "Gain (loss) related to the commitment to issue shares." } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "lang": { "en-us": { "role": { "label": "Office and administration", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r60", "r361" ] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r7", "r30" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r407", "r408", "r409" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r66" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "negatedLabel": "Loss before taxes for the year", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r1", "r57", "r77", "r139", "r142", "r145", "r148", "r306", "r312", "r392" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-related-party-expenses-details" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r158", "r159", "r364" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-related-party-expenses-details" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r159", "r364" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityNameAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority, Name [Axis]", "documentation": "Information by name of taxing authority." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncomeTaxAuthorityNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityNameDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority, Name [Domain]", "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r110", "r232", "r238", "r239", "r244", "r249", "r253", "r254", "r255", "r327" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_IncomeTaxExpenseBenefit", "totalLabel": "Total income taxes", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r80", "r86", "r124", "r125", "r140", "r236", "r250", "r316" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r97", "r234", "r235", "r239", "r240", "r243", "r245", "r325" ] }, "ovtz_IncomeTaxRateReconciliationChangeInUnrecognizedDeductibleTemporary": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "IncomeTaxRateReconciliationChangeInUnrecognizedDeductibleTemporary", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "lang": { "en-us": { "role": { "label": "Change in unrecognized deductible temporary", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to change in unrecognized deductible temporary." } } }, "auth_ref": [] }, "ovtz_IncomeTaxRateReconciliationExpectedIncomeTaxRecovery": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "IncomeTaxRateReconciliationExpectedIncomeTaxRecovery", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "lang": { "en-us": { "role": { "label": "Expected income tax (recovery)", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to expected income tax (recovery)." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "lang": { "en-us": { "role": { "label": "Effect of change in tax rates", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates." } } }, "auth_ref": [ "r233", "r237" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationNondeductibleExpense", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "lang": { "en-us": { "role": { "label": "Permanent differences", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses." } } }, "auth_ref": [ "r461" ] }, "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes", "negatedLabel": "Adjustment to prior years provision", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)." } } }, "auth_ref": [ "r461" ] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Cash paid during the year for income taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income." } } }, "auth_ref": [ "r21", "r24" ] }, "us-gaap_IncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesReceivable", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details" ], "lang": { "en-us": { "role": { "label": "Tax Receivable \u2013 Canadian GST", "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes." } } }, "auth_ref": [ "r44", "r417" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Increase in accounts payable and accrued expenses", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDueToRelatedParties", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Decrease in accounts payable and accrued expenses due to related parties", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "negatedLabel": "Decrease in prepaid expenses and other current assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r5" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "auth_ref": [ "r412" ] }, "us-gaap_InterestIncomeExpenseNonoperatingNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNonoperatingNet", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "lang": { "en-us": { "role": { "label": "Interest income", "documentation": "The net amount of nonoperating interest income (expense)." } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Cash paid during the year for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r103", "r104", "r105" ] }, "us-gaap_InternalRevenueServiceIRSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InternalRevenueServiceIRSMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "lang": { "en-us": { "role": { "label": "Internal Revenue Service (IRS) [Member]", "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_LeaseContractualTermAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseContractualTermAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases-details-textual" ], "lang": { "en-us": { "role": { "label": "Lease Contractual Term [Axis]", "documentation": "Information by contractual term of lease arrangement." } } }, "auth_ref": [ "r416" ] }, "us-gaap_LeaseContractualTermDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseContractualTermDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases-details-textual" ], "lang": { "en-us": { "role": { "label": "Lease Contractual Term [Domain]", "documentation": "Contractual term of lease arrangement." } } }, "auth_ref": [ "r416" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information", "http://www.oculusvisiontech.com/20231231/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-", "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-related-party-expenses-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-15-segmented-information", "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-tables", "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r281" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "us-gaap_LiabilitiesAndStockholdersEquity", "totalLabel": "Total Liabilities and Stockholders' Equity (Deficiency):", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r55", "r76", "r311", "r394", "r423", "r430", "r465" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_LiabilitiesCurrent", "terseLabel": "Liabilities, Current", "totalLabel": "Total Current Liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r17", "r89", "r109", "r153", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r257", "r258", "r259", "r270", "r394", "r431", "r469", "r470" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_MarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketingExpense", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "lang": { "en-us": { "role": { "label": "Marketing", "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs." } } }, "auth_ref": [ "r60" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r413" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "totalLabel": "Net cash used in operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r61", "r62", "r63" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 0.0 }, "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency", "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern-details-textual" ], "lang": { "en-us": { "role": { "verboseLabel": "Net loss", "label": "us-gaap_NetIncomeLoss", "terseLabel": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r58", "r63", "r78", "r88", "r93", "r95", "r100", "r109", "r116", "r118", "r119", "r120", "r121", "r124", "r125", "r128", "r139", "r142", "r145", "r148", "r153", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r269", "r270", "r313", "r359", "r377", "r378", "r392", "r403", "r431" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "ecd_NonRule10b51ArrAdoptedFlag", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r413" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "ecd_NonRule10b51ArrTrmntdFlag", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r413" ] }, "us-gaap_NonrelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonrelatedPartyMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details" ], "lang": { "en-us": { "role": { "label": "Nonrelated Party [Member]", "documentation": "Party not related to reporting entity." } } }, "auth_ref": [ "r425", "r426" ] }, "ovtz_NoteToFinancialStatementDetailsTextual": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "NoteToFinancialStatementDetailsTextual", "lang": { "en-us": { "role": { "label": "Note To Financial Statement Details Textual" } } }, "auth_ref": [] }, "ovtz_NotesToFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "NotesToFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Notes To Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "lang": { "en-us": { "role": { "label": "Rent", "terseLabel": "Operating Lease, Expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r467" ] }, "ovtz_OperatingLeasesMonthlyRentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "OperatingLeasesMonthlyRentExpense", "crdr": "debit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases-details-textual" ], "lang": { "en-us": { "role": { "label": "ovtz_OperatingLeasesMonthlyRentExpense", "terseLabel": "Operating Leases, Monthly Rent Expense", "documentation": "Amount of monthly rent expense incurred under the operating lease." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "lang": { "en-us": { "role": { "label": "Operatinting loss", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r40" ] }, "ovtz_OperatingLossCarryforwardsNoncapitalLossesAvailableForFuturePeriods": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "OperatingLossCarryforwardsNoncapitalLossesAvailableForFuturePeriods", "crdr": "debit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "lang": { "en-us": { "role": { "label": "Non-capital losses available for future periods", "documentation": "Represents non-capital losses available for future periods related to operating loss carryforwards." } } }, "auth_ref": [] }, "ovtz_OperatingLossCarryforwardsResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "OperatingLossCarryforwardsResearchAndDevelopment", "crdr": "debit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "lang": { "en-us": { "role": { "label": "Research and Development", "documentation": "Represents research and development operating loss carryforwards." } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-1-basis-of-presentation-and-business" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r47", "r74", "r322", "r323" ] }, "us-gaap_OtherAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsDisclosureTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets" ], "lang": { "en-us": { "role": { "label": "Other Assets Disclosure [Text Block]", "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency" ], "lang": { "en-us": { "role": { "label": "Currency translation differences", "negatedLabel": "Currency translation differences", "terseLabel": "Currency translation differences", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r4", "r56", "r272", "r273", "r274" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income (loss)" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459" ] }, "us-gaap_PolicyTextBlockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PolicyTextBlockAbstract", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "us-gaap_PolicyTextBlockAbstract", "terseLabel": "Accounting Policies" } } }, "auth_ref": [] }, "us-gaap_PreferredStockNoParValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockNoParValue", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value (in dollars per share)", "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r49", "r433" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual" ], "lang": { "en-us": { "role": { "label": "Preferred stock, authorized (in shares)", "terseLabel": "Preferred Stock, Shares Authorized (in shares)", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r49", "r339" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual" ], "lang": { "en-us": { "role": { "label": "Preferred stock, issued (in shares)", "terseLabel": "Preferred Stock, Shares Issued (in shares)", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r49", "r170" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock - no par value; authorized 250,000,000 shares, none issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r49", "r308", "r394" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 0.0 }, "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "terseLabel": "Prepaid expenses and other current assets (Note 4)", "totalLabel": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r418" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r92", "r156", "r157", "r389" ] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfessionalFees", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "lang": { "en-us": { "role": { "label": "Professional fees", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r403", "r474", "r475" ] }, "ovtz_RangeFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "RangeFiveMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "lang": { "en-us": { "role": { "label": "Range Five [Member]", "documentation": "Represents range five." } } }, "auth_ref": [] }, "ovtz_RangeFourMember": { "xbrltype": "domainItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "RangeFourMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "lang": { "en-us": { "role": { "label": "Range Four [Member]", "documentation": "Represents range four." } } }, "auth_ref": [] }, "ovtz_RangeSixMember": { "xbrltype": "domainItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "RangeSixMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "lang": { "en-us": { "role": { "label": "Range Six [Member]", "documentation": "Represents the range six." } } }, "auth_ref": [] }, "ovtz_RangeThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "RangeThreeMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "lang": { "en-us": { "role": { "label": "Range Three [Member]", "documentation": "Represents range three." } } }, "auth_ref": [] }, "ovtz_ReductionOfCommitmentToIssueShares": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ReductionOfCommitmentToIssueShares", "crdr": "debit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency" ], "lang": { "en-us": { "role": { "label": "ovtz_ReductionOfCommitmentToIssueShares", "terseLabel": "Reduction of commitment to issue shares", "documentation": "Represents a reduction of the commitment to issue shares." } } }, "auth_ref": [] }, "ovtz_ReimbursementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ReimbursementMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual" ], "lang": { "en-us": { "role": { "label": "Reimbursement [Member]", "documentation": "Represents the related party transaction for reimbursement." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r184", "r286", "r287", "r334", "r335", "r336", "r337", "r338", "r356", "r358", "r386" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r111", "r112", "r286", "r287", "r288", "r289", "r334", "r335", "r336", "r337", "r338", "r356", "r358", "r386" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-related-party-expenses-details" ], "lang": { "en-us": { "role": { "label": "Related party transactions", "terseLabel": "Related Party Transaction, Amounts of Transaction", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r43", "r286" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r286", "r287", "r468" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r184", "r286", "r287", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r334", "r335", "r336", "r337", "r338", "r356", "r358", "r386", "r468" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r283", "r284", "r285", "r287", "r290", "r328", "r329", "r330", "r362", "r363", "r364", "r383", "r385" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 0.0 }, "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details" ], "lang": { "en-us": { "role": { "label": "Research and development (Note 10)", "totalLabel": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r45", "r230", "r471" ] }, "ovtz_ResearchAndDevelopmentExpenseBusinessDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ResearchAndDevelopmentExpenseBusinessDevelopment", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details": { "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details" ], "lang": { "en-us": { "role": { "label": "Business development", "documentation": "Research and development expense during the period related to business development." } } }, "auth_ref": [] }, "ovtz_ResearchAndDevelopmentExpensePayroll": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ResearchAndDevelopmentExpensePayroll", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details": { "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details" ], "lang": { "en-us": { "role": { "label": "Payroll", "documentation": "Research and development expense during the period related to payroll." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Research and Development Expense, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r229" ] }, "ovtz_ResearchAndDevelopmentExpenseProjectManagement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ResearchAndDevelopmentExpenseProjectManagement", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details": { "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details" ], "lang": { "en-us": { "role": { "label": "Project management", "documentation": "Research and development expense during the period related to project management." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details": { "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details" ], "lang": { "en-us": { "role": { "label": "Software development", "documentation": "Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed." } } }, "auth_ref": [ "r46", "r460" ] }, "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development" ], "lang": { "en-us": { "role": { "label": "Research, Development, and Computer Software Disclosure [Text Block]", "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period." } } }, "auth_ref": [ "r79", "r231" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern-details-textual" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "terseLabel": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r52", "r68", "r310", "r320", "r321", "r326", "r340", "r394" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r87", "r113", "r114", "r115", "r117", "r123", "r125", "r154", "r155", "r221", "r222", "r223", "r247", "r248", "r260", "r262", "r263", "r265", "r267", "r317", "r319", "r331", "r476" ] }, "ovtz_RollingStockOptionPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "RollingStockOptionPlanMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual" ], "lang": { "en-us": { "role": { "label": "Rolling Stock Option Plan [Member]", "documentation": "Related to the Rolling Stock Option Plan." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "ecd_Rule10b51ArrAdoptedFlag", "terseLabel": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r413" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "ecd_Rule10b51ArrTrmntdFlag", "terseLabel": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r413" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r72" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r71" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions [Table Text Block]", "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates." } } }, "auth_ref": [] }, "ovtz_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ScheduleOfResearchAndDevelopmentExpensesTableTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Research and Development Expenses [Table Text Block]", "documentation": "Tabular disclosure of research and development expenses." } } }, "auth_ref": [] }, "ovtz_ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Selling, General and Administrative Expenses [Table Text Block]", "documentation": "Tabular disclosure of selling, general and administrative expenses." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-tables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms." } } }, "auth_ref": [ "r32" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-tables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r11", "r12", "r33" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r70" ] }, "ovtz_ScheduleOfWarrantsOrRightTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "ScheduleOfWarrantsOrRightTableTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Warrants or Right [Table Text Block]", "documentation": "Tabular disclosure of an entity's warrants or rights." } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r406" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-15-segmented-information" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r135", "r136", "r137", "r138", "r139", "r141", "r144", "r146", "r147", "r148", "r149", "r150", "r151", "r152" ] }, "ovtz_SellingGeneralAndAdministrativeDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "SellingGeneralAndAdministrativeDisclosureTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Disclosure [Text Block]", "documentation": "The entire disclosure for selling, general and administrative expenses." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 }, "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative (Notes 9 and 13)", "totalLabel": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r60" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-related-party-expenses-details" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Add back non-cash share-based compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Expiry date", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "documentation": "Date the equity-based award expires, in YYYY-MM-DD format." } } }, "auth_ref": [ "r435" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "lang": { "en-us": { "role": { "label": "Exercise price (CAD) (in CAD per share)", "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r215" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "lang": { "en-us": { "role": { "label": "Expected annualized volatility", "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement." } } }, "auth_ref": [ "r213" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercisable (in shares)", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r194" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "negatedLabel": "Expired, options (in shares)", "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements." } } }, "auth_ref": [ "r199" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details" ], "lang": { "en-us": { "role": { "label": "Expired, aggregate intrinsic value (in dollars per share)", "documentation": "The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed." } } }, "auth_ref": [ "r34" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details" ], "lang": { "en-us": { "role": { "label": "Granted, aggregate intrinsic value (in dollars per share)", "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r206" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual" ], "lang": { "en-us": { "role": { "label": "Granted, options (in shares)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r196" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "lang": { "en-us": { "role": { "label": "Fair value of options granted (CAD) (in dollars per share)", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r206" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details" ], "lang": { "en-us": { "role": { "label": "Options outstanding, aggregate intrinsic value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r32" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of options outstanding (in shares)", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "periodStartLabel": "Options outstanding (in shares)", "periodEndLabel": "Options outstanding (in shares)", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r192", "r193" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "periodStartLabel": "Options outstanding, weighted average exercise price (in dollars per share)", "periodEndLabel": "Options outstanding, weighted average exercise price (in dollars per share)", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r192", "r193" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "lang": { "en-us": { "role": { "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r188", "r189", "r190", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r212", "r213", "r214", "r215", "r216" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details" ], "lang": { "en-us": { "role": { "label": "Expired, weighted average exercise price (in dollars per share)", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired." } } }, "auth_ref": [ "r199" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "terseLabel": "Granted, weighted average exercise price (in dollars per share)", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r196" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r185", "r191", "r210", "r211", "r212", "r213", "r216", "r224", "r225", "r226", "r227" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range [Axis]", "documentation": "Information by range of option prices pertaining to options granted." } } }, "auth_ref": [ "r35" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range [Domain]", "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r36" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r434" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "lang": { "en-us": { "role": { "label": "Expected life of options (in years) (Year)", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r212" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Remaining contractual life (Year)", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r69" ] }, "ovtz_SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved": { "xbrltype": "percentItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual" ], "lang": { "en-us": { "role": { "label": "ovtz_SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved", "terseLabel": "Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved", "documentation": "The percent of issued and outstanding common shares reserved in a share-based compensation." } } }, "auth_ref": [] }, "ovtz_SharebasedCompensationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "SharebasedCompensationMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-related-party-expenses-details" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation [Member]", "documentation": "Represents share-based compensation." } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharesIssued", "periodStartLabel": "Balance (in shares)", "periodEndLabel": "Balance (in shares)", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r10" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r64", "r107" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r10", "r18", "r87", "r98", "r99", "r100", "r113", "r114", "r115", "r117", "r123", "r125", "r134", "r154", "r155", "r183", "r221", "r222", "r223", "r247", "r248", "r260", "r261", "r262", "r263", "r264", "r265", "r267", "r275", "r276", "r277", "r278", "r279", "r280", "r282", "r317", "r318", "r319", "r331", "r379" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency", "http://www.oculusvisiontech.com/20231231/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-", "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-related-party-expenses-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-15-segmented-information", "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-tables", "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r113", "r114", "r115", "r134", "r291", "r324", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r358", "r360", "r361", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r379", "r398" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency", "http://www.oculusvisiontech.com/20231231/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-research-and-development-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-", "http://www.oculusvisiontech.com/20231231/role/statement-note-11-financial-instruments-and-risks-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-components-of-temporary-difference-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-related-party-expenses-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-15-segmented-information", "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-of-options-outstanding-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-tables", "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r113", "r114", "r115", "r134", "r291", "r324", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r358", "r360", "r361", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r379", "r398" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficiency" ], "lang": { "en-us": { "role": { "label": "us-gaap_StockholdersEquity", "totalLabel": "Stockholders' Equity (Deficiency):", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r50", "r53", "r54", "r65", "r341", "r357", "r380", "r381", "r394", "r404", "r423", "r430", "r465", "r476" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-balance-sheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Deficiency):" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-6-common-stock" ], "lang": { "en-us": { "role": { "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r67", "r108", "r169", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r183", "r266", "r382", "r384", "r387" ] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern" ], "lang": { "en-us": { "role": { "label": "Substantial Doubt about Going Concern [Text Block]", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r48" ] }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-tables" ], "lang": { "en-us": { "role": { "label": "Summary of Operating Loss Carryforwards [Table Text Block]", "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r39" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-cash-flows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information:" } } }, "auth_ref": [] }, "us-gaap_TableTextBlock": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TableTextBlock", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-10-research-and-development-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-12-income-taxes-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-13-related-parties-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-tables", "http://www.oculusvisiontech.com/20231231/role/statement-note-9-selling-general-and-administrative-tables" ], "lang": { "en-us": { "role": { "label": "us-gaap_TableTextBlock", "terseLabel": "Notes Tables" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r27", "r28", "r29", "r81", "r82", "r83", "r84" ] }, "ovtz_VancouverCAOperatingLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "VancouverCAOperatingLeaseMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20231231/role/statement-note-14-operating-leases-details-textual" ], "lang": { "en-us": { "role": { "label": "Vancouver, CA Operating Lease [Member]", "documentation": "Represents the operating lease for the Vancouver, Candada location." } } }, "auth_ref": [] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual" ], "lang": { "en-us": { "role": { "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual" ], "lang": { "en-us": { "role": { "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459" ] }, "ovtz_VestingEverySixMonthsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "VestingEverySixMonthsMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20231231/role/statement-note-7-stock-options-details-textual" ], "lang": { "en-us": { "role": { "label": "Vesting Every Six Months [Member]", "documentation": "Represents the options vested every 6 months." } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20231231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r395", "r396", "r399", "r400", "r401", "r402" ] }, "ovtz_WarrantsExpiringOnJune42025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "WarrantsExpiringOnJune42025Member", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "lang": { "en-us": { "role": { "label": "Warrants Expiring on June 4, 2025 [Member]", "documentation": "Represents warrants expiring on June 4, 2025." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding \u2013 basic and diluted (in shares)", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r126", "r131" ] }, "ovtz_WorkingCapitalDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "WorkingCapitalDeficit", "crdr": "debit", "presentation": [ "http://www.oculusvisiontech.com/20231231/role/statement-note-2-going-concern-details-textual" ], "lang": { "en-us": { "role": { "label": "ovtz_WorkingCapitalDeficit", "terseLabel": "Working Capital (Deficit)", "documentation": "Represents the amount of difference between Current Assets and Current Liabilities." } } }, "auth_ref": [] }, "ovtz_statement-statement-note-10-research-and-development-research-and-development-details": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-10-research-and-development-research-and-development-details", "lang": { "en-us": { "role": { "label": "Note 10 - Research and Development - Research and Development (Details)" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-10-research-and-development-tables": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-10-research-and-development-tables", "lang": { "en-us": { "role": { "label": "Note 10 - Research and Development" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-12-income-taxes-components-of-temporary-difference-details": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-12-income-taxes-components-of-temporary-difference-details", "lang": { "en-us": { "role": { "label": "Note 12 - Income Taxes - Components of Temporary Difference (Details)" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-12-income-taxes-net-deferred-tax-assets-details": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-12-income-taxes-net-deferred-tax-assets-details", "lang": { "en-us": { "role": { "label": "Note 12 - Income Taxes - Net Deferred Tax Assets (Details)" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-12-income-taxes-reconciliation-of-income-taxes-details", "lang": { "en-us": { "role": { "label": "Note 12 - Income Taxes - Reconciliation of Income Taxes (Details)" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-12-income-taxes-tables": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-12-income-taxes-tables", "lang": { "en-us": { "role": { "label": "Note 12 - Income Taxes" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-13-related-parties-related-party-expenses-details": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-13-related-parties-related-party-expenses-details", "lang": { "en-us": { "role": { "label": "Note 13 - Related Parties - Related Party Expenses (Details)" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-13-related-parties-tables": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-13-related-parties-tables", "lang": { "en-us": { "role": { "label": "Note 13 - Related Parties" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "lang": { "en-us": { "role": { "label": "Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-4-prepaid-expenses-and-other-current-assets-tables": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-4-prepaid-expenses-and-other-current-assets-tables", "lang": { "en-us": { "role": { "label": "Note 4 - Prepaid Expenses and Other Current Assets" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "lang": { "en-us": { "role": { "label": "Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details)" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-5-accounts-payable-and-accrued-expenses-tables": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-5-accounts-payable-and-accrued-expenses-tables", "lang": { "en-us": { "role": { "label": "Note 5 - Accounts Payable and Accrued Expenses" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-7-stock-options-changes-in-options-details": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-7-stock-options-changes-in-options-details", "lang": { "en-us": { "role": { "label": "Note 7 - Stock Options - Changes in Options (Details)" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-7-stock-options-details-of-options-outstanding-details": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-7-stock-options-details-of-options-outstanding-details", "lang": { "en-us": { "role": { "label": "Note 7 - Stock Options - Details of Options Outstanding (Details)" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-7-stock-options-tables": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-7-stock-options-tables", "lang": { "en-us": { "role": { "label": "Note 7 - Stock Options" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details", "lang": { "en-us": { "role": { "label": "Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details)" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-8-warrants-schedule-of-warrants-details": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-8-warrants-schedule-of-warrants-details", "lang": { "en-us": { "role": { "label": "Note 8 - Warrants - Schedule of Warrants (Details)" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-8-warrants-tables": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-8-warrants-tables", "lang": { "en-us": { "role": { "label": "Note 8 - Warrants" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "lang": { "en-us": { "role": { "label": "Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details)" } } }, "auth_ref": [] }, "ovtz_statement-statement-note-9-selling-general-and-administrative-tables": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-note-9-selling-general-and-administrative-tables", "lang": { "en-us": { "role": { "label": "Note 9 - Selling, General and Administrative" } } }, "auth_ref": [] }, "ovtz_statement-statement-significant-accounting-policies-policies": { "xbrltype": "stringItemType", "nsuri": "http://www.oculusvisiontech.com/20231231", "localname": "statement-statement-significant-accounting-policies-policies", "lang": { "en-us": { "role": { "label": "Significant Accounting Policies" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a-c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-40/tableOfContent" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "985", "SubTopic": "730", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//985-730/tableOfContent" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-15" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r388": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r391": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r392": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r393": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r395": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r397": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r401": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r402": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r403": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r404": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r405": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r407": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r408": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r409": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r410": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r412": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r413": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r414": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r415": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r416": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r417": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r418": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r419": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r420": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r421": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r422": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r423": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r424": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r425": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r426": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r427": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r428": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r429": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r430": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r431": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r432": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r433": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r434": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r436": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r437": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r438": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r439": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r441": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r442": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r444": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r452": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r461": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r462": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r464": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r465": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r466": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r467": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r468": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r469": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r470": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r471": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r472": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r473": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r474": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r475": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r476": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r477": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 74 0001437749-24-008443-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-24-008443-xbrl.zip M4$L#!!0 ( !1@7D\ M5'_X[V$PRK[O)B$*B5#9AF1+0EE"3$*629+*8!A+]BV$HNQ+)20&V7\@H M9DRR#C-E.67,W/G^[N]W[^LN?]Q[_[FO^_O=YYSGGW,^G^><]_,\YWG>S^O0 MO]+Q .]E$W,3@(F)";C%. #Z/& $0)B9_SD9PL(X6=E965E86(]"H6SLG$ 8 3*Q,_R+ OPH3,^,= MV:#L1XYR,!9@>0%F)@B$F07RSULS[H8Q[@,L?*S\,FJ&; (V;M#C 8+JD>E% M[+(7:[N$KDV0Y<[>?A!UY*BPB*B8N/P)!<63IS0TMGG>\O'U\ Q\^>AR$"@Z)?A(3&Q>?D)B1^2PK.^?YB]SBDM*R M\HK7;]Y^J*O'-C0V?6SN[NGMZQ_X-#@T.?5E>F;VZQR.L$3\L?QS975MG?+K M]\[NWC[XY^\_N)@ "-._R?\4%Q\#%S,+"X0%^@\N)N:@?Q;PL;#*J+'Q&]I MW0($CJM'L@M>3"^J[3HB>_8:6>CV@XFCPG(:!'G*/]#^!=G_&K"H_R-D_P78 M?\6% S@A3(S@0?@ .'!XO3A1$?B/IXE+ZQS&]OG>!/OS;"9'C^S\C) O?MM0 M<>>MA4MGX:,3QG1 /++5N.PD$U;GC)7!/0&J-\0DT>.L:8!HAH(C[X['L6AP M:O5__[FO??_NO2 <8.I],A;[\Z5D ML$^E@3/<8>:1X1O*+JZD_O6X7OSMD8P&+A=6F=89 E5=*? M)7B,OFR>?3,YO""T\E)#P/I9D_ECIX]?(S3>NA4TV!>>^0W3I48'O)*2_)5H MO/-?%T4%3K=A6D-_J\'*T'8'TG1@R(EV'#.[UT$'2L0[$(J0WYE$4ZI 3C^< M_6%+C2AM%,Y'M2O=< H1&XL[C54(>%@Y:%80X2S%;]#5[.&5WT,[0J0#K*Q- MA\7E!83]7M&E6C"EHG?2Z)'D;<7=\U-Q0QB6P>EGG'P90)?0ODOX,6KXU-@F M'6#LL:WK&!=T-(8GU).N&+-WSC]V/[@8H7/NA2J,9 TE[0HZY*+/'!:VRE.B MK2G+:3$K.38MY'L5)[)>7XQ\\*MX12TP]EK7%[5.>9Z9"+W3B7\6NPH:5F)T M@RC.-J!_.UGMJJ7[VME?#1,'W8*JHDY&7U9G1Z[IY5O+0FC(=Z M-J!*/ZD2.3[_6Z4AY:B%=B%+'2G(P)9IE#M8TAIJ;HR:C: #/B.J2XCN6@JD MIYV3$D.+D<64*.RA3P8\@HTT>Y?XQ/Y@-1LUO"#*5M?.3)NEB1Z6RK9\)"-B M6QVTT]IKG!#PXISDOOS9P6>A0RO@4Z7T\<./N@IXH5B,)$II MB2=RYXVDS/1N =?@GN+@>8GE^"9$?X1^2O$'7:6E[R(#KE*ULZUZ;YTVM#5W M;B.1&Q2Y7]RZ@A\;4!$A>E8W/R2==1S?53FZ?Z!C.XF=ET4& M(O4[#\P&.8^^EWGVU!#:YH:JV,LG[^41.>@ .\K9=(8FBZJQ@I#^!L60LF]L MBNY8)"5(R22DP97TM[2MH;43B/.^BPT_8\C[MK7U8!D^302MTM#^U(BMIMIQ M0/]5ZX[#QX:,2T:; ]_P#F_1E\&V"K0F60G5NJ;=F+"CB$=^]")_4_O^G-0M M-N2CA76GSJ==#: M3DY9RXSH>1H8/7;?8 %LHSB-X<>B575MWJPVC]:4?NV3[]M8G5D[B^L2%PE^ MY?AED^GJXQ\'UE!_XP<(#MKQ'LKU;JU\V?J)1RG\_11[9^_=U_QBY0GI+O+L MU5^O223CR:CJA@C=&F+:P# LNHI .C%K_I'BD-)J^6 FA"?VG:?9VQQ5&T?SK\UB;#L3M!H9Q MO9J/NAU%J6WK;3S30@:A,;YKH!%7*[9$7N*%ZM*D[>P0(PQH'"\V2@LE&5A^S<2M+L]%^%3&)NM_S RN6W)FOC1],E!M\NZC6.0C1 MWV'Z-MM#!QI62"-55!U*>P[9'4\J=9KM2_$U*PR-M9$+<Y.?.P#AO8&K#^&.>;W^@ Z\_="0L4R++TO[53.0!LJC,HD.)"P1%A\N [\[ M?>M]Z[1-F4[BS9M7$II@>S8_;':EGS'MC?7 0 7$DQ\-T2[@])MUN"@UZ#Y+ M8Y 3:7/2T5!&LO3,/8[W#R4BB86N66NY.9LZ9*AM7:AC.Q]H<]R-00U>/C4' MM=TB]]G:^A,!ZB[9?[._H*Z1*LC1B5.(;+5:XN !UO]J[M6=B[M:<=90HENW M0S%J4=>S-"7B;C[[X%+'Q;?UN9XOU*4SQY0-M@:.ZJ0;2,<8 MH_\L\> Z',A^R;DU\>'LZ$M3:#COXND2+FP9\=+SP:!8CKAT \F7-5(;$_HP M] -R6M]8W#746&=N'%7^KU/_9YDIX, \W>&$@$36G()5UM"N)/YGA,Y?I>YV M =J<- 3\2 F\"7IZ^E5YAVM.% 57U[<]&/%;9!^2/.EPJ]?_^H#U W6E[]Y M<:O$DA?I%1X>"Q>K'XNY/K?13 =2-47=<[G.&7UP'!MK>EMW]K4]+N;C:JE M5R4=D(#[ID#WPLFO*A):W0C^0L[>UXTX1D*1GIR#/G*MRF=OWZV,[NI4RCC3 M'Z'W-O$/T?ZP_F$83Y<::L :]*,3D+ZLPB[2/P;,4&FZ0G7 #P\ M;8$/3*/H#(1#)FK$_4*[/AA*ET@ @B]$+B2O_#QJ:+]S3^D#Q>2C0NR.SBL3 M%27KF05>]MK)">FE*T_UC1];!\R^7C,0KW>(H8UU-"!Z"G 6O?]\AE15_1+W M)2X>FOY.E>_L9N,Q-L6^ZP&C,Q+.37)>52'[B=@UW;-%W]9M?+1CF\BDXP,6 MET(3U W^V'VW)5Z G\%+MRE"G!(9K 5>_S.=XM\94I"T V,'N^J=-=)+?';Z M'&MQ_(IB05A?@JM(:FU+D;Y,.QN5TN">>& M \T?ND\E!S(,/IT*C6(_%O"4Q[NX"9.\*-JJ0U;H#')5HFCDP-QB;U0M-7Y( M&OW8G&_"(7EFX&5+K2[3*K)ZLB;O^B1)57PF]$13C+S6[&7A&XV*.I+,!FXO M^3(_%7+8.HS1 >$./YZC5"'*3#I!E1]UO?_D6Z3#B2DSI*7ZA>(O+]5KMFY8 MCIWN0)W\$WG,H1'$V&>Z3OCY+T_Y:R0HN/0/6-LZ+OU(/F_B"4TF#U0!WA.N MYPX,:5_RI0YS'TY4HCH,*'*Y;.XF,P^'%5<:S"7?W_CZ)S(:W38KF?H@P*6C M1S4^@&I%;A7?$>?&%N)NLF8LZ#U@B74L\7!P%+*;/VJ$$>8V7(K0QBFE@&\H MZK 8?9$"1,NX9MOC[FFYW(T#[N\*&0MRUT9DE;0S"B'[#\(J!W4Y#NZMP@5: MI=%V!%@<@@]M5,@\I'IWQVQHL/[IO.!GL4_'DA5U*08PDPE71[+(7C891I(I M73^7S_7E3C;Q2M[FW]07F'LSL]G7 F.R3_SP@J:G=XE].MYV->*H8O'_17V[ M/[N'=H?QR/P+"!D)%P31;SLC_.G M'5W-=D+\=2T7)+QN,K!R.MO[Q,!:'&V.FS/W1<-10ZJ2KW%FVT- MI0G6GHT@@S]N'F)TX#IS>P#U6GJ_4OHA%G[[^:/M"'V9Z?IM"7#6F0*++=:> MR9)NJ=;\8J$L&TBRAW"[3][\?!][:P.U:DX"7D)QI?S9-ZCI1\61*;GD'X5-T+&"-:GF MSW_H@ ?W4NLSA \=(%LO@@IMW=NQQ-[&$,1H9=3>W[::8_BP[ULE-";5M@<= M9*LQ"61'_?183*O+4JCY4AHA-0JMR=1$!W)2[(T:EE8.EQL26?1_FQO [J*" MNK7]H] \%:"76833FK9+U VG[HXNP8 G-KN=&P@8(XAR)/M%/$]R=P9F"?OE M>H$WO@:K:1&#G;I7YF5[1$!KY3P$V*U)@./30YXY% "ZMQE,!$-0[TB/>K\Z MT6DX4,$6(0\^8H:!2@I](OU'P=-?*.OAGY5(ENZFM12VK*!RW\=/%]?V S1$ MA!O9I2^XN\7:7^]B<>B!<5.-O#O(]IC$BQ8M*&O4Y85OVT]/.QK7S@]ND!#7 MJ8C#$ET(V:(G<)WA,*[6;)[];B]5#NH-\JT+[# S,_19C= M_$Z.-@ M*+F.;)T@RQL=R1GSS*PH,JHPYB/_BY0E8V'Y%[ M>F%0M #%GQC7*Z7R#NU)]-E"FP:6M/AE#(VJ*4\XU\(?M3_^- #QECW>GD+V M3]"5H0P3RI.6HOU*-\3U*]V%B/*=B>OG&POOI"2P>)J?"DPU+.1A GT.K_^>Z;]Y'UD#K=WRXYFU!\ M* ]K^) T,_(23^B[.2XOFQ;W9HO*-[2@]*^_1CZ)Z3US&,)P8^Y(G2/RI,*1 MWN%2/6R9Y+%>>QOO9HV&M_S=*[;QRM5D]V4U4^T/6XAGP17^D@Z,!M^E%0YW M'"2/\D0M:&! D_ 3*)D?4V436'69W*7O-YZA>F %WCIF8@=%S6[ M>7$?,5#C=SZ//^@(GV2J\V(_LEGM,5!XS&$>(:VO[0V#Z!X)?;=^[F1 I5D* M=V9Q)WJX[>IFLC&+FNKGS9%D_'UU*\97"?*0H=<.7]*!6VGQ>S2ED_Y+';P^ MV@TM[V3/]PI8>'?=5C@_5%P=T+_TM9!'G,)(+5Y:OQ8-^>PGM(7K]$US%P>D#<7"_+U^T/?MK#*O')#4>0E:)TI:,N:N)&[3A6K.K')3N% MPD&I\%\\VZ:?H&M67> ,[$G[D10VH8<60I"O!EE3OB)[.+N4$=*/-3\?/PE+ MC4FI2G%%^>?YG8!E( SJ*4"5)5^*X(49U=[B:6NVA4OHRH12(/C%5+1:^:?: M=?'^N%"WNY_OMWN\USYMY98M5LCSHEWPFQ%C-#\ZC:4#(F"QF",HD?_B5101XS]>/NL81MCR"K@KV)ZJ"-AYS$3A9.HYV).O@-NB%Q\3NID5U"&V+=&G'YKRQE$^9>5LN MFO4J+L__K+2LY_T;PITR\6,0^'7:Q"(?&G)@!2I< W7P+QX6)"S(S-I8#Y9_ M;K1W$O^!J?AVT^1RO_OZ:XG0!D%. 0-1&AP,)0_OK5,&HOUV_."79ZAPMF8W,[R^D&=]_K>PP%V[%7<%+#W AC[-ZN/+6I8Q^+;4!AGN-*'=2T88$/R\+J$_[A]QY_;SQFMV:OFU0C@XDYA!422EO47#$ M\:%M^]J6B8N#OY9^B0D;O/P;7PKY\E1IK])T1IEJ6(9;=WK4[?+5Q:3., !V M\CA?EJ=>EV3T-X>?JE1!ASU>BF=![TE];:IDP\<<6\<,.F WN=,9/LTUQ!L^ M=Z\D>Y3)4_*',/ ##]D53P0E]AP9HV$U2F2@63X_AG)G6?<(T=F3]Z;KS?YA MM\?$%$+M0;;>-)EIE/L\[&;/P46T2M,'D72T.3DY.R;H2(X+]F3:S3_/F%:% MR!6; N\PW5N'11W>/(G-A(,[-5[O5.,T,A5&]B38<589NH?C\]8O@Z!?9IM7 M.QKB>E3%J=);^>B,(9)=Q1TR7)QKSRZQ@7=<#MLJUOK*?4-#4N\L&IW!!]M "NU M^[-(+A^@,=HS[6C9TB(+"B6A>@1%--%NS?60Y1T(>#_89GN_Z6$>.5-H?ZML M*0QF//%S>GO764GEE.CG2<3-F\(# M;L0+__6=2,\"?\9/K12LZ#/6;(I=Q/'C1JP*V_[ZSYA^CY&X"%S7"?"^,8GP M27W!6(L41.$9W3S#G6N4SS[8KXW MOY?KQ8758PJ@!38(E?#A$&C*+D+$ZN $6#[I7,!!U:-(('-3RU?V@W)OWI.O MJ^]:_S Z* /[QMF6 IQ(PKM8F1\V==Q9% 3+!7A2T'=S!^)W8]RS(TLC:6/( M@JV>HWW2>D;2NSL*5"$D[4I-7\?NOCL=*#MR#:=E[*"A9PLAH6,QY3#QU\I0AJ_,#("@KX M*I6CPO]N62)Z?0B5-V3((RGO\\Z[0B>;,CQ#(.(,!=;UW]M+:2CTUS0F7/!RAU?VY%CC=H)_ZMP6]2$&@% MLN6DZ _5HCF8&KOLF@&A%T*.H#T)0J%//^'L=A$>TH]7)'2T88O#][Q9!"(CSX M]/?9EF=HYKS$-[[4<\["Z*?!+ X#B_4#FZKN%!%\1<+.-&4E5?/5 M-0Z'MBF575)8M5_XG'B=\4%M"LA2#>?R%*TY0/B:EIPGC6X!QZ%K&P[F&XT&JITV)_^%BES^FY M[.Y5GEPM!DG@,_#=_DVQ%K=#O M I(FF8@XC*>=:22)D6NN9FQTX9Y5BJ2V*B%[KR1_^U:<*I+):*8<+P]G?8&_ M5GMR,;<.7SV\,>[F8#,=0=64R&6PT;TA\J/MS1;*5 \,*Q)=)>F3_S#$(;7^ MP////14/&=8NFR^'XU;[&;(;KFL'K!MG4&E[+N2&*E\I/_^M1TI-3Z(Y^2T. MXJS#R,;(\'D!1AIE4KS'EK/T)5J9/&196TL::]!$Z1VF =1QI"INF'A)&F[. M5D3NZ/Q0+RU&W-031-&YI^&!U&!TJW$0Q3 MNN&GP7,$JTT;O!;%_J-_<=X;S2,RCEE)E@W+T7Y'C[C_5H5DIKMNOT/?F@I7 M1 N#(Z&W:D_D%%57%?>%-'(<=Q7U8PJVC0 DOH\_"/\9.*KTF0[@L^H,@PZ$ MP0N&YM(2>=-N7:?"QQF3@Q,PQ,@8P8U,]$-PFO+AP*25/!!']0L1N#2ER>N/ M$?1T%RS8IK^W&[#C*@KUZYDV!!WZ&8,-9?MOXUAR 7B%T8F%3*FZH;2JWT0% MFH *'>BSAL[]^UXD%+.4)NG=SG-PRCN6D>-1GH6 Y M[O.[0K^#HNB ?PUX!>U2XHT@E^@KK<%P#@&XPPX;,B41MQC*^ELN;/$4YX_\ M[N8T+3QM,4KG5_@P'3BZ//I<0L<"XUV!>[SWG59Q?D649""=25XA^L>T*R%Q M>SF$EH3MJVFL69\;_9@L@DN:4TICBMSWO[P5>*KV24SA_#827R""-.INUP(' MES!,&^?$C:NS,/CX3?>7LO_?*Y]/MH*>%F*"RTJ3VFE)4^/\Q>8#/X2KH>YU)&!R(><;DNX;^5 MUITH-\O]7K6$L]=(T?WT29?\D25Y'(JS&T*;@%FE5-7)'9*1HT5C8_N7JH>O M4TK9KIUH>FHJO374\IRY=[\F9V?$:TEO-FFS5:8"56 _JXI=A(P0.1QK3A,; MG)%_6N./)Y^YF8="H//.?!L>-6"NU?5?2N.EFI!3:UZC\FPR#TQ["@1UX83= M]W5/JPI_>=2J?Q* GQ8OD:+.PXL4_GOS;VD5 MZ[- KT>]B66)QX MO\*7W/>/;"(M>L)/3*+=BITVQ*6+_-^N!5UVDFAQA/3C M^;G9M]B/I?;R(KLQOF]4W<&8 [V& L&S"SP2'5E2GZL$[V(^;#?=L;L-=4U$ M#K)0$)5D28$F8B_HZL8_[0MYI.08U?7SI+\R1ZS1 MRWMBYZ_U1^A_S3!.U0J2L3&QD.[^R!,+%]C93A*7Q/6GN[^>]XFRBQ*":AW\(%%&1?[GXTE6G)N'1:MH/WCSM,MF=/3J>Y0&W?2U:RL3,E= W%M&JB4= $3=-@\O19R>Q8:>= M6Z83-=H_9MOQ#__Z:>9^@_E)%^QL]" +$+;MJ!V76/]* 3&I8='R%3^MZ:96 MVW KR&I9T4>M7]_NV.\-Q,F;: .PA/OCDBK'Z*]YM&GNY-Y^3XXYNN.KOFR= MR'MX#@?^,/^G8GP$\]F#R96@NV&F>[$S]=/CFB-L_KS=RCO;(E9O0-->&>DE M'&UH3M["X3Z'>O_($YEXCUL/4(4\#:LUL>>$Z4L%U 1??#FZ5 MUBM_RVU^-+8[S]_(-_M5>NISSA6MR,AE=-//-H@AQ2%>HX ?;3*N0,%^";F: M2;0\/2/\99XDTLA[T\E0]L;\^RX>Y;$(3*0C)4(=T-N^!F:5K&'X'R(@5QLQ M\R%M*?TE=X?OH:,%.9-.>*RUJ"L,J0>/^*WGTEX5CU3T8(*%WC7'=-;7FTNP M^236L2"N8T4/F6I2:0"8=X,2U^L?^;>\)5B/5HJS2CX67.W!;_Y!Y:IBR;7% M/BR?@][>K-W!?=_]W'MYQ6!&]]#>6Z/M:7E MV"+TWQ:W^Y%GDS0[$EWEP!=5/4NA)#4TWQ*J\/WDI@LZKT7TG=O+TB3JQ>4* MS,M?6B<6XG2-4+_[^1B\B!NL0A(M+UHZ]_T-SW$+N_M8#YO5=WC8//B(/ST> M]UT^^YA:,JO*T(^(L$QC= "Q(T%:89PFMY[/CYW!,KD5H8W)6=BR19S$9Z2E MP)DM3\? A17(FW1%X@8,53/$B(6K11*M+RG2.5C&Y#B9 ]8^4==V_^R3YP=H MRA2[V1A=Q]>HW7I+EW9>^7;.)Z/1V M@0..%)>&1%W+&A\GSX&^%SMLD177[S= S0X,GGPR].B-?LPTE"W; $!Q)'63 MU>3UZI6CI?@&MJMZJ(K9KGQIBDARJQNL<[Z>XOF5!A#L<7T#'2L+^JK M8PCJBU0[("S=&.U/!WBDZ4 E^C_&(KN=CFY8_"*YH5UZS?44XQKF!KEQGCH& M/MO86_1JB_9(+FA-@Y]^O"7=*PYL>A1)92!G@XN])6)V+^=[E\$L.RD# YT0%7.-J M(2=<# 4S!&.*&]*7+$\M.DZ)]:8@'[:4*)^-,@VO^%W-F);KQGJL8IV:??,% MR"9)A!%#V]<%EM@;SJR77Y(VNF1S=RXK0C[M^L])X!O:WKKX.N7TP#@7?46N M:W[>=Q!_Z*^L*N'UAUTP#R5MR;QZUU4\7F<1.4 M=%"<88=9HL5,D\.QZIY;ZA+.PWLYUHXSM?16):2+A5_-58UGTX%L,K,53*)) MK3VNU+F7._-U4*B^8AKOP->XA"756[/JP4S>D_=R_,K7'MO_??S*-^J\BM_M M&TL)IL9VU@#L,J']1/@H'> *5_MN^(@(9UW3WMV!\+E^,V#M1:TUV/4D/UY) MW'%2A(SJ0@XN4#5!Q)L4JQY7GJF[FG96RKZG8T,+VZ,<.<[#C%Q@J8PIUGWI M<4:N5^*.CA[FJNEOUJJ=VV;[MY*S=*6/;+C("S*-HF"$V=AP\;4'/NU"$\H[ M4OJFO\5G^M4D0VN38R2YH;YY_0NL9#K0F\:Y@ KM$])P)O2M?L<[DS/9<5N5:U]QG_D'/=T'] &); M8SP3!HKL6<1_^9W;4P/%2L H/=\Q B)6YDM)YHAY>&>,W>]773Q#W&&5 U9/>C'2O7/+:K"&G$5FGOH,=!%K<.X1^D&O;^U3\RAOU\AD% M2HW.%&.4R4/4Q>8];N2CJG_(^K(U'Q <> JSJ')2=*\O[*PQ$)@/!0,8SPLQ MF])5('P_VY.+&OBK_\+WZMNX+27Z0K@+EE1.&V77 M?ZG*]AA[S_G4 7Q%WKRAWC+"0<>FT7"Q'D7POWYG5:R?% MTC&L-%W(HTOVW]PGSQ(6 M6C4[.$$ETW&L__.\80DWR>0;O'WQZV;N@[O5S_+RLUWF]9E,Y+\9TPD'9Y2QON.*(YEJ8^K,I,Z!FWH//^?QUW>3 MF5SC&+[1AX)>!/_8YBLXKYAZ)16.JR\:]:J>A;"-N?)C3WZ MQZ,1DVAHT1KNF_J?M=?.N%-780?S W*'R$GO0DZ$"*AJ1-E+.)W&<-WBC#25)71FF4>';S]VUU.JJI13 Q2 M4Q:2(LC4CX+B9R-I0H,/:#SDAA>$NOM%)\3]FIZ"W"Q+ZE@4.&PD93= M>H=L![7ZL\ZCD9.7_O,_),G;[R8,1*59R; XFAAX9ZJG762R:L>%>_QC8RV6 MQ5CXY^DNTUN."0-M-F D.:>K0\B/1**Z$=K@O8_W?CPO^B+#7[PB]L=**F[9 MQ4^0:0"$X.E 5+M04AD9$ZNQR%4VPS*Q]IX]BVP.4R2^@;]Z+&AC(!U$')M; M).3TJ2 /$'TTUG&J^9L_%E <5DL"1_Z,\:% 2/B0@76K!ZQ ##ON8JGHNBOG&V;.2-NQD= M)9+Z%GYJ2[&0^3W5#M^FU)]--GK;IU';W3=N]$B942<'4YX5]#VJ;162JGUH$+_)R)OO MYSFY36P_&?[EY"YXZ=.:=@1P_4XT# MHU*2,%Z+3,:$1]^X8^IR>O5X?-]K]X;RB^371*&Z? M7/_-WW@]6;.9^B0_<>.)W4?Y.BF:-5Y(#_-Y])J@YUYWQCGEVABV-NE$ /^H M)K*=>]:AYP[Q:OY)JHZ LT^.?@Q*M_?^B "KM4W"]?J /@\P;L\- M]%]*B8N8*]-RT8CWN\.[OIGEW?Z?N^&"TQDV\S#\%P-NJ^_&ET< '%/&K%TY:?)!_M;9]2 M<2-/9R/^\5SV-S\$,DU=,CE^\4%JIT,9H\@^7*QC\+=%2RWHY;S-8;D,Y\A0 M_8VS6P8H12(YP%@F%X*=\IN_&')Z:V[RXW9T_/_'KLC*G7_S.CZ77J M-2G*FJN56ZEHIET4#.RU1F5P7>ZJ)E%-[ZD\NB&7;W5Z_5B>EOI6I\2#"M%/ M"C/-;QGTI3YM;K^SF2?AV*P&Z;B%SBJIJNJ&<>CYV(>-HHV_BQ<_V,<#?"^% MK0%HI,TJ'6 PTD,.\QF-2A<6C(=OE)M6GN;GR?E+\@%RQ>POACK%.A_(V/P)Y\;6^*)$(HF)VG4\V%LH M^CZC% L)9QW 43Q&TRI8)2Z>35P,EK10PC7D8OE3?F1HL^F9%!T(,<877/Z' M/PY@T^9@A*LMQ3@?D7!AQ.:\Y6E+80YO_WO';>M\+K5;SQ\C>%@/62D^L$V> M)BGLN8,!16 $\K$31]^;I$^[0B\7OVG-E\8-"L2H\\JI+3M2L@=5,@)=*XR! MX#MO#LY0-6M:9ZJ> MND362B,<.(-^QYYB_[[]_FTL0*Y1(";9I&7YSNG[$4QC0AT,>R H@"<,?/VW M$N3]/U2?&@-&KM"!_ZX&I?WWI6R'P4K&Z,!_6]#^/5AKX8)>K"//9+&]NI5A MZL/]6#FC]9VZ^04O^32Y7?MP&O5!25%0%(2$B CR\7X'D-( = 04;^SW@)U)>! MAHF&AHJ*AHV!@8Z)BXV+BX.-@X.'3_0*#Y\0'P?G%>DKPM?$)"0DN 1DY*3$ MY$3$),3_>0@2RLL]J&A8:&A8Q'@X>,3_C^.Y!T"("0"AY*(@,0*0"9%0")&> M!P!T 2&M)_"<#_'DC(+QS1,3"QL'%>%C2^ B CH: @HZ+\A_7+;-#+/ "5 M$(V(@4\6_;7V)PQ&=V+^L-2?F$SO:GM)=&9AS *6'N%8V*1DY!24;UA8V=ZR M"PH)BXB*BWCZ^?EO[U6T;F]RSPKX+"HN*2TK+?=?4-C4W-+:UM??T#@T/#(Z-C<_,+?Q:7 MEE=6(="=W;W]@[^'1_"+RZOKFUO$O[O_Z$("H"#]'_%?U47XH@L9%14%%>,_ MNI"0??^S@! 5C8$/G4A6&^.3^VM&_C!,XG>I/VM[L9@$=& DEAZSV*3,@I W M\/](^R_*_MN$A?]W*?L_A?U?NE8!N"A(+\E#(00 8^ZO^+9 /]C,+T@*5?D MP(]YWL@A(4; X,HJSPIC :N?R)>0]\HL>-Q\ MQD4HP<'=RA-YG6/TXE1'X#* <&L>/0PLJ$_2G2(IXLOI+@O%XW=@SAQ12+[@ M-]:0UA(8W74_8]]Z8 9KKG%7/ ,:.9_^..;:#- &G,K_@98(_GIGF/_PS@. 4Z:O($"S3[N.?X ME!LW=1?;\PYR%Y4:'\)5>@G/B@W[^4ZP),& ;@6/Q>Y7%4($U.L(\ZFWW%65 M#$:N54QI/-PT/=]TBFYS0L4^T+N:7E<5AV*S_?I? Y5ECOI@Z3SWH!!/DA_? M.EPXEUZWR"@ ?P C-)VP+N(!.I)\59#^/\\OJ$>$/)2U,]X/2H"]# M(2OK50,!45>5I?/>Q?DI0+K$9 P"]@N#YGWOK=? [?Q-C(MS+S<<&LQ=0241:@X&Z>7#/)WA8^2 ABD9S+Z.0'\O4M<6P&\LM6&Y[EVIVAQ*G4 M/G@$L3=5PRQ4'W]\A%4F_\P_O-NX^6E'LU\04MI[ !E_NL#\\N,WR6>!I(&< MW<\R#=@V3BFD.[#C30Q(XS-@;--O9:"Y]?8-BYM*]9^*/8V+!.V 3>& %=='$<4/UWG)W38$I"N3 M-]5-]K=X7YALA9L=I2_X\]JV@YEJ&;O&878)#>\,XA!T)O/=CG01F5W4BX5ZCE^V)GVE M)N(;/$ */.7JXRAQ".[SDX-%GH.2!P&W$V!L%Y4FB5SARL91WDJ J4&"MX>. M&[N1VL<&E:0U(E3/I^W?7;2(0.FP[8W _L\6CR6:;2)T*Q<:@[M1+&IU[2&D MS';TR0/X?RZ['XBC)*=1$%RBXXYU;-,=+&UTRUL[+#^#G+QA_4-4IQT&D.LU M5VZ":7=G0-]!.SW349&FI5,?T$R*XNG5\GMP5-%7L)Z!>L'AJC,'M16(P(4S M>3IL!,/+[_R"P''"+92L,J32;8&AI:G-3+9R'VP$ZEF2#=-/!+50C;"RBIHC M450S(/"> :RC<(.GUO60OR/EU>0%,PMMJK!ST!G:;_>,E/WT ?ZWI)^ M.VDW+SX^$0MLXS=/S M0_%>I77NK-KK4?@/5R.5'W?#\MIT5E5.K7_<, K3'NKN9:IQ^;T*@GL'XMP% MK,VXU9WAVB4TPY%PN5RM[9%VM@YO&1D]')$2*UH,<4A!L@_!%3RGG2YK_QL0 M$5NY2'YK*IG%D#X^)<>-[SE/IX*N-=-%6)7B7[+NY&OLD"4D>FY,P>J?(4O3 M\:6,UE;:>80 )10P>FQFE]Q!4NH$'LPM*_XA[/^K/K?WM-$>_-Y'12N+S V. M]WT8CJRH9 Q+614_Z*&5;D-H5R/ MP/B5!8J%BK-T:,X7=:1*:*O+U"^ N7, ML^&!-X6PF-[. "X]6AM<)4M(SK9B>X8;;M#'% 9XR-+ZAP;3/@+[7 M_OX,+,%SF_B(-5_ODK]S9D9.I&7[ MJB6.A/X>)ZC(XZ.X2$R2NW9% 9WT_],=Z_\M("*>L-_"ANYNM6#-R95,#BZ5 MEN(N\VS37WVS&*U.5$6GJ[:,[X/K)54AD\#!5;2GI-]KE8MY@:_E!-4W-$M^ MTLB>R%0E2EE8::M=>)H2W"3C%U-(B-1?FM#BN*[ZGKK 2!>/\+X@"C1-2:PF M#%2Z^?-NF*DCSJ3P//+JG@&#L@6;&R 1N#Y3M%T:AWS[WS3K.*YEVLDIC"JE M &B' $OE/3/(O+6^G6C#/I..XY3:S.3UQ?O.YNI+5-_*K=77?4]HB.*(P4TB M>&YZB9-'U.6)VQO>?R?BPGRMU+[,'W=*CX+.;=.\S!OV*BQL@X7A\^7F8M^$ M?R;^/-./!*1"G4!R+.+IFZ0@G2(Q)28S>_"DS&.6;/X.W@R'ADCVJW6-\7(? MO1QBAU(X,\C[M\+N/Z!]A$&C1\W5OHW'O9C4_57UKV> =??R%#!<9!K:36S: M_]NOSW!":]@M'2U>9'/U_;C87Q,4%'IOEOIJ?<%3,<'=;PW'1P%9W&;ZW5+4 MDM2?+\I..?]\!;;3>#\(F]L"'X@]G^2W4$.6S9X!5]KE6XT8?4D:TZJP\\$M MM.B(07.:< KN 8[)P;;2?[%/C 7TR7\U\ZO-$7NP\CX@.1!",_.@Z^OOPFBJ MZFW=Y.%OL\+T[Y:H\./;:=&JU4O364$IRC=MGL8NTCDR% M4/[;N='=3@GMXN]$1,%#H.=Q#=F^#0O7FG@69B;O2EC$QKAG,(\ODX'8S?=O MEA\TNV#X^7D$13"EE:2UA.7K[S_.54E,W7KV,.\[NVX[@[1AXS>>,-8^((TY M(J)_WE0NI*R?D2NGF7T6A$%BQ['B7$L7- MC158ZE5>.L?4_B9Y4;=9E!6P4TV,E'DO\$"R&$P>TM??!H^ZC>$&\54H#IVM MJ>5T-N!'3?P>TT/52I:E& &@S'5I(.R[\#)WBE/X_3=[;@M+6 M_0,OA[ NFG=^M'M:>#KDU=.%24K ZFY[?0*ZBNP*CG69FWWEM+2Y=I#ZSIA< M"2BPT=T_=,C"E" :E; YS1B/8=X:V$+MV/XTES]Q%0K9B(YA34@VX/HT+)1 M[+%=.(7\@1(GJ7LUS8J&;]]$/W. )YY6''Y[2N(+>P9 #FY8H@(+C6T/3/]P M91AE?:X8BRQ_E=^")+.[NVM0ZE=RXP\K27)YH"AVO&LJ\?>$ #>-!,Q*+-@AUW6Q!X]W82.:H9=0[0I'2H)8)@63[$[24\(?,CWX;+_B ?\K8%\R"+;5_PP@:OCYJ=JPJYJ&'<5(/C?%@:P6G"9(I,&_EGYT7\6+=N")+>[V4!5 M_1[$J-LR:DN6\T[EP20#M8-$DZ_3UL9)WZT RJXG _>(>^!^771..%6#Y#,Z M4CI2'NK*#V8'@UDN8'UW4A'_[(ZF5_]L? "M&/D5:Q:1XL/1'520Y08N_#$N MPL1/S:O#'CWN]7 M2S&ZMU3R?Y/_S4H<-%-/?AJ:I)SZ]9.LZ&[ZE-10_%N M@+Q_W>A;::V>',Q MEBIX$F^H^'U] #]"TO/UJ)T1]U1$O MG\XHJJ/F1XXWCK\BB'348!!N&+Q$*=RX[4(UT.:3X"WH:TZ:/GB[Z*E"9,)! MOJ$CV\.H+$(A'!;:QR(10_&7Y;% D ^JZ^"&L=H@>IU @^QB*1;]IZL]RC8, MV6I?314Y8YUWGJVW5Q#IV$O;%!@/\N8T%Y^3?%WP_1G0=%[Y9L'5[HNK"96@ MC29O-5Q@!/**EI\\)XH^U)?8('TC>,98,0]:YC6:OU&XY@1'& =]G "8*9\J M]&CRT'GBQIKXXF^[]##3$73;X_!0(Q+ZVYS!IF!G:=99ZZ4KJN(SCA*B M,<(-!JVD?4'M]VF\;X)A@/0.TEH5T+S4L/: MI,J!1O."B]T"5ZC JI)X0RU*(JF,1Z>2]KH6VA''^-*.A[E?M?[\U2.[1">K MW"*P]KI2MEJRN2:D#B==0*$FA0U=@=,L^.:S3%7ZB[V1=#!!7<@4_CB#%(H; MH>IX#,;2(XWVYN/7Q8^F#+91+][.%]>7=)!RU9U]:$NL M;+T3+W0R;+*ZW\ZY8=]A:K37IY6\-=!,8OT0GH&^2 M>09XW6EAJ"M\MJ#H8B>(E*::%[*=6],G6QU,3JPIA#+6F6G4*.Y^"=8Z:SU/ M3,WY>+'8W;"87NJGLWFSI=(B3=\"%\PE2)%+^X#W6$2=6/?V"[)DD;R#6BC= M%SO78&/ C2-' L(7SDU ?43+.L?2\#0!QXBN'HPNL=K_][MBMJ)6F>K4;':4 MJAQ9CS8_5,$2I(%H_^U'-_R$"ZO*A!R;V1X,U%J,4M\:IQMSLBP2A]#) VZ%+>(4 M0GU#0531**.N*IKE-).3S=G"]K/OT8^-)"3GY0;952\#1#:5Z[@Z/^ MQCE+\/C11&O&68A'E$[Z;E)5G7;B],U_44.-BY@+I-LDG'YKO,(PV3/?D_S2\T0_J63"G0RSMC)^C M(DH^+':1R^4?!U"G(Q6*Q!)!6),YO+.^3WTY593X\^&SAR8SX#W@IHTC&^&R M4TX7MT7P(/:RI=_FURR>,"PPQ&];RAN]XM6_I1BF=C?_%'2ONVS_,XM!!2T@G7GIJP5SS^R[ MJ%LM-ORC4J/HQO&F$,Z:DMP,UFS;"J0A*/)HNQW"$U%.NN;0K_D#XL-/#?FM M66'L^*5&UU%+4)6Y"?I#^8_R1\ K C&85_GF%9 ;1#FV.?F"";>G !\"1XLEA=DC? M31TN*L;%-FIUA#&(*"?IZOOSH@74 MC/F*,8V-D]13+QOV\9%1,[L\[%?"VC7JY=Q]LWES6* M177W->Z)!]1:Z!LD(XHF-.PW+M)G1TZE._%BORB^J;Y. MR<0 GN6IK#?!A5/\@VB2NLJMI$Y2L>96);XZ4/+S4[.)L!&W->7Z@XF(,12/97QZE[.:[2 M8;KBX>!>S'5'A(Y>YQG0/G6&\E/R,TV0@A)9LJ28A*,J7:Q@*Y4Z8(M]* MJ_J]>:7*OC&D(X;5HRC6XWPC^2>;RWC+>!:ZX!68;::Q"J437X12],N*,K'+ M)[202(+Z)0-F7IRPIPOSZ0\>W/*XY\L6PN0>%3$OU[XDV!2A=?]1O@DLNI?L M/$@[]'AB3=A"G?I%2E'<'>$) M B*9Q"%,YU\K7.\U9D.[129E:/,4K$/ZS'X%M4$'&P/)ST_S[S\,%ICF@S%; MQMOLV#N2-:D7?()%8?L%11M'/KGT ME+;Q[RM$MFJZ7H*RB\:$$Y'<01+P%.O@*\ FTG^CP=7;\=_$A*VA5H]FY^4$M5:%<8/LI89_*//B95ZQ-%-$ZH<:ATY*^.6TC*X%_I MM\M^@3IS%1\:?EC)Q1B3Q;EWR.WG,',*)S;C3=_C:3P#HCJ=NZFJ@JG'BTUE M!6EIGP&1L4=I[W-5%6["\'ORST8DXEAIT 5R 5+(\1?5> \>TLPULR %VNA/ ML!>C]2U5@J*W[6-^0DI3_K429:3K^19? S"""I]_$("S%.RXX:TBP&? FA7' M6:X_R3FC]R,N:_M)16[__HY\B+\R/3U _8+?%L^6C_P_$)@\5;_JZG.A_J1L M#$F%:8I_?Z,K V4MZ$%O$ G%(*G'6"_,:Z?Q4X;J*NZKF-PMM=:VW)EQ3P&! M?WR*<];RJ@29%&_3D":#DA0 (+D*X^7)@N/5I:BKP'%-+$0"1&@K!B3A\*9] MF"$-:R\>$]7YY[==Y9V/%4B0[C;'W!18@CEL*B80M@\5*UIT#6;P&Y@4SPE:$-8MD_J.]" ']!)T8MD8JVS8M;;#6-#>JX+=*\)XJ:BW;QXQ M]F2H]RL=H(>@3T7JQ4/EPZ>KDYSXV(['+YFG4^(+T96K*NWTPO##; M]W?3?(LK1>\U,1(^(P1&2<6$77.XFZLGZGS491 M$C1Z@N$LQ%\!H[09$=]$MN-!WI"%1#? 4AIJLM"/+ MIU +#V0 /EN-):T U?\Y6@3/=E/Y6N4$V)8[!*CG)CB[G%3.;3(.*6**V;)R M3@1DL)9)@@&(RP'QYH0N;*,'S_D'H+NG'?318%@\N+N I%%Y\O$;O+8IU-A)%-O<:0O3C=@8A*=T9LAGVOT,/*US.);CO">]I'[7*>G*JQRL*H=.E)U=0[L MIYP.K^C0Y!J8.4_<8LF]"Y0?4]JT[P.J[0,#[M'T>&23/0>)D?XM%:TS W&N MUQP8LVS<<$#"H7*[TM";6_EU>O)C\KT86')+M>-CQI4)QZGEHHO; &4]XKZ_ MK3KV5^E(K\^*8,GPCPR^YSL(#>->P;OUC1)*Z]/7PL+JBBP MQ':FNU 1%BKPHH.HX-$BD_6CICRLAJN:W$#^+HU*-\DB3%OM^^5UE)S=((YS MBS>2\]R#EYBK%M0[\]+?!AY4$,,0MXB;FTN_-&B@A -#QO8X6D4ZL_:0EH!T MCT_B6*A=F2 2O"J[^'#V@0YA 1W7)'*:4_^5AW?8Q5/G9/_.'K8ZL3=1&XLQ M3;,0E3/:O:>S(2:=NMTIU_L,0)<6W7 2<%I:ZJ+,[&T&QQ^#(VF=U#3*!6_1 M)+^'\I6 ^1K=&ZI-=Q^%MK?(',S%9^T6O%KV[WE6;9M275W 9/R*@\QHY"BW M7Q-S6ZXJ+) 0W:H("&S]*&/1 &R;!UK2QW/S*DW/C[<+5Z G16$1WF&-!UQ: MK*G(EH)88=TKME\I0%:0?W-.]K=MBN!((LE\%R;,^"EE5$!A+D =C!#(8/IHC 0D1=WQ"T;_R#DG=CYX?7] ;6#'UI M A=W8,"%1;3XMZHD> +T-J41RZ8!=A#;6,DJ,\G\;'1*K&)Z-6!:;N%)'$35#*?X)B@887;O-=M0&ZM]2J+7D'K12A\VS6PP MCT/)SL[.IM#S 24L^7O)#,:!>:;5#L43"2(59%)LIE3F:('W#*A[>$NPHJ;3 MSE+@U714"EB14%QUC@00 ';V1&]3,"<)(IX!#O9%J>I365 _O,:!U.'OIP\* M+JA.DNL\X_L]\H'UX3.I#]Y7P+CK8P*H.D'%5BX9C%^?,I8PG>RPK%#ZM.5&,C(\08H+O!5Z +TB[>=35 MC"DW.8^YOJ1K;D$5DB>E@Y9&@H=,B:THV!0CVKF%T([YWDVL!:]3$\ATM&O$ MVKJ?*I0U5E*V='WRXK>AOV\E]=EP:!W.7]X Z[RSG"#5GP]JL//8#EF6I$]! M!^8\>7M[Y,Q/\N%B#TU,!'NMV,M_U>6J$?TJS7/7]]GW! U_F[ANS!0AJ>9 M#K=S593;@D2^K;\B 92 2X+HM@_G_5M)FY+QX^8+0M4 4WM]\$EEJ1E5O5OI M*//3IWBYJ16&)+J/HG3< %1LB_@G_CE)#)CTXMH@63/8&-%F$'YSK#%_YF83 MY^H[[MY(G[1NR3];;H6MXFD^7? W@#72BZ1^GM/9*XEVDS/6I>!]?C)OOA?Z]J KN)-&^U/0?T[M4C2/"T'_.4)=Z0O=.$=N]7,;/G8 M%MC!S'ZZ9K,/0C__I@JG,J]2!^3^*%!V8>8BS:G>'5BV07*/HB*8$!BI)H#9 M]?]X/9S78#?T:&#NH@@=5H!S9U4L&\E]C7: S$(B-7C;"^VW)K107/ [^=$" M>)*Z'>AB@M$[YD#*97C!%ZHCU8*(Y*R?9IN/WWO9$V+W#*VL7I\O\S[ZN&]) MI[O!J=YE0TZ[DVQ:TL;[+XU8\EDZHB"IEMZX[04?R?E&J-Y/:?"]6._CO*1# MB=EPF>,=3=&N.4DR :ICVJ$E5G&J8*#$?7=C1:+B82X1O&%@]YQ3K-H:\?,9 M@/FU"_@T"_M1V7UC^_L8KW\Y_7F MA=[$W$NNICZE[K]ZQ>V>W'&0CR'%A@)QX8=TB']<#![F]_-5;X61[+?4FH@B MKW(8*+_YC,&!.XG3;>I\4!2$!7\&]/K02CQ^[="T@IWUJ#J[_EJLK*Q@HC<7 MI$ST3?>70W3,$W\?QK5(;OQS'-)(%^X%C)/K,]FN'#^ M]$EIB'VH[!8==^WIG5:YTJ3P:U9#!$&X= ?$ZY7QTXM,&B?'>W'>CQ(EUJ-J M*0,\>_ZRH>Q/)UF05DAJPZD@/P8SBKQMMCO)/D2?ZR]Q_=*/7W0JYRAJN)0< ML-9*)'/_=-%0ED-Y<1YKCC/;\>:W8P8EP5JCB1,//D*82DKG9BMH80A(.,K! MYY6D",'2_R"TS&A2I*=EOT M/HLP2!*)T^)CD:QK8?2I%]B#G\HACV0Z<]#.BRYAI_)2$W5;0ZY"V!$=Z'0X M _I>8/D\1:J\&N%F!3G'03P#AC & V[*?AY)$\!=GEI="DQ,?O7<^=[X)6/5 M,#B8;W!U:9' :.GYACB.@EX/-%&>WC0ZV+*\/C2PG#N>;/9;&+-4EE;\B))4 MQS/12C$R)5L5TB,M-/_$YR=\J=M4USX'3=N_54Z3^$G^@Q)K-UQ#K^[QRMDC M4 M=<^@<9PWD_)C[8%!X6)?]O7$#7UGP7P$JJ4_*1+/W-/T9II*[!2/('&XY M"IN621\(\-Y(&J1EH_)RSM\\M6^0DI3\*P0+#" FY5YU>Y M+.3:87LI20RD9_6K@TX<' J>J3W)IQ,E4C)VAY-!K6H7NDY)"3%[T=*WKD'V M*! \X\USU?::/SR6&3SX6WX%0]W+$[/"TXS0/H4H/:LPSG$QV0>3:/'X/S#- M<) ZZ0\G%TBGN):D FRL7S_^P+87O];*^J:V6C).5=VQO^254%#C'LL?LX3& MX+_#*#1\FOD$8<6PVRCOZH@M?.]V*4WMI>JNE>T-#IUY-Q4"L;>L\TLU*P"$ M]1CHIJ9.H[FJU5$M]V*<^^#TC8) MB5+=W:4,'7KPJ"_.MI3(=E-)2:^O"TUUQ+7<3DJ#R01T;)7LTF44MZ@@?8(G M4HW,; 7#<6=9DFP'4QH?<;FC6!E"?*O_Q+S@M?7JKP43^L+/EJ;P+>N/B1G* M6F6FULB%H7A![Q05,4>*&_C:F00=)RG&B- -$MT/!P$>X)#!$!Q'<&YZR9IC M=K604\*Q"1MX4T] U7;058]4"[V/@!4I=&S7('&X@K7G&9#23?6@7%6X]0E. M^JWHF-+DX[=6)Q/?IHP53.K1%D6?9'8 CE.7\9:7#B'PY1RWBY4T>JF]B8ZZI"F#DC9^?#L( M!=D5R95LR0K>$I11+5NG6ONB9IF%I>HBK"[@9EP9];_\- V7!J^C!MZ=F\(> MQ-7*B>@S%>Q#*CHJA+%5RL'>)L#E3 M)R8_-2#]RW:#.KT/1O++UOP#@M[FH7MMB"@HGUKPKYLD1'8W*ZP]-;+PGFL) M]#R=T_9O6U#[>1H_EG5PN!>\^5,9?D1+7Y]5!G8C 0FW+?(I_>DZ&30MSWBD]8-)Z'75?R M+S?%5-NGKQRGTP/;A06*)LM%7(T-4C#J\U2NV_4IAP>X%'WVMY3J3>2G-<4M MF3.!\H:\(:ON9@:=C+_+F-G0DC4PC '_=FY8YRN]\E 0>?\5?"T- 9"&U+B9]?< MV=AP\Y5:?:M8UK:2R@LN0B"Q^[4[LNS5US2 M]5%&_SX-TR<&@-*',M<589AJ[4]"++'CB30ZK ;62V*:&ORPKDI30,%:EH_Q M/_VGR/\-!E'!:XOPD'X>T+N\<0N)$\*2K)1LMU5&T>EBIPTGID%SPEE)]X+Q M0D2,2L-B0^M[!\[S7T0#N]2)9=O04&G_:#?;W_".9E?&I=(SQ/=0N65-DL*-$EG M*+"]U67GWNUFO99S>!RU^PNFA"9=QWY77RM"$X+33>2P^M!%5R\^E.?UP-$IC?<^X.[AXUS1SI3>]:ASP7'5XZI@ZD5?V7_*P#E/[?XUR@D&?>YA(]^6RD*.&QP[0OL(&D&5?_/090%/8 M9HW0H%7(6-2D.-QR2P->.TN63=C]=44EOQWTFZJ$NI'X:0[343YH%QX1]51/OZEF"B/90%NEVFP[LB>6EAZ%?>=Q/,/5,R=_XA4D/G M_6Y*3+3\1_A(23W'[YI;$@U-@+TO>+"K,:1X=>/8O9#]=M-\GD->.2E+MI=] M8M#S1WLRGPP=%4C,@O#PSNWDQBOP+<^#4DEW(NW-TF?%--D#IFA.&<"ZH(5? M6(Y!,>CU(L^YI#I\1QY.FEVV; \.6/V9H->>;!-GH:F?\\DLE)_4WS 9RS/7 MZ:^+2&\;2VK%^M%B@$UGUT_W[HD?9.F=$=(2W/M(V>3K,JPLM=YND;G4W3%F MJF;"2ZKI [CHC>X.V(5+\"NOU&%6CX?"Z]7WY"=(D">^+C@N$*:AU/I]3*A@ M6S6DD3]]'W.R#2M[Z7-LZ]T2 YS_P'A14NT9@.LBM%9TR0V2*D5PF!M:TBTO M3=*L?;G7X_Q2X>/\CC#C- M2F,GJV%-XSS(!;W3-]]1US##CT<(BQ59=>36LS&RR\$"@I2)< +>5"U(RM'U MW^<1K")4CN;[VEQ+\L>\=_QQ% 3?EAEE6;Z*O@1@=7/V$'RY6YH1#B:LW[<8XVV%9BBWDW;>"Z?#4WRZ'2X5:8[&9VT\AT:%;= MC3]:^54B"?TUJA;&J#%&A*22[_U[OZUA2OY>]V(_SR%<;N>S,UR^4=Q5H0X# MHJ%E)I SHZB4C/L7IZDJ'DF'[>X5%,6.YEEOB]JAK55QGP(K?VIT)/^*^GSV M*6JZ^O>IB;B6MK2--WL'_9V,.S)!V&S@::66U-R;573Z3=?[8XZ\[]%/3#DU MVSG6'[8($:PR\.A8L'!S@9$C6(5??'E#IAKS[2WF.[Z+FZM!@,W17%X-&TG"$WN4G7-24V6"^"XL1TK73KIHYMDGM0JQ@HOM.XHQVOAB\V0UD8+0AI=(Y?7[Q&Q@DY)TH$K+"%UYG]O4GOW M\=9)VL%OL9-)"C]9F!@_,, ^9,8(22%O]:V:4@H7N=QPC(M6?K/*Q2N25P/L MO4L#_!48-(!M]0*1_10E"F(S9RDD1KA4H_?'JLR2QM\[\S&$?'N3GZ'.=.H1?+<^!HS M W9<%F;'=&@/>%!,;\SJ%Q)30CA_KU6++]YU-+O#TC--1;X7A*Y,B1X.*D#. MPS:183]F6EZXEAS6G5\2K.RLTG3L\-I2]!-RD)E&-"8KLJ'L<5C$T7)9H"!T MC1),%K+UX7:1#R:!E+['P,,H%"! G0-NATPC(3S[R Q$Q%GBK(HT/8EY MU=\4XE I4ZO6O;'$8" +E$AH8Z?BFL9\ M?CLC:IC@@B&CGV?CG\3];2)^,T5\=(ZY)]SC9F/@X!89PN1>?T<;ME<5\?.( M5S/(8^[[617J(3W^;IKUJZ%[SS]Q*/O5&MD0S4ANR4^>T#*0E.43?5NDR;J% M8(C@"'$^OC@?YD3^E_Z3OQU2UIQ/?]S\][ZRWB[NJ;=; MYSR=6SI3]$4! "_9I]HB<\H,0>X(A.L3$#IF; K,N3W(%0F!S9I7MC^T\RI] MQUK[3A]GJX/N;RNVH0SM]#2>?^)5V':B\35X!D3J XG]7$ CYT7KQYXV/JY< M8+4SMDUY_F_3Z.\4!2PT31X883;5L4*5KCQXA\=EQRKCI9-[R-S-;(K<)7MO MOJ+9#AD"L$2+(EZHNIR>?J*EKDEU<=/5CIPD^S[J$L<2U#HN&G!>@A MSR< =]L]RGVH0X3!-NA,%GFLNFBYYJNLNA?>M!C1URV02B@P+"?-5ND!-^ES MTBT^+;TM>'@+K%\%+!D((-& MK/W_X[\3=,\K_QM02P,$% @ %&!S6.(1OL*-!P "B8 T !E>%\V M,S@V-C N:'1M[5IK;]LX%OV<_ JN!],F@!]QW&:ZMF,@;=-N,-,VR'@7^VU! M2U<6$8E42'!X MT+?"9C2@N_^<=5Z=G9TT\;;?"HV'!WC_MT:#O2=)FEN*V6C&AFDI8])O54[L M6FG+,]9@G5:[TSH].7W!7G3;G6ZGS2X^L$9CT,_)-F"Q%5BA98Y&2EB1Z6\JH2)6D= M",E.FFTA>RPJM5&ZRWAI5<^M63Q8J)KW^#2=J73,.OE M7(^%[+K7M<$S.3)%K]\J!H=?6&.[[)O5OE^154LR2W>VP3,QEEVFQ3A%QTH, M%N3HCP:7__['U>NK(>NTF^U^:S38)M2?4O$(8"*]0?,WES?#JW=7;RZ&5Y\^ M[HWJ#]6\JF.2:<9ES*Y)WPIIZC"(MB*9,9MRV]TWG>=_G3,O0;O)KEC*)\0T M301-06(V%89=2%F"NFZH ($"Y^&%R>O, M\9%"'\T6[X4,M0 B#O=15L:8'0Y>LFH=,!$ZF[$"7G$@<^#+L@6**F<9MF%] MH#46;O:ZZU9FZ 6,JL*5-F@U7JB(FY0EF9J:=4AI&@MC-2S$N'L=U(#0JSH' M9)A[*=?4V'MPO&@&&8;KIGOVTZO3]B\]$]Q?Q6I(2 BY\*R21*#MR!Q["U\Q MKLF[%EX2HXR;!0@H6@YQ8,HJ]+;/N;PG\Y]1(<\6/VE@R*.5C0L_?C M[JV[9!/QTNP^Q.6<$<%5U4HA9ZA28P)$],37 G77BZ2?Q]5/"^I9IB]-&?>^ M7TL:"__5*Y)SW02X"%(9E8G8[[-,.3(B%C"24T6$=.=)5CH!4)H@W?@(,CY+ M>7Y1AB :]FY^4,$!/Y0QW/$E%)Q'UVH"P]B0&)=S/.Y&Y$0#AV$FBO>7L^Y1 M-EI%VQ@X%'PD,F%G M+M=M$@ QL H+[_$ Y >#EFHF3\!WE9)%J0M@S_AL'$5*QUXH7SV-_=%!!@CB M#14.VZX+JL4 +L2 *,"!^P^OZ)A=3GA6NOA>L3@EB3O\F,!69FO=,4^>.[!9 M>-Q<@'B$82#XQX329Z1*.U^6/2+0+O3+-XPC5_6M-FXMH]GHOL;T<47!@!"Y MYQ;<>\S$H*1@ZW47NDU754D(^3ABGD!)+JVI*"JU\\?&S+%A_EP9BTG<80MF M-1&F_%PB!6&1HVWC$D 1/+$R9$TCU.7DMY1NM^EW[D'@XR!NRLT\$SNN\?BE MV!.S-UE%FC-L%V\IJ_:7*_U7R_B%M,^?8+_]1F95X+_\Q@6^/Z")[Z%>7X2] M(ZIE:"T8P*'A"1EZ2R4VEYBC&K-*FPU)T;_",GDNK"7:B:1'"DG9B1D+2.\G M/@(>07C&<2ZNKF)TK\UB4G7W6LIB=?3?G3IOO-_9/ 4I7#8=.Y@3AXC(&&YKRQ ["J M&@R#@0042/60*PT2I2ES6 66\PI6Y+[Q5&2_F66I#+] :DLT0JX.5Y _)H(S M_>%.//OJ15\VS]9'XNHU_H,J/E+6JOP/J+OO_Z.^@[T%<739!ZY![.V_ MV[3.W-=J'TH'7HTG.^#+XC\258^&^>M9=YM@(>0;P:]=?V;$VL4=^^G$_^L] M"OSO)WG+M (^5KXY?I6=_XS!]B.-_9>-O[^-WZ2"$G9Y1U'ICD/8I[!Q^"V:<<[VS;(>!?[;4%+5Q91 MB51)RH[WU^\AJ=B.[29.T0UFO%,@M261O*]SS[VDW$MMGO5[*?&X?_"L9X7- MJ$\W_SX_?7U^WF[B::\5;AX\P_._-!KL TG2W%+,QG,V2DL9DWZG ML08[;;5/6R?')R_9RT[[K'-\Q@8?6:/1[^5D.8M2K@W9BUIID\;K6G57\IPN M:HG2.;>-F"Q%5BA98Y&2EB1&6\JH2)6D"ZEJ_8->*^C<&ZMXSHR=9WZZM TC M_D.=]G%AN_XRX;G(YIT7(Y&389]HQJY5SN6+;L'C6,A)YUA(UFP+V76K%G>6 M^N;<;8*F7 LN;4Z:I'"S MRY;RF!?([DADE4AFZ<8V>"8FLL.TF*086*G!@AZ]6Y)"%[!/P<\(C MW-),Y<(RJ\*XC0&2(C*&Z[D;DO,O%%QBT^K+8G6#IS'4@O#,41NDK0V-A([* M'!,DEF2^+K%9*A!)4[K_EBO-2%.UG#,J%R9#,4$Q8#-A4QAM"M0?:+0FH8#B M*H83IEC U[\5)^T]5$Z_!94U+R5"(@0NPDN7UX$83,08S9;/A0P%'QF'[U%6 MQE@= 5[Q:ATP$3J;LP)1<2!SX,NR)8JJ8!FV13[0&@NW>MT-*S., D95X?H7 MW#5>J8B;E"69FIE-2&F:"&,U/,2X>QS,@-+K-@=DF%LM-\S8>W"\; 8=1INN M>_[3ZY/VJZX)X:]R-10DI%RX5DDB<._0''D/#QG7Y$.+*(EQ1L[GC("G<29, MZC+5#(RFMLA#>0JN(8MPV[! QC GP".&YO$$K*B?$ M!LCUZS+#B/8I;[3/#BEHT3Z+PU6X%*ZOD %6;GWF:& %S2'23I>=!25W!"40 M!#OOP2#&NL*VOR7\U8G7X) ?L7=DT,_!@YZ]'PYOW16;B)=F]RFNYHP)H:HD MA9JA2HT%D-%3WPO4W2B2?AW7/RVI9Y6^-&7"W "&KK_!S0G7\6:$@4/!QR(3=NYJW38%D /KL/ 1#T"^,VFE M9_($?%,9692Z /:,K\91I'3LE?+=T\2?#V2 ()Y0X;#MAJ!;#.!"#H@"'+C_ M\(J.V.649Z7+[S6/4Y*X$XXI?&7N[3L6Q7,'-@N7VQL0CS!,!/^8T/J,56D7 M8MD#"NU"OWS+/')=W_K->]MH-K[M,7U>47 @5.XZ@7N/F1B4%'R]&4*WZ:HZ M"2$?1LPC*,F5-15%I7;QV%HYMJR?*V.QB#MOP:HFPI)?2Y0@"#F\;UX"*((G MUJ9L6(2^G/R6TNTV_OQ1[8O8NJTASCNWB%\JJ_>7: M^/4V?JGMBT?X;[^1637X9S^XP?<'-/$MU.O+M'=$M0JM)0,X-#RB0M_3B2TT MYNC&K-)F2U'TCR FSX6U1#N1]%BA*#LU8P'M_<*'P",(SSC.Q:?K&#>SB[Z6 M F;Z3"JE/_HV1_\77?X >WG7"0G PVUQW+8I$H1@5@5MT6W/B']QQOE MR7=3_K3I=G/_*+!4[7#8=&XA#AYCHJ$%;^P K*H'PV0@ 0U2/=1*@T)IRAQ> M@>>\@16Y;ST5V6]F66G#!RAMB4;*U1$*\L=$"*8_G*OB7P^T+^1495-RW"_Y MI#IWU-7)$N5%IN:$I[-4!8;A=] %#/S@VME\PNA8OP<8 TRD+VK'-191EE6O ML1;7IN#1[?46E=8T6E=H)F*;XNOQSY4>C8P2V^&E5;0:M-[^JTWKS+V0]HGTS)OQ:/]_6_T' M.7Z7H_^( MR?:$WO[3R4_@Y+>IH(2]7Q3ZSV'?\J>K?[RK#Z_"62"\O/2WZX@'R^/"ROU' M/]S_!_AT[=13]6ZQF+(HX\9'3/SXNI6&$^W74E@]HT7*_ENKW6OY77_\%4$L#!!0 M ( !1@U8;6^;2!#^ MW/R*.5=-$\E@P'G%CB7B.*G5)K9LU M41O5D@7LS,X\\S S.Z(=JX1WVC$E86?M35LQQ6F'7O^]T]S;V7%,E+8;U>+: M&Y3_81AP0@651-$0)E/PXT*$5!ZE"85A*A7A8$"S83<;CN5LP99K[[KV%GBG M8!B==D(5@2 F,J?JH%:HR-BKS58%2>A!+4IE0I014D4#Q5)1@R 5B@K45I33 M+$X%/1!IK;/6;E28VY,TG$*NIKS<+I21LV_4!=O*5 O*A8@DC$]=6/]:I*KE MLX3F<$:O8)0F1%2++;MO]QS':G73)"-B6C[9KW6CK- M7CNO3L4K$]71KLG21SIA K.45>4T)YTPB:QGDN::W[H6$\[1.G9LACT"!1D2 MGM?+71$31 1Z'0V&K#2M*PVU"EZ]GC33DTI9N+>JRWQ!UA69< J35.*8=%"S M<**AG,^FC<5SGI%@_GP/I!5$JX"N6*ABO+7>S7 8G$;*+<>6V4)YWKOS009' M.9SU)-[H:SAW>:E[34#XK)&K-%N8-IOOE@)3X7_>:ID[S]RY:SK/W.F8VW=W MXK4,^">->Y(JE28_7^BE_HMT#G1VA)7NPBF1>,[;^RHNS^JMLI#>E&'\;_X? MAO]$33U9Y(=3]S%@5<$;U6MU\Y2S$.SL&MY:Y:_U5-K_.."-O%&EQ\IH\BR: M?\52>T&N?U/\PRE^8)[^3?7WIWIC*!E.7!F.7'?XWOSNA*_A5<].+S6HA>P2 M D[R_*#VR1O[QM [Z1F'HY[W47_Z69(.3X[]T M>$,-_?WJG@NB:.CO69UVH_PN]R]02P,$% @ %&!S6'WV*!2=! %\V,S@V-C,N:'1M[5AM4]LX$/Y.FUA)G9L!RC8(3,F!)IK M(9G$W/0^W2BVC-6S)5>6"[E??ROEA0"%:YD>TV,N,Q[;6JWVV4>[JXT[F2KR M;B>C).ENO.@HIG+:I5=_[+;W=G?;-DH[K?G@Q@N4_V)9<$(YE431!*8SB+*: M)U0>B8+"2$A%PE@4A,\' RA)DC!^ MX8/#.#BVRW@ <2TK(7T@M1*!MEG>,+18]\VM%=\$US ,"O/ZA4A&N/*Y]C / M"B(O&/>UN-%]S:=5&71:97?C'ANW3'R+!46OE$5R=L%]R2XRM682EI>[B\IF M(L-=1-U]@Z[;7:4V[#X%["@(>WKRO[_O2(BQ,PAHE$*.[ M5 :PP '.TO->?QP-C@>],!H,SV!T/IZ$Q1._Z, G'A^%9?V(-/W[H_PYA+](2SW&>)\6? MZDJQ=':;XP'721PC"N\[J" MWUB%2A&-,QCPV(9-K?GZY9[G.4%/%"7A,_/F!EM-1"C-RB653"1 ,<03.*(Q M+:940MMM(O5>NPFD@I3E*%MAF5!,?:88$D%X OTKK%G\@@*:*%BE(6B >F:" MA1 R*BEB7 72. %]9]%$*_%Z^KRWAH$KHU' M'EU&:5KG.7*/>Y'K6%G%CZ2?:R9I@36FTHQ=\[])M@"WT-W93+96+%]'VRK2 M%E2[^^WM0,?@<^?5F_/*^+P#T&3IDY\PCE'*YKFV))TPB:R7F$6:WZ86DSS' MU;&@ZUQ!08F$5TVCE:YR"!=,F%E:)S7.JO/Y]HA2-S0FJ]/U[+*?D'5%ICF% MJ9#831TT'&Q\:)XOFI+5>U62>/G^_5W")4M4AH_.JP4.*Z>I\DUWLQ@PG8*_ M['>PX\.64.*#OB=+DU]TK8E)OJCS2I2KI>WVJS7'5/+-JHZ]^TC-M[;W2$W/ MWKFKB7?C\$_J]U0H)8J?SW4S_TDJ!QH[PDSWX91(/"[=?969@WS;)-(+X\9W M\W\__$=TWC>2_'#F/P1LGO#6?%O]2N0L ;>\@I>.^07_%/;_'O!6U9J'QYV^ MY5%$_Q>3[0G9OJ??^Y_J'T_UYD@R)+E$EJ_YUAU!&,>BY@H/V"7]6S^<_PV\ MZY/^J=J*A'V!."=5==#X$$XB:Q2>]*W#<3]\K[]GK$E')\?1^-98EEI27-X= MU*T(C$[.SD^OK>$,_5'F*S=$T=(?:? /KOG8]#=02P,$% @ %&!S6+WA MK2O0#@ Z;8 !$ !O=G1Z+3(P,C,Q,C,Q+GAS9.U=6V_;.!9^7V#_@]8O MVP56<>PD[21H.DB3IIM%VP1).C-O UFB;6YER4-*3C*_?L^A+I9L2J)DJK7' M @K4X>W'E+2VY^?9ZZQ((Q3WSOO#0X.>P;Q;-^AWN2\]_7!O'BXO+GI M&3RP/,=R?8^<]SR_]_.[O__M[3],\R/Q"+,"XABC%^-Q&GH.85?^C!B_O;__ M9)C&8'AV='SWV?CZ>&D,#X?'YN&1.3@US7=OG[ESQNTIF5D&<.#Q,R@X[TV# M8'[6[S\]/1T\'1WX;-(?'AX.^K]]_O0@VO;BQK8?>@%[23L\CYA[P(E],/$7 M_;@2N@Z/T@XA8R!748^X-M?%(53>&BKR#0-F!B]SPG/\BRXH 53WL1K[')J' M W,X2'H2VY&3@(H<"?)L3PM:0DVNJ4N];W)&0)5'?:P>69PDS3V+VEP^M*C* MC>TO@C]S8_MVZ(9\01$] ;&G![8_$ST&\"_IQ:DM)P 5N>$Y"]*&8XN/!-=0 MN-IH1=O9IE%5OD,P9P7TH2;7-.3FQ++FZR/'%:N-"_A(:G+-D;(3Y!F)K7+2 MCRJS36F)#:F'T]%.;?B\9O-X\@Q.3T_[HK9G6$' Z"@,R+7/9E=D;(4N4.##Q73(C7I!KD*D.+#8AP1=K1OCEL[K/ \*2# M%$D9^8E/OFT%PDL5=L&_S*2?B47F8&@>#0Z =*^OP$4A_F4L\.(.T4\3?S:C MG?=A2M2S79(_-N @XUB4R*?MQ:\-""_=JQ+=I#G^J$=5XF)**:ZU[Q,WX,+K M-)=VZ0.5I$V:XX^&TJYX)S61LPXP$CL9IH'L:VY/<8(G'7!FGS14]]+EJ^D[ M:2]^-<=7 Y6OHZR!O@M6L V,CB7U>*B.AHK8J>HI_N8-/6P^YE-SL=D^Z5^; M.-DTSE/SL7%S_+&!#6#ZG/:9[Y*^1R88O:O-0)>Q7"^XP Y>K_)A>9X? MB*%$65(ZGU-O[,=%4(B1R5D2D=Z3L2%BE3.+V4BG/*+ISYD_)RR@,*TR0:T8 M8,K(^+R'T:J9Q""_N];H ,*EI,D:@7PD(>2$+L3]M&0OZ8NH.^]Q4+9+8JF_ MNSBVY=85![I E":LLJ5".61<5RCH0CVZQ3+-&:DK$W3A$(U$>LJE-(^4PX75HN MVL:H;%K?'1X>&J9Q%=/*_KSP'..#(&O<+,F^[:_06F,CY,2Y]=Z)WRLS).X< MMRCKF$>A>K]52\M[QJ6):=4L;OL>]UWJ"$\]LERQ)>)30@*NP=IEH^NR] #, M^Y!0A-^7&9K&^XBF\2!H=F:6&,*<6Q"?!%,24)"X9:NO$M,%@J$Z"(Q7=SD> M_M6A0A@J+>:F/S9Q\1(DN?#48&[@8TH\3A?$='VN'2=UR>M"SE$9,3,-4A26)*'OCVMZGO.H1QD_P1XHJ/$M@4=T7MPJB"MBX, M':MCZ"'#T3^-#X(EX]55RE/GC61VM"T^-<>N_]2RV\G0T86-$W5L7 )UXQJI M[R\(/#\@Y@"B!DZ%1;*DQ%(P"CGUB);U1YV6+C"\QJT(Y3:L8"$C\,<78,' M"/8],H$@N,LP(9:9]S$3>XZ)H3GQJ3?!V6L3IF,K*AU6EZ7?2"V-8>I'I(=N M .GMN5&/3![.9A9[$8LUG7@4UD$+LP.V.)I"R\S!6\+:R$U=)J]'5!<@?I(" M0D2?$39Y#V$VBS8$/6SEF1FEV,"+G M>G(7M4GJ0LJI%"D88]Y%O!@?8E[$^G"+O!B7$2_&A>!ESX%RDDQES#>\6".7 M"*M!(0O)TI2Z0*)*3A- !H=2@&"@&?L,;MQ%? B 7$1\I*C9B U]6NQCT!RT7YRSRWZ)E*ZZ<]%'U673H=2F;\0^ M$>@9MQ&]/3?J3^:3Q1@$0MKLF1E1ERF/I*;$4._7F-2>6_'4Y,1U,:*>B#O M;K0R.C/@E@>835T07?95HJ7+\L=2RV/H]A Q\6\CNO7L1FMPCHL]!\7@T$0* M%K.GPD0.61#7GV,#;5F=$A*Z(' B3^9@='8?TQ:VOUK2WG?##TQ@S/)L:D47 M<%D8I5[11(SR;_HV^2JD= &A(*N'L=MUPH-QL^1!H.(>>=AW/ S!-&!*8@;6 ML[[]V.JPNNPLS^F)>.Y&T#,>D=Z^&_4(7*\K#E?FEK@ IS4EK]G2ZP-K-++\4"Z; M]>_LJYZ2UVSY.B0U8D)^J*=X'M#!I3)KKQDE"I0T@D-^3%AZ4M!!0IK+U0T# M^>@:32\_)US+&7?F+DKQZK9X(0&-1B\X&91DDSN[2Z]A@S\.+.J";]U\AHQ(#\4'#M C@^^R-X,!XC'O8=";5N9[<$DXUXT(@A^8%CO3OC'< V M2#%F8*#>*0;$CTB);L2O1N#J2*3F0%XC_QK#?=]AKIH*S4!&K8-F>+?.IT98 M;YKDS4%:,2_[.\6[XH,?DLXJ"*C$0CR9++D MQ*!#0JF)[*GE3<#M4V_5:FV!HH2B1GPH/BV"CB/BQZ#>&F@ZL,CGLWC33%3D MAX%X>SGN[5H&CB)UC2"2)Z!E($J\C'C=351XN^2M U2!29\(G4PQJ6@M"+,F M!/=6X2RN7%AN&+U4(GDES?=R49NRI1&"\D2X#(*_QDP;%Q'3N+-+F#9^29A. M7Z;3.;OBLV]\7ZL3P@X)+)P6:L:<*CF-6)+GUW,'\ "KF!D$RO)"9Z 4'F/LDA,5]TH8P1-GZM(TWLY5Z_9/S:AKA%+!XU9K MMU[0&V5YPU@M?RVF\TE2DWH$5Y0Q80PV=U#4TMEC7;+Z('1:\!B7!$)?2 #K M6,04%G8G@>5&Q)<^PY,UAXY!B01?UMTRC&IPH!%1\DR[#%&7 M*7_HD!X3_J!WPE\'KN+[=&T%1]64-()%GG:77^'K@I\J0V7_?FDM:5"?L$; M%-SQE@$F7_+2;?(57C+0FE=1(*41)077P67O(=@KO_*VO_KEK[@D_X4P\7VP M^/NC CCX$:7?+UT(0V_'<9+WEMWC^0%,*@H!X57(0*5WA%'?Z8DOGIWW:K2G MKHMW<\Y[L.G%3XR&(Q[0($2&/C(_G)_WQ%=8SRA@JF=$GUR*2OC4 GW<0#F* MV3.BTKD8^%&T<\+H:Q+9+Z(UEBTY-(G/3#X\$V933NX8Q4^CUI.[8JPF.DD_ M?HP:>$#5M*.9S%EE8XVHC]&^)J*OU ;U%7%/9A;,8F]R"9Z0638ZD$?"9J62 MEW1J/A$28[9C9_Y25I*Q1 MFYY7:5;Y'@]=7(_C\&S)^'I%=E7Y7'YT'?'&^^KA M^2[B+M5R95K^ M\(4H3:NB_WT&8E E1IN&VS3R(E+#N7L$MZ@6C@R6(._P*.)8J- MHA7I8@$3"H6X]MEU&(2,1.D!OJZ'38;:LEA+05'E 6>#?ENF@L(9?X_K\#5= MD/S&8;WX1^X9*KCW0R;C/EN\O=P_T&<)\]G2[>7]<%7SK1&PW$#+>P+KLC;IN35B8UR$=R(CSY9+F?7Y% MFZW<*?P""Z0?+@B[O,AG6?*B53?;3ND(%^>&F*'%31LFCE8.X'PY.\;"H-MR(2^=5GW] A1"FL*S*F-DT#R:+*74GB9#[* MH?/1ND@Y;0V^=/ZC2U"9#[ZX&*Y_^J:FVZO%V M5U>JC][55)GRL+NK.55O5=1MAR2O_\1"E5(:C+C3^E(%2TG/W9'_^[U"MD*= MWY&1OZ9U%&';:,C=T5C[[XJMT.]W8."O9PU%[-8>;G<=D!5:JC74[FI( M]<6'-;6E/.SN:DYQMA5VVUW)-WZW84V5;4YO=W2M_*Z^"AVJC[.3NE& MNR-O>^_DJU!;BX3_8MI7Q&&]L79"1^K?"B_638TQOIM.HL?,T6?.+/CS_U!+ M P04 " 48'-8AP>C=RP) #G< %0 &]V='HM,C R,S$R,S%?8V%L M+GAM;.U=46_BN!9^O]+]#USNLTMI9QXZFNZ*:3LCI,X4T?9J]VEED@-X)]BL M[5#87[_'26@I)<$)P;&N*E5%),?V^8[MIC&/ 1Y+6;0^NW+\+9%6MVS3^GD^5(1B="3CIGIZ?GG;5T.Q,W=T/]7&!3 M^&,GO?DL^J;JI_-$MGMQ<=%)[CZ+*K9+$"OM=G[[?GL?3&%&">/&(H'11;%/ M*KEX*P*J$S/NA=#*E3#?R%J,F$ND>T;.NR=+%;;1ZJU6:CHI(AC"N&4^'X?] M5VV*((YBM6"F3S4$TY- S+#VL_,N_G5,B0YJKV$&7)- <"4B%II>)",:&51$ M30&T0G!)6U,)X\NV6.B_R;H6H\Y_2U6B5W,<.XK-YA&T.QM( AJAOHGE;O%[ M)FZT/"JH5!]8:L!!FYEVK5(D@E?0C1IJ/<3&5(V2_HH5F5 Z3Y3H0*35^DIB MI<1"V84_>D$@8J[5@*[H*((>#_&*C"&\973$(J89J*M82M1]K5]$1Q!=M@^H M(448F5$I9&;R8R*,9Z8;(;S34Y!78C:7, 6NV +ZZ%%F<"N4ZBTHBPR KT+> MTPCN(8AEHGPO_#-6VO3>#]!WXP>ZS+?$L5IR:[$P9&;0TVA 6=CG5W3.-(WR M4!=+N]5OJ)2KC"@_8]&,>2H M7:JL6U1B-A/\7HO@9R& '#&GNFXX(S1FHLQ41$@*E#&J7N7H;ENL*2S%KMD3 M#SS :@";#_<.E0))UQK/T9G=+.?HO$U(2_QYZD"*35ZBI%-$0]"4<0AOJ.3H M--1&K+J&,0M8'B#[@D[Q6,_@:G-V@_KU9- 2$HM?MG$)\@1L,M79>B2MA\K@ M#2=\39TSB8Z*9[.D3L*0#J[+CZ68Y48I<<#0PF:M8'4;A54AOMD"<]%?!3Y6 MU$"2?8):,)5$"1_NT["T@V1%<6UAG7D#JYB8V>(Y]P;/T==?MB;YX(U)RD9O MG]R--?<6]M'>)]]3!9]]N/C[OFR(F),Q-PD8;$212@/47)C0I(( MYV+%1%[%5IK+]!VDL%TJ\*WQS!5T\ES%D<;)GQ''+9Y<+%2&T^/('<+$V$#(U5?8F1 JEG1*RZOQ\1J(>.U(OE/Y$_(SR9;G]8'L=7"5..7&-=9Z! W[NSBL57KJ&'?L[#I 5VAY;V$>/7MRM2N(,::8"\U:#O0;0M39P_T.40]1J^ M:OUJ2OD$^OR1&ZTFG/UM'D,-XT"S400/,)L+2>7V28Z::ZV!,Q4H8Z9,H(UW M7(O@[064!K6W'L&]D@WH_GN,7/#J;%RU@7[\)2IPP>4 M/X29Q=E$*&:[%6KP >% ,B%_Q]#U?#\WZ5NA!C^Y[+[I)8[D,GWBN!8V.'AD M^\1B#\>[?YS[Q%YK&..6$=2G5.OAO6P3D[SAZQQ,VC ]+&@N$9H<$JV)J%O6 MWCQ#+Z7H0=3\.FL%AT5V;#@]R&C<_^X5X"[66KT6IXSAC9K?9/Y3Z<7"S>J= M?Q"@2+19G5^V\M",R4GNL9!/5(;6';"_AF81FA.S:8R((O&4O7'+"EE^23_Y MYIZY(6KH1)^HY7ZXM7C!"H^ 'N]QUD)'4M3!^\:RUQUK"W)'+&B"0Q4<* VH MFI(Q]D ]!VK?5N?+R=D\S0ZB1?]W)U3-NU2VWJ>"+DE+9M8$V?M67E_8D$R? M6L;UA31/X5Q#^HG?T^V?FV60K#',NN)F/,8E5D[<:T8)IW9.F[X;;ZJ#(^$0 MX,\0KYF:"T4C=#[QW 02IG!>8"R-(;Q[/C^>8WM_%'.=)-P:+S;OWN;2O4"S1='(+5_!^RGQMX]G[SQ4F*-NL;"?R[H*HT240UR!_!_U MQ%X%N.[.*GH&O,;C?B[V"PX#64>H]VD?H6YK[&4$MN _^CO3ZR0*%7([QSL( MV\PR3!Q.1WS*'35O1=^6=(WM(GX@\W1"OIR4-6<1A)F,)$A?BK?>0DNZ5JY, MYLB^4+7M1]=JN=^W; :AH]_!V'@J8@@!X!3!L+_O2:)=LN_O*:\141D,);1N M+AJ7,7ONJ[^]?]EW1906\ZJQJ/.1T&Q)0.;IFB!]=T.Z*GAQ;AN.SZY M6CC M2AWW4<8MLO=?63H.PE)@&M;;6''[>/U>_2T*^1F!J@RD_!\R\#X4'0[7NJBTR,#(S,3(S,5]D968N>&UL[7U;<^.VLN[[J=K_8I?%E MCL^>C%2VD^R]7U(P"4EYB%GZR^N3[[Y__8JF(8OB=/'+Z]^N@\GUZ>7EZUWFUN7ZW!)5R2(4S4BH9)%Q#^+ MXN$7%I*L&,9:%5YI2ZA_!;MB@7H4G+P-WIU\=R^BUW+47[TJAX[PD+.$7M'Y MJ^U??[NZ?#X6<9J]B>+5FVV9-R1)I,A%"TM.YUI1=P.H)/B@^OX_>S6SS5I. M Q&OU@E]_::]4!%;D3@-5G1U2WE#\2K;Z%S0>$53M5*"LKNFLFJ:Z5KQYC.29YD[0?Y:3M:@7?2'HJJ^F)AGN3B+E8-9C1R ME>SW[;L3^;\WA>!R0\BH[#,+4I;1X.1#(.A"_9M&GZK"[[.]@ MUTXAMV4S6FVDUG$:JZ)?Y#^WI96@/>M5"D3O,RH/@^V6M9,I8>&SEREVDT'0 M\+L%NWL3T;B00/VE&)KR==+XS_,TB[/-V9,UDY!;FOSR6O=S*4VB=F;&M^/C M7IKJ*=B+5%_H@B1EWY/[6%0(IBG16*8Y$;?%,LQ%L"!D70I&DTSLGCQ*N'WP MYUDLPH2)G-,;.5,^R?;_FMR*C),P.Y#8HH93#:[+-7!%UXQG$BQ5R*?1Q**F M6XUVZUSN%_12_O5P\M07'$;>&W*;T#I9GQ0RR?FX;TYX^(IQB6A_>2U1<7F^ M_*Q>%8U^>9WQ_*&Y[='5$.C,.5N!!I%_O*E E_V!Z+<28LI2-,C(/7UX3U#L7%W; M/60VR8%(&9'R42/ERV+JWY![.$2&5$%LC-@8L3%B8\3&B(V[Q,;PLV77;)Y](YS"477K]A!R(^1&R(V0&R$W0NXN(7='!]-0>/QC(&@BVUT$ MBR(<+BEP*XE6LG.E=!;?/8PR$)C;-.D M5W2.F'4B("Y^@;CX-"%"3.=_E#-BRJ_BQ3(S8F!8#<2[B'<1[R+>1;R+>!?Q M[@/>M3D\A\*V'P(2ABR7^#!8DXUZ 26E&H9R *. WJ_E9+8.?[9LU3DJ;B0? M0N9CALRM4=)D.Z-FY812YFTYG;[$Y#9.Y"RF AXQT;(U1.2(R!&1(R)'1(Z( M'!'YOFZ='*Q#H?7WP9K3-8D?(6J!6UFVI#P(<\Y526ET4&NJND'+SE%[8QD1 MN2-R/VK\.E5+8%+,?+B) :N$.!QQ..)PQ.&(PQ&'=XG#;4Z?P3YW#&Z)B$7 MY@IY"OF\R#=7H,[;7,A7)ZP3@U@TZ?X#2&OA$%DCLCYN9,T7)(W_+M;!*4L% M2^*H^,Z?HO=?S M:@"\'\G2Q5\4UJ7%1&V6.AO8D$ML;R52+XA^(KN/E @7"5E48-7*WWM$SY,\ MBF6C%S%?7495\E3]WK\\7[;7..@E.BS1OTQ?R>H0&FE^[5&64W6B<$I.650E M3-7/?4I3NIHNY#9&DO^FA)^GT9E<;%62U13M47M7T99-<5[E_94+@I.DDMI0MS_)]UHQ=24 MZU\^MEHQB1ZDS7F])'*DIGE6W# 7IU6( UZI?\E+*/F0.5^]XQ G]FN_S1\\$?%[$B53\ M5.YT"\;U(U=9JG?95#9?+A=? ?Z*[?A4!9[RC?&H =5R('M&%?6GLC*0C&SW M$H/0IN*]2SO+;Y,XO$@8T8M84:9WN:[HHDAND68:$L54K'?IKIHVG:I" M_4NV(DGRZ2#>X+EH5:5ZE^V&W%]&BD.=QR435[,IUI3O7=[?62*W#\++35 _ MFIIRO(FSBJ9'%V1P2( 7HR'',2C MH9^\R9OJV4\.YFJ9#5OJ^#7J?>:VZ@$8#Z!N;SW5S01A@:J]\TXU@U,:J--[ M[W2"^2.!ZGWP3CV@OPVHWP^>ZZ?QU &U^]%;[9X[58 J_>2M2GKO.E"UC]ZJ M9O ?0D_L_L/<&D]%H^<1JI^OD$3'V$+U\A6.6)"H4%7]@R<6_!)42?_P"M"9 M#570/\0"\H-#U?,/L,!]TE =_8,MT!@!J(;^H1A]?"54)__@BYEMA-KC_B$7 M,U\)U" M*N8K>(''RD(U]0_):#]^@ZKD'W Q?E\(5(F7Q:O!O,Y./7KF&9R:?ICCD4?'X7B'RU(GRC MLE2*>)$6GF^5W*9,[*] Z9I)VSJF(K $UXW:=@Z]6TB)P!R!N>D**]E]%">Y M_6P'L\KB8/ MI]5L>UC5&G=6E9$0. )"8'MWJG&&5Y9!LQ[-^A:*N,0GK"D.&!T/XASU>6>< M@U\PLS[!O>*0/%T__7!57LP2PRGH5C_D2Y$O/6:^M($1,A17^D,0%M$X@FMG/H;)0#L?,Q8^?G4#DSA+2+7_$%R^ [%^IT)9T>=WE&^NX_M?Y01?"KU4@.(#V1G3 MN:(SY;%'RI0QB5R/T2D3F2CI3"+WY!G9J"5:Z^WLJ%6TN*PT4/-;$:V&F)6J M(H/(: S#J"[DNYR#!H<\KJ;]]3;Y1GBD\D"%2SI-J=$5W: %Y!..@$_8GDB& M3:.BQ! 2&I=B91F_I;39+Y!G09X%&/91M5H9:*'XJ$TE8&$PJ# Z%JP>I7G' MI6C&GUD;85X1?,UFGP\1&AW.0NVQ[]TDK-[3F*W)[>44M-G.?9B ;5Y7:U,$ MJ&I'^4?0[X%^CR/V>W1*X@WE#3DY"60_E*.V9."G/B?%[OEYW 2\MA&!-N/KXQQ9@:QMPCZ=K1$'X?,SP61/Q<\I2(;6,T\4% MI890'U.Y+N*A:+RZS;DHIJLA#$I?K ,A"OO_]I"ITTL#*8\6CI4&ZL*H%7T\ M)+=9< W^?$ -'S0P>M)!=<:MQ:#Q1%N2;R9/O4UQD1P):V85H(8/&AC?!ZC. MN+7P<599,#(-6D!6!ED99&6\4\0&C;!&![^/VD).2=;H0!H=XV8-'+RC<6!O MAT$M,:\8QCXF[$CB4^Q>:[V9/]H(,+"AZ-W*A)T2S)J5\'*)=GF"MEJB&%>% MWASTYM1Y67R=SMA?2!6D;5!UN:(61L;>#@ 45-WE][N+W#BQK9%ET1.,]F0V#EF M8J>U]?(\)7X-=5)?P:G\IT0L)VFD_E!I2N](HKX3*$3;U!F_5G7=:L52(<6( M"A\54!E %:M6[/ MJ?:?&8N^Q4DB1;M,,Y(N8@ES)A(70)>9?0-N0YA7:Q)S=<).N81':R9(,IU_ M81+NQ'T\'P-ID >K[P5-]FS(Z0+5_\%1M& T"5/)'3Y6T(F"!NO[DJ:ZM M#7&@_A\]U;\C(AJ*17Q%7>VHP*$^4'@?K#F5!V\4T/*@*1.>LFQ)>1 6KS0+ M2+$I!YFR!FR_7VC>@?//&]J*BDYR=)*;/C"@LV0)8 M7Z?E4*C]PRYT4P1KLE%*%TA5/I0#NP=?&R'V9HT[1^MMQ$2DCDC=A/;")8WR MA$[G6XM>S,H9)K>'23F_OL3D-DYBE=<8A+FZ:!(1.B)T1.B(T!&A(T(_7H3> MW4DY%#K_,1#JTM: %2Z@ABC>+&@,QZ'](JD"POLW7?'?HWGHP9B$F;QG7SYEK9*VX8' M'X_MU9K%_;?[8O].DKS,]"A$OBJ?-1Z;]IV@98>6'5IV:-FA98>6W4NP[+K! M%=Y%KW^BX)L-45<(:RA&X*= 2LY)VC2(3EO?.0]0(PE2 ,=, >AN M,GQ8L7]LY\:47\6+969$Q$VJHIV$=A+:26@GH9V$=M+QV4G-3\2A<.W'0- D M4?D#%S2EG"1E"%:TDIVK+V749T_-$&^#EIUCX<8R(DI^T2CYNIPUG\M)H]S: M3Z;,]HM?LS^BRR8152.J1E2-J!I1-:+JHT?5'9R40Z'MD^\#OLT14B#-Z#%+ M2#.0#6_0.;:V%0TA]8N&U,;<.59(NDE+"* 10". 1@"- !H!]-$#Z.8'Y&"X M^6T0%TG7)'*\;_I5M+D1]_@8( YBXF/&Q!W&R^^2(MR0^S+Q@5S;S3]P;M3: M0)J?S^=411K2AZR,5W*975%Y@H12WB*VS%+]YDVB&7$$9L1UOEH1OIG.'^^[ M8T*<$LXW<\95 &/M=@3V(MA+:2F@KH:V$ME*MN=#D=!P*.K\-%DQ%_BL[CG(U[3(2)Q)E M2C%S\O!^@0 :V)IS&&TE%X+I8P;3FA"L/QC_2\Z0;29M:?#'87QXLW1]0:>( M["O-2C)&F><:0%99QJF45VJII33:W:0U"<-\E1<;9/4HVU=$^\*]?8$@%T'N ML"!7^XZ.#>2ZX\1A*AG.%._8;IA&MD<-4$UW-]2:U83BEJ%LD'>!*%T. 9L' M(EZDL12.J#OJ'NXA#-;;FPM;&BA==.7<>NE.:#1MCMFT:8T5)[+[*$YRY>>] MIF'."_?F^7V8Y'+27,@M1^5XR[/R8MCYX>6XDY6:C1J(V6G;8QJ53YOJ!BKF M@<,>/1C!KV1%*]>I;;5CT*6SO:B)3N?R*&,;2O=2$O[Z!&T<*%-;'BWR(_#X M;?/V&&="91GD#7I5Q.4IP9KNQJ,C6IR?O=ZYN, OF%F?!%Z15)ZNGWX\OE[, M$L,IX58_)&21D#T^0K8'TWHH*O"'0!99R=E:8_"_Z5)=)F>"[EO?#N0!%ZA \$^RW<@E->'BFFJ.HVS8B=E MET+DM.RZ2CZ;>DY-W+V!^\IFA*M[&'06N;'L4%(?WK-1+[NNQK :3/-,[I)I M),\EJ H559SJ,./;KX)L7@2LTN!Z%.O21H>G%9#^PX <+XDUM/_0_CL^^P^ M3$8:F /&+2.+R+$'-4 %WWNFH W> :KX800J5L$AH'H_>**>K6$)5.]'G]2S MMTN'XL4.KZUO1XP!6W/.C%G)A=38"Z3&KEB1]?S@)M'*$ 5P^2X2.*NMXO;P M$M2)\GHMBOD]DV:'_&,Z+T^&21KMG?3;7;;8;E162G[WS/;NN9<.AN!W*E0@ MZOD=Y9OK^/Y7N>:70O]B ,7=AG4E14?R%*^\SW:;%E1CK=M5=LONR.FNG+.& M:,.J(H/(: R@JR[DNYR#AO55S\:]_>+3IOIJXNVMQ)^+:]LN4[FMQ"SZS/6? M&?;8DP\CIB15'W*'2SI-J3$@KD$+[C4TG2';-W5[^*:*_VQW[>(>/[$];ALY#=JMG,0!/)1VTJ M@2.#0;;1^7WJT;)W ;V:\6?6MK%7+JUFL\^'Z-H.9Z'V6/1N$E;O:F?E1AJ4T(2N M'\KQ>W(2R'[DN1J3)(A3(4=._2B*RV1Y+/YJZPMNWH'[9.@M146/\3%[C-L' MI1.A+@-4?YS_*X_O2*(FUR0K;CZ09X3QXP";NDZUVKNGXC3GG&H3M.@+(M6. MX=Q:0V+DM!X:>6CD>09/&YPE(S7=ZHZ8CWUTD#*.T6L9?+> MQQU:]:K."7T0!J"&#QH8PQ] =<:MQ:#!AII+3\KD(F(ZWWNFT:U!"UYHJ%\W M@!H^:&"<<: ZX]9BV"!=Y#N0[^@T+ MR6K-&!Z./VD+V6-9H.QL=EV5]['@7 M+ 1[.PR*\[WB[OJ8L",)*K)[K?5&Y&C#]L"&E'=JM(;R??45QBK_H%3ET\EL3HEA+(L$*Q*L(R98 M:S='9K\5C99LA)T4WO$9@/?"FASG7IG!W4Y8'\A&9#*0R3@>)J.),3/24$\ M'AR EI%36K DCHKPQUN2R)V>!F)):294-*0LLJ19')+D0:=Z8L:^39?43%/I MD)PY9G(&+U(YEHM4C#=WU)0>5O+17P%3._'KB@\H.UY?@]?7(#WE.SV%UB]: MO\=C_=H=BR.U>WNX ,6W-#,=7X#B6[:8[FY7\NWFFJYO5_+EZAHK

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end XML 76 ovtz20231231_10k_htm.xml IDEA: XBRL DOCUMENT 0001107280 2023-01-01 2023-12-31 0001107280 2023-06-30 0001107280 2024-03-19 0001107280 2023-12-31 0001107280 2022-12-31 0001107280 us-gaap:NonrelatedPartyMember 2023-12-31 0001107280 us-gaap:NonrelatedPartyMember 2022-12-31 0001107280 us-gaap:RelatedPartyMember 2023-12-31 0001107280 us-gaap:RelatedPartyMember 2022-12-31 0001107280 2022-01-01 2022-12-31 0001107280 us-gaap:CommonStockMember 2021-12-31 0001107280 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2021-12-31 0001107280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001107280 us-gaap:RetainedEarningsMember 2021-12-31 0001107280 2021-12-31 0001107280 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001107280 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2022-01-01 2022-12-31 0001107280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001107280 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001107280 us-gaap:CommonStockMember 2022-12-31 0001107280 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2022-12-31 0001107280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001107280 us-gaap:RetainedEarningsMember 2022-12-31 0001107280 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001107280 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2023-01-01 2023-12-31 0001107280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001107280 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001107280 us-gaap:CommonStockMember 2023-12-31 0001107280 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2023-12-31 0001107280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001107280 us-gaap:RetainedEarningsMember 2023-12-31 0001107280 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001107280 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001107280 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001107280 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001107280 ovtz:RollingStockOptionPlanMember 2023-12-31 0001107280 ovtz:RollingStockOptionPlanMember ovtz:VestingEverySixMonthsMember 2023-01-01 2023-12-31 0001107280 ovtz:RollingStockOptionPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-01-01 2023-12-31 0001107280 ovtz:RollingStockOptionPlanMember 2023-01-01 2023-12-31 0001107280 ovtz:RollingStockOptionPlanMember 2022-01-01 2022-12-31 0001107280 ovtz:RangeThreeMember 2023-12-31 0001107280 ovtz:RangeThreeMember 2023-01-01 2023-12-31 0001107280 ovtz:RangeFourMember 2023-12-31 0001107280 ovtz:RangeFourMember 2023-01-01 2023-12-31 0001107280 ovtz:RangeFiveMember 2023-12-31 0001107280 ovtz:RangeFiveMember 2023-01-01 2023-12-31 0001107280 ovtz:RangeSixMember 2023-12-31 0001107280 ovtz:RangeSixMember 2023-01-01 2023-12-31 0001107280 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001107280 us-gaap:EmployeeStockOptionMember 2022-12-31 0001107280 ovtz:WarrantsExpiringOnJune42025Member 2023-12-31 0001107280 ovtz:WarrantsExpiringOnJune42025Member 2023-01-01 2023-12-31 0001107280 us-gaap:ForeignCountryMember us-gaap:CanadaRevenueAgencyMember 2023-12-31 0001107280 us-gaap:ForeignCountryMember us-gaap:CanadaRevenueAgencyMember 2022-12-31 0001107280 us-gaap:DomesticCountryMember us-gaap:InternalRevenueServiceIRSMember 2023-12-31 0001107280 us-gaap:DomesticCountryMember us-gaap:InternalRevenueServiceIRSMember 2022-12-31 0001107280 ovtz:ConsultingFeesMember 2023-01-01 2023-12-31 0001107280 ovtz:ConsultingFeesMember 2022-01-01 2022-12-31 0001107280 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-12-31 0001107280 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001107280 ovtz:SharebasedCompensationMember 2023-01-01 2023-12-31 0001107280 ovtz:SharebasedCompensationMember 2022-01-01 2022-12-31 0001107280 ovtz:ReimbursementMember 2023-01-01 2023-12-31 0001107280 ovtz:ReimbursementMember 2022-01-01 2022-12-31 0001107280 ovtz:ConsultingFeesMember 2023-01-01 2023-12-31 0001107280 ovtz:ConsultingFeesMember 2022-01-01 2022-12-31 0001107280 ovtz:VancouverCAOperatingLeaseMember 2023-01-01 2023-12-31 0001107280 ovtz:VancouverCAOperatingLeaseMember 2022-01-01 2022-12-31 iso4217:USD shares thunderdome:item iso4217:USD shares pure utr:Y iso4217:CAD shares 0001107280 OCULUS VISIONTECH INC. false --12-31 FY 2023 0 0 250000000 250000000 0 0 0 0 0 0 500000000 500000000 91422569 91422569 91422569 91422569 -0.01 0 500000000 91422569 0 0 2024-01-29 2024-06-10 2024-10-14 2025-01-31 12500000 false false false false 10-K true 2023-12-31 false 000-29651 WY 06-1576391 #507, 837 West Hastings Street Vancouver BC V6C 3N6 604 685-1017 Common Stock, no par value No No Yes Yes Non-accelerated Filer true false true false false 4000000 91422569 Davidson & Company LLP Vancouver, BC. Canada 731 156574 687602 27381 30238 183955 717840 136248 133796 137475 168627 273723 302423 46850710 46850710 1479031 1394997 -32863 -34856 -48386646 -47795434 -89768 415417 183955 717840 148500 135000 95884 1137883 274498 399467 84034 396520 602916 2068870 11704 5153 0 414128 -591212 -1649589 1993 41046 -589219 -1608543 -0.02 91422569 91422569 91422569 46850710 998477 414128 6190 -46145845 2123660 0 396520 0 0 0 396520 0 0 -414128 0 0 -414128 -0 -0 -0 41046 -0 41046 0 0 0 0 -1649589 -1649589 91422569 46850710 1394997 0 -34856 -47795434 415417 0 84034 0 0 0 84034 0 0 0 1993 0 1993 0 0 0 0 -591212 -591212 91422569 46850710 1479031 0 -32863 -48386646 -89768 -591212 -1649589 84034 396520 -0 414128 -2857 -7594 2452 180387 -31152 0 -533021 -1479216 1993 -41633 -531028 -1520849 687602 2208451 156574 687602 0 0 0 0 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">1.</em> </b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>BASIS OF PRESENTATION AND BUSINESS</b></p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The accompanying consolidated financial statements include the accounts of Oculus Visiontech Inc. (“Oculus”) and its wholly-owned subsidiary, ComplyTrust Inc. (“CTI”), (together “the Company”). All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company is a designer of digital watermarking services and solutions. At <em style="font: inherit;"> December 31, 2023 </em>and for the <em style="font: inherit;">two</em>-year period then ended, substantially all of the Company's assets and substantially all its operations are located and conducted in the United States and Canada.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">2.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>GOING CONCERN </b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">These consolidated financial statements are prepared on a going concern basis which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses from inception and does <em style="font: inherit;">not</em> currently have the financial resources to sustain operations in the long-term. As shown in the financial statements, the Company has incurred a loss of $591,212 for the year ended <em style="font: inherit;"> December 31, 2023 </em>and, in addition the Company incurred losses of $1,649,589 for the year ended <em style="font: inherit;"> December 31, 2022. </em>As of <em style="font: inherit;"> December 31, 2023, </em>the Company had an accumulated deficit of $48,386,646 and a working capital deficiency of $89,768. As a result of the Company’s current financial position and challenging access to capital, there can be <em style="font: inherit;">no</em> assurance that the Company will be able to raise additional funds in the future, in which case the Company will be unable to meet its financial obligations. These material uncertainties raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do <em style="font: inherit;">not</em> include adjustments to amounts and classifications of assets and liabilities that might be necessary should the Company be unable to continue operations. The Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company’s management will continue to be available to the Company when needed.  </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">There are many external factors that can adversely affect general workforces, economies and financial markets globally. Examples include, but are <em style="font: inherit;">not</em> limited to, the COVID-<em style="font: inherit;">19</em> global pandemic and political conflict in other regions. It is <em style="font: inherit;">not</em> possible for the Company to predict the duration or magnitude of adverse results of such external factors and their effect on the Company’s business or ability to raise funds.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> -591212 -1649589 -48386646 89768 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><em style="font: inherit;">3.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b></b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Basis of consolidation</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">These consolidated financial statements are presented in United States dollars and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). On <em style="font: inherit;"> March </em><em style="font: inherit;">19th,</em> <em style="font: inherit;">2024,</em> the Board approved the consolidated financial statements dated <em style="font: inherit;"> December 31, 2023.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">These consolidated financial statements include the financial statements of the Company and the entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Control is defined as the exposure, or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee. Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly affect the investee’s returns. This control is generally evidenced through owning more than <em style="font: inherit;">50%</em> of the voting rights or currently exercisable potential voting rights of a Company’s capital stock. All significant intercompany transactions and balances have been eliminated.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The controlled entities are listed in the following table:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 23%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Name of Subsidiary</p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 23%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Country of</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Incorporation</p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Ownership</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Interest at</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;"> December 31,</em></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">2023</em></p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-top: 1px solid black;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Ownership</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Interest at</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;"> December 31,</em></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">2022</em></p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-top: 1px solid black;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 24%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Principal Activity</p> </td></tr> <tr><td style="vertical-align: bottom; width: 23%;"> </td><td style="vertical-align: bottom; width: 23%;"> </td><td style="vertical-align: bottom; width: 1%;"> </td><td style="vertical-align: bottom; width: 1%;"> </td><td style="vertical-align: bottom; width: 12%;"> </td><td style="vertical-align: bottom; width: 1%;"> </td><td style="vertical-align: bottom; width: 1%;"> </td><td style="vertical-align: bottom; width: 1%;"> </td><td style="vertical-align: bottom; width: 12%;"> </td><td style="vertical-align: bottom; width: 1%;"> </td><td style="vertical-align: bottom; width: 24%;"> </td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 23%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">ComplyTrust Inc.</p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 23%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">US/Delaware</p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">100%</em></p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">100%</em></p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 24%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Software Development</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Significant judgments, estimates and assumptions</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are <em style="font: inherit;">not</em> limited to the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><span style="text-decoration: underline; ">Significant judgments</span></p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 27pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the determination of functional currencies; and</p> </td></tr> <tr style="vertical-align: top;"><td style="width: 27pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">share-based compensation and warrants issued in connection with private placements, using the fair value method. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based compensation. This estimate also requires determining the most appropriate inputs to the valuation model. The main factor affecting the estimates of the fair value of stock options is the stock price, expected volatility used and the expected duration of the instrument. The Company currently estimates the expected volatility of its common shares based on historical stock price information. The Company recognizes the commitment to issue shares, based on the trading price at the date of the commitment on a percentage basis on the likelihood of the completion of the event.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b></b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Cash and cash equivalents</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Cash equivalents include highly liquid investments with original maturities of <em style="font: inherit;">twelve</em> months or less, and which are subject to an insignificant risk of change in value. Cash equivalents are held for the purpose of meeting short-term cash commitments rather than for investment or other purposes.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b></b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Impairment of long-lived assets and long-lived assets to be disposed of</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount and the fair value less costs to sell.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b></b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Research and development </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Expenditure on research activities is recognized on the consolidated statements of operations and comprehensive loss as incurred. Development expenditures are capitalized as part of the cost of the resulting intangible asset only if the expenditures can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. Management determined that as at <em style="font: inherit;"> December 31, 2023 </em>it was <em style="font: inherit;">not</em> yet able to demonstrate with sufficient certainty that it is probable that any economic benefits will flow to the Company. Accordingly, all research and development costs incurred to date have been expensed. </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b></b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Intangible asset</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Identifiable intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is valued at fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The useful lives of intangible assets are assessed as either finite or indefinite.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment annually whenever there is an indication that the intangible asset <em style="font: inherit;"> may </em>be impaired. The amortization period and method for an intangible asset with a finite useful life are reviewed at least at each financial year-end. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in profit or loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Intangible assets with indefinite lives are measured at cost less any accumulated impairment losses. These intangible assets are tested for impairment on an annual basis and more frequently if there are indicators that intangible assets <em style="font: inherit;"> may </em>be impaired.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b></b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Income taxes</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company accounts for income taxes under the asset and liability method. Current income taxes are the expected taxes payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to taxes payable in respect of previous years. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under the asset and liability method, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than <em style="font: inherit;">not</em> that some portion or the entire deferred tax asset will <em style="font: inherit;">not</em> be recognized.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b></b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Net loss per share</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Basic loss per share is calculated using the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or contracts that <em style="font: inherit;"> may </em>require the issuance of common shares in the future were converted, unless the impact is anti-dilutive. For the year ended <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022,</em> this calculation proved to be anti-dilutive, and therefore the Company’s 1,565,000 (<em style="font: inherit;">2022:</em> 5,415,000) stock options and 12,500,000 (<em style="font: inherit;">2022:</em> 17,400,000) warrants were excluded from the calculation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b></b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Stock-based compensation</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Section <em style="font: inherit;">718</em> “Compensation - Stock Compensation”, which establishes accounting for equity-based compensation awards to be accounted for using the fair value method. Equity-settled share-based payment arrangements are initially measured at fair value at the date of grant and recorded within shareholders’ equity. Arrangements considered to be cash-settled are initially recorded at fair value and classified as accrued liabilities, and subsequently re-measured at fair value at each reporting date. The Company’s stock option plan is an equity-settled arrangement.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The fair value at grant date of all share-based payments is recognized as compensation expense over the period for which benefits of services are expected to be derived, with a corresponding credit to shareholders’ equity or accrued liabilities depending on whether they are equity-settled or cash-settled. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and estimate the expected forfeiture rate at the date of grant.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b></b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Functional currency</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company’s consolidated financial statements are presented in U.S. dollars, which is the Company’s reporting currency. The functional currency of Oculus is the Canadian (“CAD” or “C”) dollar and the functional currency of CTI is the U.S. dollar.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In accordance with ASC <em style="font: inherit;">830,</em> Foreign Currency Matters, for companies that have a functional currency other than the US dollar, the Company translates the assets and liabilities into U.S. dollars using the rate of exchange prevailing at the balance sheet date and the statements of operations and comprehensive loss and cash flows are translated at an average rate during the reporting period. Adjustments resulting from the translation from CAD into U.S. dollars are recorded in shareholders' equity as part of accumulated other comprehensive (income) loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Foreign currency transactions are translated into the functional currency of the respective currency of the entity or division, using the exchange rates prevailing at the dates of the transactions (spot exchange rate). Foreign exchange gains and losses resulting from the settlement of such transactions and from the re-measurement of monetary items denominated in foreign currency at period-end exchange rates are recognized in profit or loss. Non-monetary items that are <em style="font: inherit;">not</em> re-translated at period end are measured at historical cost (translated using the exchange rates at the transaction date), except for non-monetary items measured at fair value, which are translated using the exchange rates as at the date when fair value was determined. Gains and losses are recorded in the statement of operations and comprehensive loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b></b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Recently adopted accounting pronouncements</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company has reviewed new and revised accounting pronouncements that have been issued but are <em style="font: inherit;">not</em> yet effective. The Company does <em style="font: inherit;">not</em> expect any material impact from future accounting pronouncements.</p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Basis of consolidation</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">These consolidated financial statements are presented in United States dollars and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). On <em style="font: inherit;"> March </em><em style="font: inherit;">19th,</em> <em style="font: inherit;">2024,</em> the Board approved the consolidated financial statements dated <em style="font: inherit;"> December 31, 2023.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">These consolidated financial statements include the financial statements of the Company and the entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Control is defined as the exposure, or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee. Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly affect the investee’s returns. This control is generally evidenced through owning more than <em style="font: inherit;">50%</em> of the voting rights or currently exercisable potential voting rights of a Company’s capital stock. All significant intercompany transactions and balances have been eliminated.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The controlled entities are listed in the following table:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 23%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Name of Subsidiary</p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 23%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Country of</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Incorporation</p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Ownership</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Interest at</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;"> December 31,</em></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">2023</em></p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-top: 1px solid black;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Ownership</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Interest at</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;"> December 31,</em></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">2022</em></p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-top: 1px solid black;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 24%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Principal Activity</p> </td></tr> <tr><td style="vertical-align: bottom; width: 23%;"> </td><td style="vertical-align: bottom; width: 23%;"> </td><td style="vertical-align: bottom; width: 1%;"> </td><td style="vertical-align: bottom; width: 1%;"> </td><td style="vertical-align: bottom; width: 12%;"> </td><td style="vertical-align: bottom; width: 1%;"> </td><td style="vertical-align: bottom; width: 1%;"> </td><td style="vertical-align: bottom; width: 1%;"> </td><td style="vertical-align: bottom; width: 12%;"> </td><td style="vertical-align: bottom; width: 1%;"> </td><td style="vertical-align: bottom; width: 24%;"> </td></tr> <tr style="background-color: rgb(204, 238, 255);"><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 23%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">ComplyTrust Inc.</p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 23%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">US/Delaware</p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">100%</em></p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">100%</em></p> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 24%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Software Development</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Significant judgments, estimates and assumptions</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are <em style="font: inherit;">not</em> limited to the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><span style="text-decoration: underline; ">Significant judgments</span></p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 27pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the determination of functional currencies; and</p> </td></tr> <tr style="vertical-align: top;"><td style="width: 27pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">share-based compensation and warrants issued in connection with private placements, using the fair value method. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based compensation. This estimate also requires determining the most appropriate inputs to the valuation model. The main factor affecting the estimates of the fair value of stock options is the stock price, expected volatility used and the expected duration of the instrument. The Company currently estimates the expected volatility of its common shares based on historical stock price information. The Company recognizes the commitment to issue shares, based on the trading price at the date of the commitment on a percentage basis on the likelihood of the completion of the event.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Cash and cash equivalents</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Cash equivalents include highly liquid investments with original maturities of <em style="font: inherit;">twelve</em> months or less, and which are subject to an insignificant risk of change in value. Cash equivalents are held for the purpose of meeting short-term cash commitments rather than for investment or other purposes.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Impairment of long-lived assets and long-lived assets to be disposed of</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount and the fair value less costs to sell.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Research and development </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Expenditure on research activities is recognized on the consolidated statements of operations and comprehensive loss as incurred. Development expenditures are capitalized as part of the cost of the resulting intangible asset only if the expenditures can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. Management determined that as at <em style="font: inherit;"> December 31, 2023 </em>it was <em style="font: inherit;">not</em> yet able to demonstrate with sufficient certainty that it is probable that any economic benefits will flow to the Company. Accordingly, all research and development costs incurred to date have been expensed. </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Intangible asset</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Identifiable intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is valued at fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The useful lives of intangible assets are assessed as either finite or indefinite.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment annually whenever there is an indication that the intangible asset <em style="font: inherit;"> may </em>be impaired. The amortization period and method for an intangible asset with a finite useful life are reviewed at least at each financial year-end. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in profit or loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Intangible assets with indefinite lives are measured at cost less any accumulated impairment losses. These intangible assets are tested for impairment on an annual basis and more frequently if there are indicators that intangible assets <em style="font: inherit;"> may </em>be impaired.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Income taxes</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company accounts for income taxes under the asset and liability method. Current income taxes are the expected taxes payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to taxes payable in respect of previous years. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under the asset and liability method, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than <em style="font: inherit;">not</em> that some portion or the entire deferred tax asset will <em style="font: inherit;">not</em> be recognized.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Net loss per share</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Basic loss per share is calculated using the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or contracts that <em style="font: inherit;"> may </em>require the issuance of common shares in the future were converted, unless the impact is anti-dilutive. For the year ended <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022,</em> this calculation proved to be anti-dilutive, and therefore the Company’s 1,565,000 (<em style="font: inherit;">2022:</em> 5,415,000) stock options and 12,500,000 (<em style="font: inherit;">2022:</em> 17,400,000) warrants were excluded from the calculation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p> 1565000 5415000 12500000 17400000 <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Stock-based compensation</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Section <em style="font: inherit;">718</em> “Compensation - Stock Compensation”, which establishes accounting for equity-based compensation awards to be accounted for using the fair value method. Equity-settled share-based payment arrangements are initially measured at fair value at the date of grant and recorded within shareholders’ equity. Arrangements considered to be cash-settled are initially recorded at fair value and classified as accrued liabilities, and subsequently re-measured at fair value at each reporting date. The Company’s stock option plan is an equity-settled arrangement.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The fair value at grant date of all share-based payments is recognized as compensation expense over the period for which benefits of services are expected to be derived, with a corresponding credit to shareholders’ equity or accrued liabilities depending on whether they are equity-settled or cash-settled. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and estimate the expected forfeiture rate at the date of grant.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Functional currency</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company’s consolidated financial statements are presented in U.S. dollars, which is the Company’s reporting currency. The functional currency of Oculus is the Canadian (“CAD” or “C”) dollar and the functional currency of CTI is the U.S. dollar.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In accordance with ASC <em style="font: inherit;">830,</em> Foreign Currency Matters, for companies that have a functional currency other than the US dollar, the Company translates the assets and liabilities into U.S. dollars using the rate of exchange prevailing at the balance sheet date and the statements of operations and comprehensive loss and cash flows are translated at an average rate during the reporting period. Adjustments resulting from the translation from CAD into U.S. dollars are recorded in shareholders' equity as part of accumulated other comprehensive (income) loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Foreign currency transactions are translated into the functional currency of the respective currency of the entity or division, using the exchange rates prevailing at the dates of the transactions (spot exchange rate). Foreign exchange gains and losses resulting from the settlement of such transactions and from the re-measurement of monetary items denominated in foreign currency at period-end exchange rates are recognized in profit or loss. Non-monetary items that are <em style="font: inherit;">not</em> re-translated at period end are measured at historical cost (translated using the exchange rates at the transaction date), except for non-monetary items measured at fair value, which are translated using the exchange rates as at the date when fair value was determined. Gains and losses are recorded in the statement of operations and comprehensive loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Recently adopted accounting pronouncements</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company has reviewed new and revised accounting pronouncements that have been issued but are <em style="font: inherit;">not</em> yet effective. The Company does <em style="font: inherit;">not</em> expect any material impact from future accounting pronouncements.</p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><em style="font: inherit;">4.</em></b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>PREPAID EXPENSES AND OTHER CURRENT ASSETS</b></p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Prepaid expenses and other current assets consist of the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"> <tbody> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">December 31,</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">December 31,</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2023</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2022</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid expenses</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">16,014</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">28,028</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Tax Receivable – Canadian GST</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">11,367</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,210</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">27,381</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">30,238</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"> <tbody> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">December 31,</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">December 31,</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2023</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2022</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid expenses</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">16,014</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">28,028</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Tax Receivable – Canadian GST</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">11,367</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,210</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">27,381</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">30,238</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody> </table> 16014 28028 11367 2210 27381 30238 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><em style="font: inherit;">5.</em></b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ACCOUNTS PAYABLE AND ACCRUED EXPENSES</b></p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Accounts payable and accrued expenses consist of the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"> <tbody> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">December 31,</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">December 31,</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2023</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2022</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts payable</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">87,422</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">81,927</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Accrued fees and expenses</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">48,826</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">51,869</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">136,248</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">133,796</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"> <tbody> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">December 31,</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">December 31,</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2023</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2022</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts payable</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">87,422</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">81,927</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Accrued fees and expenses</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">48,826</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">51,869</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">136,248</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">133,796</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody> </table> 87422 81927 48826 51869 136248 133796 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">6.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>COMMON STOCK</b> </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company has no par value common stock with 500,000,000 authorized shares and 91,422,569 outstanding on <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company has authorized the issuance of 250,000,000 non-voting preferred shares without par value, none issued.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">As of <em style="font: inherit;"> December 31, 2023, </em>there were <span style="-sec-ix-hidden:c108851708">Nil</span> common shares held in escrow.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During the year ended <em style="font: inherit;"> December 31, 2022, </em>the Company wrote-off the commitment to issue shares of $414,128 due to the uncertainty in the Company meeting the required performance conditions.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> 0 500000000 91422569 250000000 0 414128 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">7.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>STOCK OPTIONS</b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During the year ended <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022,</em> the Company adopted a Rolling Stock Option Plan. Up to 10% of the Company’s issued and outstanding common shares <em style="font: inherit;"> may </em>be reserved for granting of stock options. All of the options granted vest 20% every <em style="font: inherit;">six</em> months.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">However, all options will be considered vested if <em style="font: inherit;">one</em> of the following criteria are met by the Company:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">i.</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Meeting sales forecasts:</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 72pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">-</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The greater of either the 20% vesting every <em style="font: inherit;">six</em> months or based on a pro rata percentage of revenue earned by the Company’s subsidiary.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">ii.</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the listing of the Company on any national securities exchange.</p> </td></tr> <tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">iii.</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">a Change of Control Event.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During the year ended <em style="font: inherit;"> December 31, 2023, </em>the Company did <span style="-sec-ix-hidden:c108851719">not</span> grant any stock options and recorded $84,034 (<em style="font: inherit;">2022:</em> $396,520) of share-based compensation for vested portion of options that were previously granted.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The changes in options are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table cellpadding="0" cellspacing="0" class="finTable" style="width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 18pt; margin-right: auto;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 55%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Number of </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>options</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Weighted </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>average exercise price</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>(CAD)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Aggregate </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Intrinsic Value</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 55%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 12%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 12%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 12%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options outstanding, December 31, 2021</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>5,315,000</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>0.49</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>3,910,950</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">100,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">0.80</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options outstanding, December 31, 2022</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>5,415,000</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>0.50</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>-</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Expired</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(3,850,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">0.36</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options outstanding, December 31, 2023</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b> </b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>1,565,000</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>0.85</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>-</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for the options that were in-the-money at <em style="font: inherit;"> December 31, 2023.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Details of options outstanding as at <em style="font: inherit;"> December 31, 2023 </em>are as follows: </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 9pt; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Exercise price </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(CAD)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Number of </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>options</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>outstanding</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 29%; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Expiry date</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Number of options</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>exercisable</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Remaining </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>contractual life (years)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1.200</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">500,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 29%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><span style="-sec-ix-hidden:c108851747">January 29, 2024*</span></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">500,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.08</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.800</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">375,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 29%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><span style="-sec-ix-hidden:c108851752">June 10, 2024</span></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">375,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.44</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.600</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">590,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 29%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><span style="-sec-ix-hidden:c108851756">October 14, 2024</span></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">472,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.79</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.800</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">100,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 29%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><span style="-sec-ix-hidden:c108851760">January 31, 2025</span></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">60,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1.09</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,565,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 29%;"><em style="font: inherit;"> </em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,407,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> </tbody></table> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">* expires subsequent to <em style="font: inherit;"> December 31, 2023</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The following weighted average assumptions were used for the Black-Scholes valuation of stock options granted:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table cellpadding="0" cellspacing="0" class="finTable" style="margin-right: auto; margin-left: 18pt; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 62%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>December 31, 2023</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>December 31, 2022</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Risk-free interest rate</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1.24</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercise price (CAD)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.80</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected life of options (in years)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3.00</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected annualized volatility</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">119.10</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Fair value of options granted (CAD)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.55</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 62%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected dividend rate</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> 0.10 0.20 0.20 84034 396520 <table cellpadding="0" cellspacing="0" class="finTable" style="width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 18pt; margin-right: auto;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 55%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Number of </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>options</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Weighted </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>average exercise price</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>(CAD)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Aggregate </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Intrinsic Value</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 55%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 12%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 12%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 12%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options outstanding, December 31, 2021</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>5,315,000</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>0.49</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>3,910,950</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">100,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">0.80</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options outstanding, December 31, 2022</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>5,415,000</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>0.50</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>-</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Expired</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(3,850,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">0.36</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options outstanding, December 31, 2023</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b> </b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>1,565,000</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>0.85</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>-</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 5315000 0.49 3910950 100000 0.8 0 5415000 0.5 0 3850000 0.36 0 1565000 0.85 0 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 9pt; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Exercise price </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(CAD)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Number of </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>options</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>outstanding</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 29%; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Expiry date</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Number of options</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>exercisable</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Remaining </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>contractual life (years)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1.200</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">500,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 29%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><span style="-sec-ix-hidden:c108851747">January 29, 2024*</span></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">500,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.08</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.800</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">375,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 29%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><span style="-sec-ix-hidden:c108851752">June 10, 2024</span></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">375,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.44</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.600</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">590,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 29%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><span style="-sec-ix-hidden:c108851756">October 14, 2024</span></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">472,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.79</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.800</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">100,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 29%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><span style="-sec-ix-hidden:c108851760">January 31, 2025</span></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">60,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1.09</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,565,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 29%;"><em style="font: inherit;"> </em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,407,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> </tbody></table> 500000 500000 P0Y29D 375000 375000 P0Y5M8D 590000 472000 P0Y9M14D 100000 60000 P1Y1M2D 1565000 1407000 <table cellpadding="0" cellspacing="0" class="finTable" style="margin-right: auto; margin-left: 18pt; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 62%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>December 31, 2023</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>December 31, 2022</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Risk-free interest rate</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1.24</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercise price (CAD)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.80</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected life of options (in years)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3.00</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected annualized volatility</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">119.10</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Fair value of options granted (CAD)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.55</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 62%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected dividend rate</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> </tbody></table> 0.0124 0.8 P3Y 1.191 0.55 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">8.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>WARRANTS</b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The changes in warrants are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 18pt; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Number of </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>warrants</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Weighted </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>average exercise </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>price</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>(CAD)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Aggregate </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Intrinsic Value</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Warrants outstanding, December 31, 2021 and 2022</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">17,400,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>0.28</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><em style="font: inherit;">-</em></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Expired</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(4,900,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(1.00</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Warrants outstanding, December 31, 2023</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b> </b></td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>12,500,000</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>0.001</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b><em style="font: inherit;">-</em></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Details of warrants outstanding as at <em style="font: inherit;"> December 31, 2023 </em>are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 18pt; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Exercise price</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 6%; border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Number of </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>warrants</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>outstanding</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23%; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Expiry date</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Number of </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>warrants</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>exercisable</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Remaining </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>contractual life </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>(years)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.001</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 6%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><sup style="vertical-align:top;line-height:120%;">(1)</sup> (USA)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><span style="-sec-ix-hidden:c108851795">12,500,000</span></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><em style="font: inherit;">June 4, 2025</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1.43</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 6%;"><em style="font: inherit;"> </em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">12,500,000</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23%;"><em style="font: inherit;"> </em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 27pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(<em style="font: inherit;">1</em>)</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><em style="font: inherit;">No</em> share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being <em style="font: inherit;">1</em>) targeted revenue sales projections met, or <em style="font: inherit;">2</em>) listing on a major US exchange, or <em style="font: inherit;">3</em>) change of control.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 18pt; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Number of </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>warrants</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Weighted </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>average exercise </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>price</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>(CAD)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Aggregate </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Intrinsic Value</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Warrants outstanding, December 31, 2021 and 2022</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">17,400,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>0.28</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><em style="font: inherit;">-</em></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Expired</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(4,900,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(1.00</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Warrants outstanding, December 31, 2023</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b> </b></td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>12,500,000</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>0.001</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td><td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b><em style="font: inherit;">-</em></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 18pt; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Exercise price</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 6%; border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Number of </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>warrants</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>outstanding</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23%; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Expiry date</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Number of </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>warrants</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>exercisable</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Remaining </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>contractual life </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>(years)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.001</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 6%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><sup style="vertical-align:top;line-height:120%;">(1)</sup> (USA)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><span style="-sec-ix-hidden:c108851795">12,500,000</span></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><em style="font: inherit;">June 4, 2025</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1.43</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 6%;"><em style="font: inherit;"> </em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">12,500,000</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23%;"><em style="font: inherit;"> </em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> </tbody></table> 17400000 0.28 4900000 -1 12500000 0.001 P1Y5M4D <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">9.</em> </b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>SELLING, GENERAL AND ADMINISTRATIVE</b>  </p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The breakdown of selling, general and administrative for the years ended <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022</em> is as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"> <tbody> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2023</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2022</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Filing and regulatory fees</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">32,862</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">40,158</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Marketing</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">76,459</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Professional fees</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">78,089</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">104,801</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Rent</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">43,269</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">38,922</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Office and administration</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">120,278</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">139,127</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">274,498</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">399,467</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"> <tbody> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2023</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2022</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Filing and regulatory fees</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">32,862</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">40,158</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Marketing</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">76,459</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Professional fees</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">78,089</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">104,801</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Rent</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">43,269</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">38,922</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Office and administration</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">120,278</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">139,127</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">274,498</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">399,467</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody> </table> 32862 40158 0 76459 78089 104801 43269 38922 120278 139127 274498 399467 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">10.</em> </b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>RESEARCH AND DEVELOPMENT</b>  </p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The breakdown of research and development for the years ended <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022</em> is as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"> <tbody> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2023</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2022</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Project management</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">11,990</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Software development</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">61,446</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">820,996</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Business development</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,952</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">133,588</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Payroll</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">30,486</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">171,309</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">95,884</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,137,883</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"> <tbody> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2023</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2022</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Project management</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">11,990</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Software development</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">61,446</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">820,996</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Business development</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,952</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">133,588</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Payroll</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">30,486</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">171,309</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">95,884</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,137,883</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody> </table> 0 11990 61446 820996 3952 133588 30486 171309 95884 1137883 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">11.</em> </b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>FINANCIAL INSTRUMENTS AND RISKS</b>  </p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Financial instruments measured at fair value are classified into <em style="font: inherit;">one</em> of <em style="font: inherit;">three</em> levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The <em style="font: inherit;">three</em> levels of the fair value hierarchy are described below.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Level <em style="font: inherit;">1</em> - quoted prices (unadjusted) in active markets for identical assets or liabilities;</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Level <em style="font: inherit;">2</em> – inputs other than quoted prices included in Level <em style="font: inherit;">1</em> that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Level <em style="font: inherit;">3</em> - inputs for the asset or liability that are <em style="font: inherit;">not</em> based on observable market data (unobservable inputs).</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Fair value of financial instruments</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company has various financial instruments including cash, receivables, accounts payable and accrued liabilities and accounts payable and accrued liabilities - related parties. The carrying values of cash and cash equivalents, receivables, accounts payable and accrued liabilities, and accounts payable and accrued liabilities - related parties approximate their fair values due to the short-term nature of these financial instruments.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Cash is carried at a level <em style="font: inherit;">1</em> fair value measurement.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company’s risk exposures and the impact on the Company’s financial instruments are summarized below:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>Credit risk </i></b></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company is exposed to credit risk only with respect to uncertainties as to timing and amount of collectability of receivables. The Company believes its credit risk is low because a portion of receivables are comprised of goods and services tax (GST) and other government refunds, which is recoverable from the governing body in Canada. Management does <em style="font: inherit;">not</em> believe the receivables are impaired. The Company doesn’t believe there is significant credit risk associated with cash as these amounts are held with major Canadian banks.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><i>Liquidity risk </i></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Liquidity risk is the risk that the Company will <em style="font: inherit;">not</em> be able to meet its financial obligations as they fall due. The Company’s approach to managing liquidity risk is to ensure that it will have sufficient liquidity to meet liabilities when due. As at <em style="font: inherit;"> December 31, 2023, </em>the Company had a cash balance of $156,574 (<em style="font: inherit;">2022</em> – $687,602) to settle current liabilities of $273,723 (<em style="font: inherit;">2022</em> – $302,423). All of the Company’s financial liabilities have contractual maturities of <em style="font: inherit;">30</em> days or due on demand and are subject to normal trade terms.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><i>Interest rate risk </i></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Interest rate risk is the risk that the future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The risk that the Company will realize such a loss is limited as it does <em style="font: inherit;">not</em> have any significant interest-bearing financial instruments.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><i>Foreign currency risk </i></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">As at <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022,</em> the Company is exposed to foreign currency risk as certain monetary financial instruments are denominated in Canadian currency. The Company’s sensitivity analysis suggests that reasonably expected changes in the rates of exchange in United States would change foreign exchange gain or loss by an insignificant amount.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> 156574 687602 273723 302423 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">12.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>INCOME TAXES</b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">A reconciliation of income taxes at statutory rates with the reported taxes is as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>December 31, </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>2023</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>December 31, </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>2022</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Loss before taxes for the year</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(591,212</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(1,649,589</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected income tax (recovery)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(165,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(461,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Effect of change in tax rates</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">37,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Permanent differences</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">23,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(5,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Adjustment to prior years provision</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(7,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(5,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in unrecognized deductible temporary</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">135,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">434,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Total income taxes</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Current income tax</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred tax recovery</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The significant components of the Company’s deferred tax assets that have <em style="font: inherit;">not</em> been included on the consolidated statement of financial position are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>December 31, </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>2023</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>December 31, </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>2022</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Research and development</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">213,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-capital losses</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">6,936,120</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">5,445,227</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">7,149,120</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">5,445,227</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Unrecognized deferred tax assets</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(7,149,120</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(5,445,227</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net deferred tax assets</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The significant components of the Company’s temporary differences, unused tax credits and unused tax losses that have <em style="font: inherit;">not</em> been included on the consolidated statement of financial position are as follows: </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 44%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Expiry Date</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Range</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2022</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Expiry Date</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Range</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Temporary Differences</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Research and development</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">760,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"> </p> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 11%;"><em style="font: inherit;">No expiry date</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-capital losses available for future periods</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">24,787,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"> </p> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 11%;"><em style="font: inherit;">2023 to indefinite</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">25,155,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"> </p> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 11%;"><em style="font: inherit;">2023 to indefinite</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Canada</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">18,610,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><em style="font: inherit;">2023</em> to <em style="font: inherit;">2037</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">18,334,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><em style="font: inherit;">2023</em> to <em style="font: inherit;">2037</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>USA</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">5,350,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"> </p> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); width: 11%;"><em style="font: inherit;">No expiry date</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">6,821,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"> </p> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); width: 11%;"><em style="font: inherit;">No expiry date</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; width: 1%;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>December 31, </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>2023</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>December 31, </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>2022</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Loss before taxes for the year</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(591,212</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(1,649,589</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected income tax (recovery)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(165,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(461,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Effect of change in tax rates</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">37,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Permanent differences</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">23,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(5,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Adjustment to prior years provision</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(7,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(5,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in unrecognized deductible temporary</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">135,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">434,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Total income taxes</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Current income tax</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred tax recovery</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> -591212 -1649589 -165000 -461000 0 37000 23000 -5000 -7000 -5000 135000 434000 0 0 0 0 0 0 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>December 31, </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>2023</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>December 31, </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>2022</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Research and development</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">213,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-capital losses</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">6,936,120</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">5,445,227</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">7,149,120</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">5,445,227</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Unrecognized deferred tax assets</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(7,149,120</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(5,445,227</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net deferred tax assets</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> </tbody></table> 213000 0 6936120 5445227 7149120 5445227 7149120 5445227 0 0 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 44%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Expiry Date</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Range</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2022</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Expiry Date</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Range</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Temporary Differences</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Research and development</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">760,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"> </p> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 11%;"><em style="font: inherit;">No expiry date</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-capital losses available for future periods</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">24,787,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"> </p> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 11%;"><em style="font: inherit;">2023 to indefinite</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">25,155,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"> </p> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 11%;"><em style="font: inherit;">2023 to indefinite</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Canada</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">18,610,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><em style="font: inherit;">2023</em> to <em style="font: inherit;">2037</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">18,334,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><em style="font: inherit;">2023</em> to <em style="font: inherit;">2037</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>USA</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">5,350,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"> </p> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); width: 11%;"><em style="font: inherit;">No expiry date</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">6,821,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"> </p> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); width: 11%;"><em style="font: inherit;">No expiry date</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; width: 1%;"> </td></tr> </tbody></table> 760000 0 24787000 25155000 18610000 18334000 5350000 6821000 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">13.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>RELATED PARTIES</b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Related parties include the Board of Directors, officers, close family members and enterprises that are controlled by these individuals as well as certain persons performing similar functions.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company defines its key management as the Board of Directors, Chief Executive Officer, President, and Chief Financial Officer. Remuneration of directors and key management personnel of the Company was as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Years ended </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>December 31,</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2022</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Consulting</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>148,500</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">135,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Selling general and administrative</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>94,356</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">80,331</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Share-based compensation to directors and officers</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b> </b></td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>1,442</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">47,062</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>$</b></td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>244,298</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">262,393</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company for the years ended <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022</em> reimbursed a related party $94,356 and $80,331, respectively, for selling, general and administrative expenses paid on behalf of the Company. The Company incurred $148,500 (<em style="font: inherit;">2022</em> - $135,000) of consulting fees accrued to a company controlled by a director of the Company for the years ended <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company also recorded share-based compensation of $1,442 (<em style="font: inherit;">2022</em> - $47,062) for options vested to related parties during the years ended <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Years ended </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>December 31,</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2022</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Consulting</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>148,500</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">135,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Selling general and administrative</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>94,356</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">80,331</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Share-based compensation to directors and officers</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b> </b></td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>1,442</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">47,062</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>$</b></td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>244,298</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">262,393</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> </tbody></table> 148500 135000 94356 80331 1442 47062 244298 262393 94356 80331 148500 135000 1442 47062 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">14.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>OPERATING LEASES</b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company has <em style="font: inherit;">one</em> operating lease with unrelated <em style="font: inherit;">third</em> parties for office space at Vancouver, Canada.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The lease at the Vancouver, Canada location is on a month-to-month basis with monthly rental payments of $4,645 (CAD). For the years ended <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022</em> rent expense was $41,241 and $36,894, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> 4645 41241 36894 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><a href="#" id="footnoteend" title="footnote_end"></a><em style="font: inherit;">15.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>SEGMENTED INFORMATION</b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company currently operates in a single reportable operating segment. All of the Company’s assets and expenditures are located in the United States. Since the Company does <em style="font: inherit;">not</em> have any revenue producing activities, there is <em style="font: inherit;">no</em> segment information by revenues.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <div>   </div> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><a href="#" id="item9b" title="item9b"></a>Item <em style="font: inherit;">9B.</em></b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Other Information </b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><span style="-sec-ix-hidden:c108851973"><span style="-sec-ix-hidden:c108851974"><span style="-sec-ix-hidden:c108851975"><span style="-sec-ix-hidden:c108851976">Not</span></span></span></span> applicable</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> expires subsequent to December 31, 2023 No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) revenue sales projections per ComplyTrust Inc.’s 5-year proformas, or 2) listing on a major US exchange, or 3) change of control.